Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Open accessAbstract
Background and Purpose—: This scientific statement provides an overview of the evidence on vascular contributions to cognitive impairment and dementia. Vascular contributions to cognitive impairment and dementia of later life are common. Definitions of vascular cognitive impairment (VCI), neuropathology, basic science and pathophysiological aspects, role of neuroimaging and vascular and other associated risk factors, and potential opportunities for prevention and treatment are reviewed. This statement serves as an overall guide for practitioners to gain a better understanding of VCI and dementia, prevention, and treatment. Methods—: Writing group members were nominated by the writing group co-chairs on the basis of their previous work in relevant topic areas and were approved by the American Heart Association Stroke Council Scientific Statement Oversight Committee, the Council on Epidemiology and Prevention, and the Manuscript Oversight Committee. The writing group used systematic literature reviews (primarily covering publications from 1990 to May 1, 2010), previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and, when appropriate, formulate recommendations using standard American Heart Association criteria. All members of the writing group had the opportunity to comment on the recommendations and approved the final version of this document. After peer review by the American Heart Association, as well as review by the Stroke Council leadership, Council on Epidemiology and Prevention Council, and Scientific Statements Oversight Committee, the statement was approved by the American Heart Association Science Advisory and Coordinating Committee. Results—: The construct of VCI has been introduced to capture the entire spectrum of cognitive disorders associated with all forms of cerebral vascular brain injury—not solely stroke—ranging from mild cognitive impairment through fully developed dementia. Dysfunction of the neurovascular unit and mechanisms regulating cerebral blood flow are likely to be important components of the pathophysiological processes underlying VCI. Cerebral amyloid angiopathy is emerging as an important marker of risk for Alzheimer disease, microinfarction, microhemorrhage and macrohemorrhage of the brain, and VCI. The neuropathology of cognitive impairment in later life is often a mixture of Alzheimer disease and microvascular brain damage, which may overlap and synergize to heighten the risk of cognitive impairment. In this regard, magnetic resonance imaging and other neuroimaging techniques play an important role in the definition and detection of VCI and provide evidence that subcortical forms of VCI with white matter hyperintensities and small deep infarcts are common. In many cases, risk markers for VCI are the same as traditional risk factors for stroke. These risks may include but are not limited to atrial fibrillation, hypertension, diabetes mellitus, and hypercholesterolemia. Furthermore, these same vascular risk factors may be risk markers for Alzheimer disease. Carotid intimal-medial thickness and arterial stiffness are emerging as markers of arterial aging and may serve as risk markers for VCI. Currently, no specific treatments for VCI have been approved by the US Food and Drug Administration. However, detection and control of the traditional risk factors for stroke and cardiovascular disease may be effective in the prevention of VCI, even in older people. Conclusions—: Vascular contributions to cognitive impairment and dementia are important. Understanding of VCI has evolved substantially in recent years, based on preclinical, neuropathologic, neuroimaging, physiological, and epidemiological studies. Transdisciplinary, translational, and transactional approaches are recommended to further our understanding of this entity and to better characterize its neuropsychological profile. There is a need for prospective, quantitative, clinical-pathological-neuroimaging studies to improve knowledge of the pathological basis of neuroimaging change and the complex interplay between vascular and Alzheimer disease pathologies in the evolution of clinical VCI and Alzheimer disease. Long-term vascular risk marker interventional studies beginning as early as midlife may be required to prevent or postpone the onset of VCI and Alzheimer disease. Studies of intensive reduction of vascular risk factors in high-risk groups are another important avenue of research.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
136 of 627 cited sources checked · 45 supported · 6 flagged · accuracy not yet measured
- Premisecitation
High waist-hip ratio strengthened the association with hypertension and dementia in the highest quartile of waist-hip ratio.
“High waist-hip ratio strengthened the association with hypertension and dementia in the highest quartile of waist-hip ratio.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [322] source
The Results (page unavailable) report no significant association between late-life waist–hip ratio and dementia. The Discussion (page unavailable) likewise states that the authors found no association for waist–hip ratio in old age; it does not report a strengthened hypertension–dementia association in the highest waist–hip-ratio quartile. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
A 6-month study in elderly women supports a potent nonpharmacological intervention improving executive control in older women at high risk of cognitive decline.
“A study of 6 months’ duration in elderly women provides support, using rigorous controlled methodology, for a potent nonpharmacological intervention that improves executive control processes for older women at high risk of cognitive decline.473”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [473] source
The Discussion reports a five-year trial of daily low-dose aspirin, a pharmacological intervention, in men and women over 50—not a six-month nonpharmacological study in elderly women. It found no significant cognitive benefit, including on measures of executive function. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
White matter lesions also occur in older subjects and patients with Alzheimer disease in epidemiological studies.
“However, WMLs also occur in older subjects and patients with Alzheimer disease in epidemiological studies.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [34] source
- Premisecitation
Several studies have shown that patients with mild cognitive impairment can return to normal cognition.
“Several studies have shown that patients with MCI can return to normal cognition.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [44] source
- cites [45] source
The Materials and Methods (p. 2) say this paper reports cognitive performance at a baseline visit, not whether patients later returned to normal cognition. The Discussion (p. 5) says cognitive dysfunction may persist after depression is treated, but does not address recovery from mild cognitive impairment. Searches for return to normal cognition and cognitive recovery found no supporting passage. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [46] source
- Premisecitation
Infarcts occur commonly in older people with and without dementia.
“occur commonly in older people with and without dementia”
Quote in the paperNot a substantial claim1 of 6 sources checked
- Premisecitation
Infarcts typically are accompanied by Alzheimer disease and other pathologies.
“typically are accompanied by Alzheimer disease and other pathologies.”
Quote in the paperNot a substantial claim1 of 8 sources checked- cites [12] source
- cites [13] source
- cites [16] source
- cites [17] source
- cites [54] source
The Introduction (page unavailable) says dementia, including probable AD, is often associated with mixed pathology involving AD, cerebral infarcts, and/or Lewy bodies. The Results and Discussion (pages unavailable) also report infarcts alongside mixed pathologies in community participants with probable AD. These passages support co-occurrence, but they do not establish the broader claim that infarcts are typically accompanied by AD and other pathologies. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [55] source
- cites [56] source
- cites [57] source
- Premisecitation
White matter degeneration and microbleeds are associated with both vascular cognitive impairment and clinical Alzheimer disease.
“neuroimaging studies have shown that white matter degeneration, as measured by both fluid-attenuated inversion recovery and diffusion tensor imaging, and microbleeds are associated with both VCI and clinical Alzheimer disease,70,72,76,77,81”
Quote in the paperNot a substantial claim1 of 5 sources checked- cites [70] source
- cites [72] source
- cites [76] source
The Introduction (page unavailable) calls brain microbleeds a biomarker of cerebrovascular disease, and the Discussion reports that participants with microbleeds were more likely to progress to dementia. The paper does not establish the claimed association of white matter degeneration with both vascular cognitive impairment and clinical Alzheimer disease. Its MR imaging Methods list FLAIR but not diffusion tensor imaging, and its cognitive-testing Methods say participants developing a disorder other than Alzheimer disease were removed. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [77] source
- cites [81] source
- Premisecitation
Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
Quote in the paperSubstantial claim1 of 8 sources checked - Premisecitation
In one study, pure infarct and mixed Alzheimer disease and infarct pathology occurred as often as pure Alzheimer disease pathology in both amnestic and nonamnestic mild cognitive impairment.
“In 1 study the frequency of pure infarct and mixed Alzheimer disease and infarct pathology was comparable to the frequency of pure Alzheimer disease pathology in both amnestic and nonamnestic MCI.61”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [61] source
- Premisecitation
Recent pathological studies show no relationship between white matter lesions measured by MRI and Alzheimer disease neuropathology.
“although recent pathological studies show no relationship between WMLs as measured by MRI and Alzheimer disease neuropathology,82”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [82] source
- Premisecitation
Hippocampal volume visualized on antemortem neuroimaging may be related to either Alzheimer disease or vascular pathology.
“Hippocampal volume visualized on antemortem neuroimaging may also be related to either Alzheimer disease or vascular pathology,82”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] source
- Premisecitation
Cerebral microbleeds appear to be a common vascular abnormality.
“Cerebral microbleeds, visualized by new imaging techniques, also appear to be a common vascular abnormality.74–77”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [74] source
- cites [75] source
- cites [76] source
The Results (§3.4; page not provided) found microbleeds in 9 of 26 participants who progressed to dementia, but none of 33 normal participants. The Discussion (§4; page not provided) says many microbleeds may escape imaging detection. Together, these passages support their occurrence in the studied dementia group, but not the broader claim that cerebral microbleeds are a common vascular abnormality generally. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [77] source
- Premisecitation
In mild cognitive impairment, Alzheimer disease is the most frequently found pathology.
“Alzheimer disease has been found to be the most common pathology,61,65,66,69”
Quote in the paperSubstantial claim1 of 4 sources checked - Premisecitation
The neurovascular unit is profoundly disrupted in vascular cognitive impairment and Alzheimer disease.
“The neurovascular unit is profoundly disrupted in VCI and Alzheimer disease.95,100–103”
Quote in the paperSubstantial claim2 of 5 sources checked- cites [95] source
The Introduction’s “Vascular Factors” passage describes disruption of the neurovascular unit in Alzheimer disease, and “Alzheimer’s Disease” describes associated neurovascular dysfunction. The “Vascular versus Neuronal Origin of Brain Disorders” passage includes vascular dementia among conditions involving vascular effects on neuronal function, but does not establish that the neurovascular unit is profoundly disrupted across vascular cognitive impairment. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [100] source
- cites [101] source
- cites [102] source
The Alzheimer Disease section describes substantial structural and functional cerebrovascular abnormalities in AD. The Conclusions and “How Does Cerebrovascular Dysfunction Lead to Cognitive Deficits?” sections also link vascular and blood–brain barrier changes to cognitive deficits. The paper does not specifically discuss vascular cognitive impairment (VCI) as a condition or state that the neurovascular unit is profoundly disrupted in VCI. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [103] source
- Premisecitation
Inflammation enhances oxidative stress by upregulating expression of reactive oxygen species-producing enzymes and downregulating antioxidant defenses.
“Inflammation, in turn, enhances oxidative stress by upregulating the expression of reactive oxygen species–producing enzymes and downregulating antioxidant defenses.126”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [126] source
The “Interactions between TLR4 and NADPH oxidase” section reports increased NADPH oxidase subunits after dendritic cells were stimulated with TLR-activating substances, supporting the ROS-producing-enzyme part in that setting. It does not report that inflammation downregulates antioxidant defenses, and its evidence does not establish the full mechanism as a general effect of inflammation. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Experimental studies suggest that radicals produced by nicotinamide adenine dinucleotide phosphate oxidase are responsible for cerebrovascular alterations induced by vascular cognitive impairment risk factors and amyloid beta.
“Experimental studies suggest that radicals produced by the enzyme nicotinamide adenine dinucleotide phosphate oxidase are responsible for the cerebrovascular alterations induced by VCI risk factors and Aβ.112,122–124”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [112] source
- cites [122] source
- cites [123] source
- cites [124] source
The Discussion reports that Nox2-derived radicals contribute to neurovascular dysfunction in APP-overexpressing mice, supporting the Aβ-related part of the claim. The paper does not establish the same mechanism for cerebrovascular alterations induced by VCI risk factors; its experiments concern Tg2576 mice. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Neural activity induces functional hyperemia, which is thought to deliver energy substrates and remove toxic byproducts of brain activity.
“neural activity induces a powerful increase in CBF (functional hyperemia) that is thought to deliver energy substrates and remove toxic byproducts of brain activity.88”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [88] source
The Introduction (page not supplied) says regional cerebral blood flow increases during brain activation. The Concluding remarks (page not supplied) link that increase to sufficient glucose supply. The paper does not say that functional hyperemia removes toxic byproducts of brain activity. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Transporters on the abluminal side of vessels remove metabolic byproducts from the brain, including amyloid beta.
“transporters on the abluminal side of the vessels remove metabolic byproducts from the brain, including amyloid beta (Aβ).95”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [95] source
The Introduction’s “BBB Clearance of Aβ” section says Aβ binds LRP1 at the abluminal side of the blood–brain barrier, initiating clearance from brain to blood. It does not establish that abluminal vessel transporters generally remove metabolic byproducts; its “Passive Transport by the Brain Fluids” section describes metabolic waste removal through the CSF and other routes. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
The relationship between carotid intima-media thickness and cognitive function has been analyzed cross-sectionally and longitudinally in few studies.
“The relationship between carotid IMT and cognitive function has been analyzed cross-sectionally185,186 and longitudinally187–189 in few studies.”
Quote in the paperNot a substantial claim1 of 5 sources checked - Premisecitation
Population-based clinical-pathological studies show that advanced cerebral amyloid angiopathy is associated with worse cognitive performance, independent of Alzheimer disease pathology severity.
“Population-based clinical-pathological studies have identified associations between advanced CAA and worse cognitive performance, and these associations remain independent after controlling for severity of Alzheimer disease pathology.55,140,141”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [55] source
- cites [140] source
The Results and Discussion report that moderate-to-very severe CAA was associated with lower perceptual speed and episodic memory after controlling for AD pathology. The study found no association with the composite cognitive measure, and the Discussion cautions that its Religious Orders cohort may not be representative of the general population. Thus, the source supports an independent association in specific cognitive domains, but not an unqualified population-based finding of worse cognitive performance overall. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [141] source
- Premisecitation
In animal models, exogenously applied or genetically overexpressed amyloid beta production diminished vasodilation to pharmacological or physiological stimuli, even in the absence of vascular amyloid beta deposits.
“evidence for this possibility comes from animal models in which exogenously applied or genetically overexpressed Aβ production diminished vasodilation to pharmacological or physiological stimuli, even in the absence of vascular Aβ deposits.115,160,161”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [115] source
- cites [160] source
The Introduction discusses Aβ accumulation and treatments in animal models, while the Results report reduced Aβ production after γ-secretase inhibition in human participants. Neither section addresses impaired vasodilation, exogenous or genetically overexpressed Aβ, or the absence of vascular Aβ deposits; searches for those terms found no supporting passage in our copy. Page numbers were not available. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [161] source
- Premisecitation
A recent study found an association between coincident hypertension and larger volumes of white matter lesions in patients with cerebral amyloid angiopathy.
“A recent study found an association between coincident hypertension and larger volumes of WMLs in patients with CAA,159”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [159] source
- Premisecitation
Carotid atherosclerosis and intima-media thickness have been associated with cardiovascular risk factors, including metabolic, inflammatory, and dietary factors, that have also been associated with cognitive decline.
“Carotid atherosclerosis and IMT have been associated with cardiovascular risk factors, including metabolic, inflammatory, and dietary factors, that have also been associated with cognitive decline.189–192”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [189] source
The Discussion (page not provided) links carotid atherosclerosis with metabolic, immunologic, and lifestyle factors associated with lower cognitive function; it does not specifically identify dietary factors. The paper also reports that greater carotid IMT predicts cognitive decline, but the cited Discussion passage links the risk-factor categories to lower cognitive function rather than decline. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [190]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [191]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [192] source
- Premisecitation
An inverse relationship between pulse wave velocity and cognitive performance was reported cross-sectionally.
“An inverse relationship between pulse wave velocity and cognitive performance was reported cross-sectionally.186,202,203”
Quote in the paperSubstantial claim1 of 3 sources checked - Premisecitation
Risk factors for silent cerebral infarction are generally the same as those for clinical stroke.
“Risk factors for silent cerebral infarction are generally the same as those for clinical stroke.237,238”
Quote in the paperNot a substantial claim1 of 2 sources checked - Premisecitation
Progression of WMLs is a better predictor of persistent cognitive impairment than baseline WML burden.
“Recent evidence also suggests that progression of WMLs is a better predictor of persistent cognitive impairment than baseline WML burden,248 although there is a strong association between baseline WML volume and increase in WML volume.249”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [248] source
- Premisecitation
Gray matter volumes are associated with both vascular and Alzheimer disease processes.
“Gray matter volumes, however, were associated with both vascular and Alzheimer disease processes, and hippocampal volumes were associated with both hippocampal sclerosis and Alzheimer disease.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [82] source
- Premisecitation
Cross-sectional studies of CVBI in convenience samples often find increased SBI and WMLs in subjects with dementia, consistent with community-based pathological studies.
“Cross-sectional studies of CVBI in convenience samples often find increased evidence of both SBI and WMLs in subjects with dementia,254,255 consistent with recent community-based pathological studies.12”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [254] source
The Results and Discussion (page numbers unavailable) report greater white matter hyperintensity burden with cognitive impairment in this cross-sectional, partly clinic-recruited sample. The paper does not report increased silent brain infarcts (SBI) in subjects with dementia; its Discussion says individuals with cortical infarction were excluded. The community-based pathological studies are attached to a different citation in the citing sentence. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [255] source
- cites [12] source
- Premisecitation
Incident cognitive impairment occurs in association with CVBI.
“Incident cognitive impairment also occurs in association with CVBI.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [240] source
The Results section, under “Association of WMHV, EXT-WMHV and BI with incident dementia and MCI,” reports that all three MRI markers were associated with incident dementia. It also says none was associated with incident MCI overall; associations with amnestic MCI appeared only in specified age or sex subgroups. The unqualified claim about incident cognitive impairment is therefore broader than the findings. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [244] source
- cites [245] source
- Premisecitation
Amyloid imaging techniques have shown an association with Alzheimer disease pathology.
“Recent amyloid imaging techniques have proved an association with Alzheimer disease pathology235 and may prove useful for evaluating the independent and combined effects of vascular and Alzheimer disease brain injury on cognitive changes during normal aging in the future.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [235] source
- Premisecitation
Low educational level has been reported to be associated with an increased risk for VaD.
“Low educational level has been reported to be associated with an increased risk for VaD.280”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [280] source
The Methods and Results sections examine genetic variants associated with incident stroke, not vascular dementia (VaD). Searches for low educational level, education, and dementia found no passage in our copy addressing the claimed association; page numbers were not available. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Premisecitation
Several prospective and interventional studies show no benefit of consuming antioxidants to preserve cognitive function or reduce decline.
“However, several prospective285 and interventional286,287 studies show no benefit of consuming antioxidants to preserve cognitive function or reduce decline.”
Quote in the paperNot a substantial claim1 of 3 sources checked - Premisecitation
Questionnaire data rely on the recall of subjects who may be cognitively impaired.
“Questionnaire data rely on the recall of subjects who by definition of the research may be cognitively impaired.263”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [263] source
The Introduction describes cognitive impairment in dementia, but does not discuss questionnaires or subjects’ ability to recall information. Searches for questionnaire recall and recall bias found no passage addressing that methodological concern; page numbers were not available in our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measured
- Premisecitation
In the Framingham Offspring Study, higher waist-hip ratio was associated with lower cognitive function measured 12 years later.
“In the Framingham Offspring Study, higher waist-hip ratio was associated with lower cognitive function, which was measured 12 years later.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [322] source
The Methods describe the Cardiovascular Health Study, not the Framingham Offspring Study. The Results address late-life waist-to-hip ratio and dementia, but do not report cognitive function measured 12 years later in Framingham. Searches for “Framingham Offspring Study” and “12 years cognitive function waist hip ratio” found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Physical activity has been identified as having potential protective benefits in brain health and plasticity and in VCI and related conditions.
“Physical activity has been identified as having potential protective benefits in brain health and plasticity and in VCI and related conditions.308–314”
Quote in the paperNot a substantial claim1 of 3 sources checked - Premisecitation
There is some evidence that a Mediterranean diet can reduce cognitive decline.
“There is some evidence that a Mediterranean diet can reduce cognitive decline.301”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [301] source
The Introduction and Discussion (page unavailable) address homocysteine lowering and B-vitamin supplementation, not a Mediterranean diet. Searches for “Mediterranean diet cognitive decline” and “Mediterranean dietary pattern cognitive function” found no passage in our copy addressing whether that diet reduces cognitive decline. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
Longer diabetes duration is associated with poorer cognitive function.
“Studies suggest that the longer the duration of diabetes, the poorer the cognitive function.347,348,352”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [347] source
The Introduction (page unavailable) says diabetes mellitus has been related to cognitive decline and dementia risk. But neither that passage nor the study’s findings in the Comment (page unavailable) address whether longer diabetes duration is associated with poorer cognitive function; searches for diabetes duration found no such result. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [348] source
- cites [352] source
- Premisecitation
At 1- or 6-year follow-up, cognitive decline in CABG patients was no different from controls with equivalent coronary artery disease burden who received medical treatment or PCI.
“However, at 1- or 6-year follow-up, the cognitive decline in these patients was no different from that observed in controls with an equivalent burden of coronary artery disease who opted for medical treatment or percutaneous coronary intervention.364,365”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [364] source
- cites [365] source
The Analytical sample and Results sections examine coronary artery calcium and cognitive performance in the AGES-Reykjavik cohort. Although the Potential confounders section mentions prior bypass surgery or angioplasty as part of coronary heart disease history, our copy does not report 1- or 6-year cognitive decline after CABG compared with medical treatment or PCI. Searches for those follow-up comparisons found no supporting passage; page numbers were not available. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Plasma levels of α1-antichymotrypsin and C-reactive protein are increased before VaD onset over an 8-year follow-up.
“Plasma levels of inflammatory proteins, specifically α1-antichymotrypsin and C-reactive protein, were found to be increased before the onset of VaD over an 8-year follow-up period359”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [359] source
The Results sections on incident VaD and prospective analysis report associations with plasma lipids, not α1-antichymotrypsin or C-reactive protein. Searches for both inflammatory proteins found no passage addressing whether their levels increased before VaD onset; the prospective analysis reports a mean observation period of 4.8 years, not the claimed eight-year finding. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Coronary artery disease is an independent risk factor for VaD.
“Coronary artery disease has also been identified as an independent risk factor for VaD.34”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [34] source
The Results (table E-2; page not supplied) report an association between prior coronary artery disease and VaD after adjustment for age, race, and sex. They do not establish that coronary artery disease is an independent risk factor after adjustment for other vascular factors; the multivariable analysis in table 3 reports angina rather than coronary artery disease as a predictor of VaD. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
In a medical-records study, high midlife cholesterol increased the risk for VaD over 30 years.
“In a study based on medical records, high midlife cholesterol level increased the risk for VaD that developed over a 30-year period.355”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [355] source
The Methods and Results examine hypoglycemic episodes and subsequent dementia in patients with type 2 diabetes; the Abstract lists hyperlipidemia only as an adjustment variable. A search for midlife cholesterol and vascular dementia found no passage reporting the claimed association over 30 years. The References list related dementia studies, but do not establish this finding in the cited paper. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
In people with recurrent stroke, dementia risk rises to about 30%, regardless of number and severity of prior vascular risk factors.
“In people with recurrent stroke, the risk of dementia rose to ≈30%, regardless of the number and severity of vascular risk factors they had been exposed to before the stroke.269”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [269] source
The Discussion (page unavailable) reports no association between dementia and a history of stroke in this cohort of adults aged 90 or older. Our copy does not assess recurrent stroke, report a 30% dementia risk for that group, or compare risk by the number and severity of prior vascular risk factors; searches for those terms found no decisive passage. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Interpretationcitation
Low cardiac output may be a key factor in onset and progression of cognitive impairment, especially in older people with systolic heart failure.
“Low cardiac output may represent a key factor in the onset and progression of cognitive impairment, especially in older people with systolic heart failure.380,383”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [380] source
- cites [383] source
The Abstract reports that older patients with stable cardiovascular disease and low cardiac output performed worse on two executive-function tests. The Discussion suggests that chronic hypoperfusion may increase dementia risk, but says a longitudinal study is needed to determine that outcome. The study does not establish onset or progression of cognitive impairment, or a finding specific to older people with systolic heart failure. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Study design and conductcitation
Published trials had heterogeneity in dementia screening and diagnosis.
“(2) heterogeneity in screening and diagnosis of dementia441;”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [441] source
In Results > Cognitive Dysfunction, Table 2 lists different dementia diagnostic criteria across the included studies, supporting variation in diagnosis. It does not document differences in dementia screening, and it identifies the studies as population-based prospective studies rather than trials. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
In four of six large randomized antihypertensive trials, treatment had no clear effect on dementia risk.
“Four of these trials reported that treatment had no clear-cut effect on the risk of dementia440,441,443,444 or cognitive function.441,443,444”
Quote in the paperNot a substantial claim3 of 4 sources checked- cites [440] source
The Discussion (Strengths and limitations; page unavailable) describes this paper’s observational cohorts, not a comparison of six randomized antihypertensive trials. The References list individual studies, but no passage found states that four of six trials had no clear effect on dementia risk (searched for the trial count and for randomized-trial results). (LLM, conf=0.73)
Experimental — accuracy not yet measured - cites [441] source
The Results > Cognitive Dysfunction section analyzes diabetes and dementia in prospective studies, not randomized antihypertensive trials. It mentions one study finding no effect of diabetes treatment on incident dementia, but does not address whether four of six antihypertensive trials found no clear effect. Searches for randomized antihypertensive trials and blood-pressure-lowering treatment found no relevant passage. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [443] source
- cites [444] source
- Premisecitation
In SHEP, active treatment with a diuretic and/or beta-blocker and placebo groups had similar dementia rates (1.6% vs 1.9%).
“In the Systolic Hypertension in the Elderly Program (SHEP),440 a similar rate of dementia was found in the group receiving active treatment with a diuretic and/or β-blocker (1.6%) and the group receiving placebo (1.9%).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [440] source
The Results section reports dementia outcomes for angiotensin receptor blockers, lisinopril, and a cardiovascular comparator, not for SHEP treatment and placebo groups. Searches for SHEP, the trial’s full name, and the 1.6% and 1.9% rates found no passage in our copy addressing the claimed comparison; page numbers were not available. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Study design and conductcitation
Published antihypertensive dementia trials commonly had short follow-up.
“All published trials share common limitations: (1) short follow-up duration442,444;”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [442] source
- cites [444] source
The Discussion says PRoFESS’s average 2.5-year follow-up might have been too short to show an effect on cognitive function. It does not establish that all published antihypertensive dementia trials had short follow-up; it notes that trials with favourable results had longer follow-up. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
In three of those trials, treatment had no clear effect on cognitive function.
“Four of these trials reported that treatment had no clear-cut effect on the risk of dementia440,441,443,444 or cognitive function.441,443,444”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [441] source
The Results > Cognitive Dysfunction section describes prospective observational studies, not three treatment trials. It reports one study finding no treatment effect on incident dementia, while its discussion of cognitive decline mentions an association with insulin use in one of two studies. Searches for treatment effects on cognitive function found no passage supporting the claim about three trials; page numbers were not available in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [443] source
- cites [444] source
- Interpretationcitation
Syst-Eur provided the most compelling support for dementia prevention by BP lowering.
“The most compelling support for the prevention of dementia by blood pressure lowering was observed in the Systolic Hypertension Europe (Syst-Eur) trial.442,449”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [442] source
- cites [449] source
The Discussion reports findings on recurrent stroke after blood-pressure lowering, but does not discuss dementia prevention or the Syst-Eur trial. Searches for Syst-Eur and dementia in our copy found no passage addressing the claim. (LLM, conf=0.74)
Experimental — accuracy not yet measured
- Premisecitation
In Syst-Eur, dementia occurred in 21 placebo and 11 active patients, a 50% (95% CI 0-76) reduction in dementia incidence with active treatment.
“Dementia was diagnosed in 21 patients from the placebo group and 11 patients from the active treatment group, corresponding to a 50% (95% confidence interval 0% to 76%) decrease in the incidence of dementia in subjects receiving active treatment.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [442] source
- cites [449] source
The Methods (Study Protocol; page unavailable) describe a telmisartan-versus-placebo trial in patients with recent ischemic stroke, while the Results (Other Outcomes; page unavailable) report outcomes other than dementia. Searches for the stated dementia counts and for Syst-Eur with the 50% reduction found no passage in our copy addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
In patients with mild to moderate cognitive decline and different dementias, folic acid had no benefit on cognition or mood.
“In patients with mild to moderate cognitive decline and different forms of dementia, there was no benefit from folic acid on measures of cognition or mood.476”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [476] source
The Design, Setting, and Patients section describes a cohort of elders without dementia studied for diet, physical activity, and Alzheimer disease risk. The Comment discusses those associations, but neither it nor the passages found by searching for folic acid and folate supplementation reports folic acid’s effects on cognition or mood in patients with cognitive decline or dementia. (LLM, conf=0.77)
Experimental — accuracy not yet measured
- Premisecitation
In PRoFESS, after median 2.4 years, no difference was observed between two antiplatelet regimens on cognition, severe cognitive decline, or dementia.
“After a median follow-up of 2.4 years, no difference was observed between the 2 antiplatelet regimens on any measure of cognition (median MMSE score ≤24) or severe cognitive decline (decrease in MMSE score ≥3 points between baseline and penultimate visit) or dementia.441”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [441] source
The Results section on Cognitive Dysfunction discusses diabetes, cognitive decline, and dementia, but does not report a comparison of antiplatelet regimens. Searches for PRoFESS, 2.4 years, and the specified MMSE decline found no passage addressing the claimed trial result; page numbers were unavailable in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
None of the meta-analyses examined all five trials combined.
“None examined all 5 trials combined, even among those most recently published.444,455”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [444] source
The Methods (Statistical analysis) describe comparisons within the PRoFESS trial, not a review of meta-analyses. The Discussion likewise does not address whether any meta-analysis combined all five trials. Searches for 'meta-analyses examined all five trials combined' and 'meta-analysis five trials combined' found no passage supporting the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [455] source
- Premisecitation
Few trials of antiplatelet therapy have included cognitive evaluation.
“Few trials on antiplatelet therapy have included a cognitive evaluation.441,469”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [441] source
The Results > Cognitive Dysfunction section describes prospective studies of diabetes and cognitive performance, not trials of antiplatelet therapy. A table mentions aspirin use as a covariate in one study, but neither that passage nor searches for antiplatelet trials and cognitive evaluation address how many such trials included cognitive testing. Page numbers were not available in our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measured - cites [469] source
- Premisecitation
In a Netherlands study, 800 μg daily oral folic acid for 3 years in 818 participants significantly improved cognitive domains that decline with age.
“However, in another study from The Netherlands, supplementation with 800 μg daily of oral folic acid for 3 years in 818 participants significantly improved domains of cognitive function that tend to decline with age.477”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [477] source
The Abstract (Participants) describes 33 adults with mild cognitive impairment, and the Abstract (Design) describes a six-month trial; the Methods (Procedure) identifies aerobic exercise and stretching groups. Our copy does not report the claimed Netherlands folic-acid study or its cognitive results (searched: 800 μg, 818 participants, folic acid, Netherlands). (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
Greater adherence to a Mediterranean-type diet is associated with less cognitive decline in older community subjects.
“Recently, a better adherence to a Mediterranean-type dietary pattern was associated with less cognitive decline in a community with older subjects.471”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [471] source
The Cognitive cohort and Discussion sections examine aspirin treatment and cognitive decline, not Mediterranean-type diet adherence. Searches for Mediterranean dietary patterns and diet-related cognitive decline found no passage in our copy addressing the claimed association; page numbers were not available. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
A systematic review found no beneficial effect of folic acid 750 μg/d on cognition or mood in healthy older women.
“According to 1 systematic review, there was no beneficial effect of folic acid 750 μg/d on measures of cognition or mood in healthy older women.476”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [476] source
The Design, Setting, and Patients section describes a prospective cohort study of Mediterranean-type diet, physical activity, and Alzheimer disease risk, not a systematic review of folic acid. Searches for folic acid at 750 μg/d and for supplementation effects on cognition or mood found no passage addressing the claimed result. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Observational research links greater physical activity to better cognitive function.
“The same beneficial effects of increased physical activity on cognitive function have also been documented in observational studies,472 but only 1 small intervention trial has followed up subjects for cognitive improvement after increasing physical exercise.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [472] source
The Results and Discussion report associations between NSAID or aspirin use and cognitive performance, not between physical activity and cognitive function. Searches for physical activity and exercise found no passage in our copy addressing the claimed observational link; page numbers were not available. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Vascular oxidative stress and inflammation are key pathogenic factors in neurovascular dysfunction.
“Vascular oxidative stress and inflammation are key pathogenic factors in neurovascular dysfunction.”
- Also stated in: § 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation · plain
“Vascular oxidative stress and inflammation are key pathogenic factors in neurovascular dysfunction.101,119–121”
Quote in the paperSubstantial claim - Also stated in: § 4.3. Mechanisms of Neurovascular Dysfunction: Role of Oxidative Stress and Inflammation · plain
- Interpretationnone given
Diabetes and hyperglycemia are associated with VCI.
“Diabetes and hyperglycemia are associated with VCI.”
Quote in the paperNot a substantial claim - Premisecitation
The presence of white matter lesions or leukoaraiosis is critical for the diagnosis of CADASIL, a genetic form of vascular dementia in relatively young people.
“the presence of white matter lesions (WMLs) or leukoaraiosis (rarefaction of the white matter thought to be secondary to small-vessel occlusive disease) is critical for the diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL),33 a genetic form of VaD in relatively young people.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] source
- Premisecitation
There are patients who have not had a clinical stroke, and severe cerebrovascular disease is evident only in neuroradiological studies.
“In addition, there are patients who have not had a clinical stroke, and severe cerebrovascular disease is evident only in neuroradiological studies.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Detection and control of traditional risk factors for stroke and cardiovascular disease may be effective in preventing vascular cognitive impairment, even in older people.
“However, detection and control of the traditional risk factors for stroke and cardiovascular disease may be effective in the prevention of VCI, even in older people.”
Quote in the paperSubstantial claim - Interpretationnone given
Cognitive impairment caused by vascular disease, including subclinical brain injury, silent brain infarction, and clinically overt stroke, is important as an independent cause and contributor to cognitive dysfunction.
“cognitive impairment caused by vascular disease, including subclinical brain injury, silent brain infarction (SBI), and clinically overt stroke are important as independent causes and contributors to cognitive dysfunction.”
Quote in the paperNot a substantial claim - Premisenone given
There is pathological and clinical evidence for cholinergic compromise in both Alzheimer disease and vascular cognitive impairment.
“Finally, there is pathological and clinical evidence for cholinergic compromise in both Alzheimer disease and VCI”
Quote in the paperNot a substantial claim - Premisecitation
Population MRI studies have revealed a high prevalence of covert small-vessel disease in the elderly population (23% for silent lacunes and 95% for incidental hyperintensities) associated with increased risk for stroke and dementia.
“population magnetic resonance imaging (MRI) studies have revealed the high prevalence of covert small-vessel disease in the elderly population (23% for silent lacunes14 and 95% for incidental hyperintensities15) associated with increased risk for stroke and dementia.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Multiple sets of criteria exist for the constructs of vascular cognitive impairment and vascular dementia.
“In addition to the threshold issue, multiple sets of criteria exist for the constructs of VCI and VaD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] source
- Premisenone given
In many cases, risk markers for vascular cognitive impairment are the same as traditional risk factors for stroke.
“In many cases, risk markers for VCI are the same as traditional risk factors for stroke.”
Quote in the paperNot a substantial claim - Premisecitation
Cerebrovascular disease can also cause mild cognitive deficits that can affect multiple cognitive functions.
“Cerebrovascular disease can also cause mild cognitive deficits that can affect multiple cognitive functions”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia.
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
White matter lesions with or without infarcts are associated with cognitive deficits and neuropsychiatric disorders in patients with autoimmune disorders such as systemic lupus erythematosus and Sjögren disease.
“For example, WMLs with or without infarcts are associated with cognitive deficits and neuropsychiatric disorders in patients with autoimmune disorders (eg, systemic lupus erythematosus, Sjögren disease).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisereasoning
Subcortical forms of vascular cognitive impairment with white matter hyperintensities and small deep infarcts are common.
“subcortical forms of VCI with white matter hyperintensities and small deep infarcts are common.”
Quote in the paperNot a substantial claim - Premisecitation
In 1 study, the inclusion of other measures of vascular pathology such as microscopic infarcts, small-vessel disease, and white matter changes increased the frequency of cerebrovascular disease in older people to >75%.
“In 1 study,55 the inclusion of other measures of vascular pathology such as microscopic infarcts, small-vessel disease, and white matter changes increased the frequency of cerebrovascular disease in older people to >75%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] source
- Premisecitation
Some studies suggest that multiple microscopic infarcts are related to dementia, even after accounting for macroscopic infarcts.
“some studies suggest that multiple microscopic infarcts are related to dementia, even after accounting for macroscopic infarcts.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
The heterogeneity of cerebrovascular disease works against a single, unifying neurocognitive pattern of deficits in vascular cognitive impairment.
“In addition, the heterogeneity of cerebrovascular disease (eg, strokes that differ in location, size, and number) works against a single, unifying neurocognitive pattern of deficits in VCI.”
Quote in the paperNot a substantial claim - Premisecitation
Regions such as the thalamus, angular gyrus, and basal ganglia may be more likely than other regions to result in cognitive impairment.
“Regions such as the thalamus, angular gyrus, and basal ganglia may be more likely than other regions to result in cognitive impairment.”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
In some community-based studies, microscopic infarcts are more common than macroscopic infarcts.
“In some community-based studies, microscopic infarcts are more common than macroscopic infarcts.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Studies have generally shown an inconsistent relation between volume and number of infarcts and cognitive impairment.
“Studies have generally shown an inconsistent relation between volume and number of infarcts and cognitive impairment.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
There may be a reversibility component in vascular mild cognitive impairment.
“This means that there may be a “reversibility” component in VaMCI.”
Quote in the paperSubstantial claim - Interpretationreasoning
Multiple microscopic infarcts may denote a more generalized phenomenon such as diffuse hypoxia, inflammation, oxidative stress, or disruption in the blood-brain barrier.
“Multiple microscopic infarcts may denote a more generalized phenomenon such as diffuse hypoxia, inflammation, oxidative stress, or disruption in the blood-brain barrier (BBB).”
Quote in the paperNot a substantial claim - Interpretationnone given
The most important cerebrovascular pathology that contributes to cognitive impairment is cerebral infarcts.
“The most important cerebrovascular pathology that contributes to cognitive impairment is cerebral infarcts.”
Quote in the paperNot a substantial claim - Interpretationreasoning
White matter degeneration and microbleeds on MRI, often considered specific for vascular disease, may signify degenerative pathology.
“Thus, white matter degeneration and microbleeds on MRI often considered specific for vascular disease may signify degenerative pathology”
Quote in the paperSubstantial claim - Premisecitation
The hippocampus can atrophy as part of both degenerative and vascular processes.
“pathological studies show that the hippocampus can atrophy as part of both degenerative or vascular processes.83”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] source
- Interpretationcitation
White matter degeneration and microbleeds most likely reflect direct tissue damage.
“White matter degeneration and microbleeds most likely reflect direct tissue damage,71,78–80”
Quote in the paperNot a substantial claim0 of 4 sources checked - Premisecitation
Microbleeds are related to cerebral amyloid angiopathy.
“white matter degeneration is related to Alzheimer disease pathology78 and microbleeds to CAA.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] source
- Premisecitation
Disturbances of episodic memory, considered the hallmark of Alzheimer disease, are associated with infarcts even after accounting for Alzheimer disease pathology.
“Moreover, disturbances of episodic memory, considered the hallmark of Alzheimer disease, are associated with infarcts even after accounting for Alzheimer disease pathology.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In some studies, neuropathological measurements of white matter lesions were not clearly associated with cognitive function except as part of a combined vascular score that also included infarcts.
“In some studies, neuropathological measurements of WMLs have not been clearly associated with cognitive function unless as part of a combined vascular score that also includes infarcts.52”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] source
- Premisecitation
The neurovascular unit components are structurally, functionally, and developmentally interrelated and work together to maintain homeostasis of the cerebral microenvironment.
“Neurons, glia, and perivascular and vascular cells, collectively termed the neurovascular unit, are structurally, functionally, and developmentally interrelated and work in concert to maintain the homeostasis of the cerebral microenvironment.85”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
White matter degeneration is related to Alzheimer disease pathology.
“white matter degeneration is related to Alzheimer disease pathology78”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] source
- Interpretationreasoning
There is a complex interplay between vascular and Alzheimer disease pathologies in the evolution of vascular cognitive impairment, dementia, and clinical Alzheimer disease.
“they highlight the complex interplay between vascular and Alzheimer disease pathologies in the evolution of VCI, dementia, and clinical Alzheimer disease.”
Quote in the paperSubstantial claim - Interpretationreasoning
If the neuropathological substrate of amnestic mild cognitive impairment is assumed to be pure Alzheimer disease rather than vascular or mixed pathology, the role of vascular pathology may be underestimated.
“Thus, assuming the underlying neuropathological substrate of amnestic MCI is pure Alzheimer disease pathology rather than vascular or mixed pathology, the role of vascular pathology may be underestimated.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The underlying neuropathological substrate of amnestic mild cognitive impairment is pure Alzheimer disease pathology rather than vascular or mixed pathology.
- Interpretationreasoning
Some vascular pathologies may represent either vascular or degenerative processes.
“Second, some vascular pathologies may represent either vascular or degenerative processes.”
Quote in the paperNot a substantial claim - Premisecitation
White matter degeneration and microbleeds are related to lipohyalinosis.
“pathological studies demonstrate white matter degeneration and microbleeds are related to lipohyalinosis.58,70,79,80”
Quote in the paperNot a substantial claim0 of 4 sources checked - Interpretationcitation
Hippocampal volume loss, often considered a specific biomarker for early Alzheimer disease, may reflect vascular pathology.
“whereas hippocampal volume loss, often considered a specific biomarker for early Alzheimer disease,84 may reflect vascular pathology.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [84] source
- Premisecitation
Cerebrovascular autoregulation keeps cerebral blood flow relatively constant within a range of blood pressures, protecting the brain from unwanted swings in perfusion pressure.
“Cerebrovascular autoregulation keeps CBF relatively constant within a range of blood pressures, protecting the brain from unwanted swings in perfusion pressure.89”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] source
- Premisecitation
Specialized endothelial receptors transduce mechanical and chemical stimuli and release signaling molecules such as nitric oxide, endothelin, and prostanoids.
“Specialized receptors on endothelial cells transduce mechanical (shear stress) and chemical stimuli and release potent signaling molecules such as nitric oxide, endothelin, and prostanoids.90”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [90] source
- Premisecitation
In vulnerable periventricular white matter, reactive astrocytosis and microglial activation are associated with expression of hypoxia-inducible genes, suggesting local hypoxia.
“In the vulnerable periventricular white matter, reactive astrocytosis and microglial activation are associated with expression of hypoxia-inducible genes, suggesting local hypoxia.71,108”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Cerebrovascular control mechanisms ensure that the brain's blood supply is well matched to its energy requirements.
“sophisticated cerebrovascular control mechanisms ensure that the brain's blood supply is well matched to its energy requirements.87”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [87] source
- Interpretationnone given
Alterations in neurovascular function are involved in the pathogenesis of vascular cognitive impairment.
“Alterations in neurovascular function are involved in the pathogenesis of VCI.”
Quote in the paperSubstantial claim - Premisecitation
Loss of growth factors such as brain-derived neurotrophic factor may contribute to brain atrophy associated with Alzheimer disease and vascular cognitive impairment.
“loss of growth factors, such as the brain-derived neurotrophic factor,96 may contribute to the brain atrophy associated with Alzheimer disease and VCI.134,135”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Tight junctions between cerebral endothelial cells and specialized membrane transporters regulate molecular trafficking between blood and brain, forming the basis of the blood-brain barrier.
“The tight junctions between cerebral endothelial cells, coupled with highly specialized membrane transporters, regulate the trafficking of molecules between blood and brain, which is at the basis of the BBB.94”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] source
- Interpretationcitation
A similar process may contribute to white matter lesions observed in Alzheimer disease and vascular cognitive impairment, which play a prominent role in the expression of dementia.
“A similar process may contribute to the WMLs observed in Alzheimer disease and VCI, which play a prominent role in the expression of dementia.110”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] source
- Premisecitation
White matter blood-brain barrier alterations are early findings in vascular cognitive impairment.
“White matter BBB alterations are early findings in VCI.127”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [127] source
- Premisecitation
Vascular cognitive impairment and Alzheimer disease are associated with marked alterations in cerebral microvascular structure.
“VCI and Alzheimer disease are associated with marked alterations in cerebral microvascular structure.104,105”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.
“Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.165”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [165] source
- Interpretationnone given
It has been difficult to reproducibly induce white matter damage and behavioral dysfunction by lowering cerebral blood flow in a spatial-temporal pattern consistent with human disease.
“it has proved difficult to reproducibly induce white matter damage and behavioral dysfunction by lowering CBF in a spatial-temporal pattern consistent with the human disease.”
Quote in the paperSubstantial claim - Premisenone given
A large number of studies have reported strong relationships between indices of vascular aging and either cognitive impairment or silent cerebral small-vessel disease.
“Recently a large number of studies have reported strong relationships between indices of vascular aging and either cognitive impairment or silent cerebral small-vessel disease.”
Quote in the paperSubstantial claim - Premisecitation
Advanced cerebral amyloid angiopathy can trigger destructive vessel wall changes including loss of smooth muscle cells, microaneurysms, concentric splitting, fibrinoid necrosis, and perivascular leakage of red blood cells.
“Advanced CAA can trigger a series of destructive changes in the vessel wall, including loss of smooth muscle cells, development of microaneurysms, and concentric splitting and fibrinoid necrosis of the vessel wall and perivascular leakage of red blood cells.137–139”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Vascular aging is well exemplified by the strong relationship between age and changes in large-artery structure and function.
“Vascular aging is well exemplified by the strong relationship between age and changes in large-artery structure and function.181”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [181]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Several arterial parameters have been selected for clinical investigation based on feasibility and repeatability of measurement and predictive value for cardiovascular events.
“Several arterial parameters have been selected for clinical investigation, based on the feasibility and repeatability of their measurement and their predictive value of cardiovascular events.182”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [182] source
- Premisecitation
In the absence of direct neuropathological assessment, cerebral amyloid angiopathy is most commonly diagnosed by detection of hemorrhages confined to cortical or cortico-subcortical (lobar) brain regions.
“In the absence of direct neuropathological assessment, CAA is most commonly diagnosed by the detection of hemorrhages confined to cortical or cortico-subcortical (“lobar”) brain regions.”
Quote in the paperNot a substantial claim - Premisenone given
No treatments have been identified to successfully prevent or slow cognitive impairment caused by noninflammatory cerebral amyloid angiopathy.
“No treatments have been identified to successfully prevent or slow cognitive impairment caused by noninflammatory CAA.”
Quote in the paperNot a substantial claim - Premisenone given
CADASIL is the most commonly encountered hereditary cause of vascular cognitive impairment.
“The most commonly encountered hereditary cause of VCI is CADASIL.”
Quote in the paperNot a substantial claim - Premisecitation
For the subset of patients with cerebral amyloid angiopathy-related inflammation, treatment with a course of high-dose corticosteroids or cyclophosphamide has been reported to cause clinical and radiological improvement.
“For the subset of patients with CAA-related inflammation, treatment with a course of high-dose corticosteroids or cyclophosphamide has been reported to cause clinical and radiological improvement.152”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [152] source
- Interpretationnone given
Cerebral amyloid angiopathy appears to be a relatively common and important contributor to age-related small-vessel dysfunction and vascular cognitive impairment.
“CAA appears to be a relatively common and important contributor to age-related small-vessel dysfunction and VCI.”
Quote in the paperNot a substantial claim - Premisecitation
Cyclic vessel distention in normal aging is thought to cause fragmentation and depletion of elastin and increased collagen deposition, resulting in a nearly 3-fold increase in intima-media thickness between the ages of 20 and 90 years.
“cyclic vessel distention in normal aging (ie, beat-to-beat change in vessel diameter in response to the pulsatility of blood pressure) is thought to cause fragmentation and depletion of elastin and increased collagen deposition, resulting in a nearly 3-fold increase in intima-media thickness (IMT) between the ages of 20 and 90 years.145”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [145] source
- Premisenone given
Deposition of amyloid beta peptide in the walls of penetrating arterioles and capillaries of the leptomeninges and cortex is the hallmark of sporadic cerebral amyloid angiopathy, a common pathology in the elderly.
“Deposition of Aβ peptide in the walls of penetrating arterioles and capillaries of the leptomeninges and cortex is the hallmark of sporadic CAA, a common pathology in the elderly.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The independence of these relationships from age and classic cardiovascular risk factors suggests common pathophysiological mechanisms linking large-artery damage to cerebral small-vessel disease.
“That these relationships were independent of age and classic cardiovascular risk factors suggests common pathophysiological mechanisms linking large-artery damage to cerebral small-vessel disease.”
Quote in the paperSubstantial claim - Interpretationcitation
Soluble amyloid beta itself may trigger altered vascular reactivity and brain injury.
“soluble Aβ itself may also trigger altered vascular reactivity and brain injury.”
Quote in the paperSubstantial claim - Premisecitation
Most CADASIL patients also appear to demonstrate characteristic ultrastructural changes in skin and muscle vessels, in particular deposition of granular osmiophilic material in the arteriolar media.
“Most CADASIL patients also appear to demonstrate characteristic ultrastructural changes in skin and muscle vessels, in particular the deposition of granular osmiophilic material in the arteriolar media.168–170”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationnone given
Coexisting vascular risk factors such as hypertension, diabetes, and smoking may worsen the effects of cerebral amyloid angiopathy and CADASIL.
“Coexisting vascular risk factors such as hypertension, diabetes, and smoking may worsen the effects of CAA and CADASIL”
Quote in the paperNot a substantial claim - Interpretationnone given
Increasing evidence indicates that alterations in neurovascular function play a key role in both the pathobiology of vascular cognitive impairment and Alzheimer disease.
“There is increasing evidence that alterations in neurovascular function play a key role not only in the pathobiology of VCI but also in Alzheimer disease.”
Quote in the paperNot a substantial claim - Interpretationnone given
The neurovascular unit is a major target of deleterious effects of vascular risk factors promoting vascular cognitive impairment and Alzheimer disease, and of amyloid beta.
“The neurovascular unit is a major target of the deleterious effects of vascular risk factors promoting VCI and Alzheimer disease and of Aβ.”
Quote in the paperSubstantial claim - Interpretationcitation
Cerebral amyloid angiopathy is an important contributor to age-related cognitive impairment.
“there is growing evidence that it is an important contributor to age-related cognitive impairment as well.”
Quote in the paperSubstantial claim - Premisecitation
Identification of Notch3 mutations, which can also occur de novo in sporadic cases of CADASIL, has become the primary method of diagnosis.
“Identification of such mutations, which can also occur de novo in sporadic cases of CADASIL,166,167 has become the primary method of diagnosis.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The thicker the carotid artery, the lower the cognitive performance.
“Specifically, the thicker the artery, the lower the cognitive performance.”
Quote in the paperSubstantial claim - Premisecitation
Carotid-femoral pulse wave velocity, the gold standard for evaluating arterial stiffness, was higher in any group of cognitively impaired subjects with or without dementia.
“Carotid-femoral pulse wave velocity, the “gold standard” for evaluating arterial stiffness,182 was higher in any group of cognitively impaired subjects with or without dementia.201”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Brain damage may arise from small-vessel endothelial leakage.
“In addition, brain damage may arise from small-vessel endothelial leakage.225”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [225] source
- Interpretationcitation
Noninvasive investigation of large and small arteries could help determine the relative contribution of each arterial parameter to all types of dementia in the general population.
“In addition, such a noninvasive investigation could help in determining the relative weight of each arterial parameter in contribution to all types of dementia (from VaD to Alzheimer disease) in the general population.227”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [227] source
- Premisecitation
In an autopsy series, the presence of large-vessel cerebrovascular disease, or atherosclerosis, was strongly associated with an increased frequency of neuritic plaque.
“In an autopsy series, the presence of large-vessel cerebrovascular disease, or atherosclerosis, was strongly associated with an increased frequency of neuritic plaque.194”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [194] source
- Premisecitation
Not all vascular lesions, such as microinfarcts, can be detected by MRI.
“Not all lesions attributed to CVBI on MRI are in fact caused by vascular injury,234 and not all vascular lesions (eg, microinfarcts) can be detected by MRI.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [234] source
- Premisereasoning
Despite heterogeneity, a significant inverse relationship between carotid intima-media thickness and cognitive function was observed in all studies.
“Despite this heterogeneity, a significant inverse relationship between carotid IMT and cognitive function was observed in all studies.”
Quote in the paperSubstantial claim - Premisecitation
Left ventricular remodeling and hypertrophy are associated with greater frequency and severity of subclinical brain damage.
“Of note, left ventricular remodeling and hypertrophy have been associated with higher frequency and severity of subclinical brain damage.212”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [212] source
- Rests on an assumption: Stiffer large arteries are associated with increased left ventricular mass.
- Premisecitation
Aortic stiffness predicts cardiovascular events independently of carotid IMT.
“Aortic stiffness predicts cardiovascular events independent of carotid IMT.226”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [226] source
- Premisecitation
These relationships remained significant after controlling for age, sex, education, and blood pressure levels.
“These relationships remained significant after controlling for age, sex, education, and blood pressure levels.”
Quote in the paperSubstantial claim - Premisecitation
Putative mechanisms for accelerated small-vessel disease include thickening of capillary basement membranes and perivascular collagen deposition that occludes end arterioles.
“Putative mechanisms for this are increasing thickening of the basement membrane of capillaries and perivascular deposition of collagen leading to occlusion of end arterioles.224”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [224] source
- Premisecitation
Small-vessel disease is increasingly recognized as a systemic process.
“There is increasing recognition that small-vessel disease is a systemic process.222”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [222] source
- Premisecitation
Other studies reported a significant positive relationship between arterial stiffness and volume or localization of white matter lesions on neuroimaging.
“Other studies reported a significant positive relationship between arterial stiffness and volume or localization of WMLs, a known factor predisposing to dementia,206 on neuroimaging.207,208”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Several studies have described associations between craniocervical artery atherosclerosis and cognitive impairment.
“several studies have described associations between craniocervical artery atherosclerosis and cognitive impairment.”
Quote in the paperNot a substantial claim - Premisecitation
In participants over 90 years of age, intracranial atherosclerosis emerged as an important predictor of dementia in subjects with low Alzheimer disease pathology scores.
“in participants >90 years of age, intracranial atherosclerosis emerged as an important predictor of dementia in subjects with low Alzheimer disease pathology scores.193”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [193] source
- Interpretationreasoning
The precise causal association of carotid intima-media thickness with vascular cognitive impairment is uncertain.
“The precise causal association of carotid IMT with VCI is uncertain.”
Quote in the paperNot a substantial claim - Premisecitation
Not all lesions attributed to CVBI on MRI are actually caused by vascular injury.
“Not all lesions attributed to CVBI on MRI are in fact caused by vascular injury,234 and not all vascular lesions (eg, microinfarcts) can be detected by MRI.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [234] source
- Premisecitation
Large-/small-artery cross-talk has been described in hypertensive patients.
“A large-/small-artery cross-talk has already been described in hypertensive patients.210”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [210] source
- Premisecitation
The most simple, noninvasive, robust, and reproducible method to determine aortic stiffness is measurement of carotid-femoral pulse wave velocity using the foot-to-foot velocity method from various waveforms.
“The most simple, noninvasive, robust, and reproducible method with which to determine aortic stiffness is the measurement of carotid-femoral pulse wave velocity, using the foot-to-foot velocity method from various waveforms (pressure, Doppler, distention).182”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [182] source
- Interpretationreasoning
Small-vessel disease manifests as systemic arteriolar dysfunction.
“This manifests as systemic arteriolar dysfunction.”
Quote in the paperNot a substantial claim - Interpretationnone given
Nearly all types of vascular disease that may increase intima-media thickness may also affect cognitive function through a variety of mechanisms, directly or indirectly.
“Nearly all types of vascular disease that may increase IMT may also affect cognitive function through a variety of mechanisms, directly or indirectly.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The mechanistic pathways linking microvascular brain damage to carotid IMT, aortic stiffness, and small-artery remodeling are complementary.
“The mechanistic pathways linking microvascular brain damage to carotid IMT, aortic stiffness, and small-artery remodeling are complementary.”
Quote in the paperSubstantial claim - Premisecitation
Higher left ventricular mass in older adults is independently associated with about twice the likelihood of dementia, independent of blood pressure levels.
“Recently, higher left ventricular mass in older people has been independently associated with a 2-fold higher likelihood of having dementia, independent of blood pressure levels.213”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [213] source
- Premisecitation
Carotid-femoral pulse wave velocity was also associated prospectively with cognitive decline before dementia in studies using a cognitive screening test and more specifically tests of verbal learning, delayed recall, and nonverbal memory.
“Carotid femoral pulse wave velocity was also associated prospectively with cognitive decline before dementia in studies using a cognitive screening test204,205 and more specifically tests of verbal learning and delayed recall and nonverbal memory.205”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Noninvasive investigation of large and small arteries could demonstrate additional and independent predictive value for VCI and dementia.
“These data suggest that the noninvasive investigation of large and small arteries could demonstrate additional and independent predictive values for VCI and dementia.”
Quote in the paperSubstantial claim - Premisenone given
Studies of carotid intima-media thickness and cognition were heterogeneous in study population, definition of carotid intima-media thickness, and neuropsychological tests used.
“The studies were heterogeneous for the study population (small groups, sex composition, healthy subjects or affected by Alzheimer-type dementia), the definition of carotid IMT (mean of left and right common carotid artery, IMT at bifurcation, sum of IMT at multiple carotid sites), and the neuropsychological test adopted to evaluate cognition (single or repeated measures of the Mini Mental State”
Quote in the paperNot a substantial claim - Premisenone given
Among patients with a first stroke, poststroke dementia prevalence varies with the interval after stroke, dementia definition, infarct location and size, and other inclusion and exclusion criteria.
“Among patients who have experienced a first stroke, the prevalence of poststroke dementia (PSD) varies in relation to the interval after stroke, definition of dementia, location and size of the infarct, and other inclusion and exclusion criteria.”
Quote in the paperNot a substantial claim - Premisecitation
Approximately one third of people with poststroke dementia have significant medial temporal atrophy.
“Approximately 15% to 30% of people with PSD have a history of dementia before stroke,38,253 and approximately one third have significant medial temporal atrophy.38”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] source
- Premisecitation
Proposed mechanisms for vascular depression in patients with cerebrovascular diseases include autonomic dysfunction, platelet activation, hypothalamic-pituitary axis activation, endothelial dysfunction, inflammatory mechanisms, genetic factors, and hyperhomocysteinemia.
“Proposed mechanisms for vascular depression in patients with cerebrovascular diseases include but are not limited to autonomic dysfunction, platelet activation, hypothalamic-pituitary axis activation, endothelial dysfunction, inflammatory mechanisms, genetic factors, and hyperhomocysteinemia.258”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [258] source
- Premisecitation
Combined effects of CVBI and atrophy persist even among people clinically diagnosed with VaD according to NINDS-AIREN criteria.
“Interestingly, the combined effects of CVBI and atrophy persist even among people clinically diagnosed with VaD according to NINDS-AIREN criteria.257”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [257] source
- Premisecitation
A clear pattern of effect of CVBI on cognition in convenience samples is confounded by a general focus on Alzheimer disease and exclusion of people with coincident VCI.
“Unfortunately, a clear pattern of effect of CVBI on cognition in convenience samples is confounded by a general focus on Alzheimer disease and the exclusion of people with coincident VCI.232”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [232] source
- Premisecitation
There is a strong association between baseline WML volume and increase in WML volume.
“Recent evidence also suggests that progression of WMLs is a better predictor of persistent cognitive impairment than baseline WML burden,248 although there is a strong association between baseline WML volume and increase in WML volume.249”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [249] source
- Premisecitation
Depression in late life may be associated with vascular disease.
“Depression in late life may be associated with vascular disease.258,259”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [258] source
- cites [259]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Firm conclusions about imaging of CVBI are limited by the lack of accurate measures of concurrent Alzheimer disease pathology.
“It is evident that firm conclusions about imaging of CVBI relate to lack of accurate measures of concurrent Alzheimer disease pathology.”
Quote in the paperSubstantial claim - Premisecitation
Approximately 15% to 30% of people with poststroke dementia have a history of dementia before stroke.
“Approximately 15% to 30% of people with PSD have a history of dementia before stroke,38,253 and approximately one third have significant medial temporal atrophy.38”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In at least one study of people with subcortical vascular brain injury presenting with memory impairment, incident lacunar infarction was associated with subtle declines in executive function over time.
“In at least 1 study of people with subcortical vascular brain injury presenting with memory impairment, incident lacunar infarction was associated with subtle declines in executive function performance over time.256”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [256] source
- Premisecitation
In the Lille study, incidence of dementia 3 years after stroke was significantly greater in patients with versus without medial temporal atrophy (81% vs 58%).
“In the Lille study, the incidence of dementia 3 years after stroke was significantly greater in those patients with versus those without medial temporal atrophy (81% versus 58%).38”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] source
- Interpretationnone given
It is difficult to determine how much cognitive impairment after stroke is attributable to stroke versus concomitant Alzheimer disease.
“It is difficult to determine to what extent cognitive impairment may be attributable to stroke versus concomitant Alzheimer disease.”
Quote in the paperNot a substantial claim - Premisecitation
Pathological findings show an association between infarctions found at autopsy and episodic memory performance.
“These data are consistent with recent pathological findings of an association between infarctions found at autopsy and episodic memory performance.12,59”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Estimates of the proportion of patients with poststroke dementia with presumed Alzheimer disease vary widely between 19% and 61%.
“Estimates of the proportion of patients with PSD with presumed Alzheimer disease vary widely between 19% and 61%.40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] source
- Premisecitation
WMLs are associated with declining scores on the modified MMSE and the Digit Symbol Substitution Test.
“Similarly, WMLs have been associated with declining scores in the modified MMSE and the Digit Symbol Substitution Test,246,247 as well as with incident MCI, dementia, and death.240”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Long-term mortality is 2 to 6 times higher in patients with poststroke dementia after adjustment for demographic factors, cardiac disease, stroke severity, and stroke recurrence.
“Long-term mortality is 2 to 6 times higher in patients with PSD after adjustment for demographic factors, associated cardiac diseases, stroke severity, and stroke recurrence (for review, see Leys et al252).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [252] source
- Premisecitation
Several pathophysiological pathways leading to vascular and neurodegenerative processes are similar.
“Furthermore, several pathophysiological pathways leading to vascular and neurodegenerative processes are similar.262”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [262] source
- Premisecitation
Cross-sectional and longitudinal studies consistently show that increasing plasma homocysteine levels are associated with poorer performance in global and multiple cognitive domains.
“Cross-sectional and longitudinal studies consistently show that increasing levels of plasma homocysteine are associated with poorer performance in global as well as multiple cognitive domains.297–299”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
VCI is likely to be more common as age increases.
“As with most neurocognitive disorders of late life, VCI is likely to be more common as age increases.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Reverse causation is a particular concern in studies that measure cognitive function in late life shortly after or simultaneously with a risk factor.
“This is a particular concern in studies that measure cognitive function in late life, shortly after or simultaneously with the measure of a risk factor.”
Quote in the paperSubstantial claim - Premisecitation
Neuropathological studies show that a high proportion of older people have mixed pathology, with Alzheimer disease lesions and vascular lesions being the most prevalent.
“Also, neuropathic studies show a high proportion of older people have mixed pathology, with Alzheimer disease lesions and vascular lesions being the most prevalent.18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] source
- Interpretationcitation
The utility of MRI or computed tomography for diagnosing VCI is not yet clearly defined.
“However, the utility of MRI or computed tomography for the diagnosis of VCI is not yet clearly defined.259a”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 259a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
When SBI and WMLs are found in combination, they likely indicate significant underlying CVBI.
“Thus, SBI and WMLs at least offer a readily available surrogate marker for the early detection and prevention of VCI and when found in combination are likely to indicate significant underlying CVBI.”
Quote in the paperSubstantial claim - Interpretationreasoning
SBI and WMLs offer a readily available surrogate marker for early detection and prevention of VCI.
“Thus, SBI and WMLs at least offer a readily available surrogate marker for the early detection and prevention of VCI and when found in combination are likely to indicate significant underlying CVBI.”
Quote in the paperSubstantial claim - Premisecitation
Cognitive tests have an education component that may reflect years or quality of schooling, socioeconomic status, chronic disease or less healthy lifestyle patterns, acculturation, racial socialization, or cognitive reserve.
“However, cognitive tests have an education component, which may reflect years or quality of schooling, socioeconomic status, chronic disease or less healthy lifestyle patterns, acculturation, racial socialization, or cognitive reserve.281”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [281] source
- Interpretationcitation
There is no apparent association of apolipoprotein E ε4 and VCI.
“There is no apparent association of apolipoprotein E ε4 and VCI.”
Quote in the paperNot a substantial claim - Premisecitation
A 3-year observational study of cognitive decline in elderly men reported high fish intake to be inversely associated with cognitive impairment.
“A 3-year observational study of cognitive decline in elderly men reported high fish intake to be inversely associated with cognitive impairment.289”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [289]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Recent data from prospective population-based samples with relatively low likelihood of Alzheimer disease show that progressive SBI and WMLs correlate with worsening cognitive impairment, especially executive function.
“Recent data from prospective population-based samples (where the likelihood of Alzheimer disease is relatively low) clearly show that progressive SBI and WMLs are correlated with worsening of cognitive impairment, especially executive function.”
Quote in the paperSubstantial claim - Premisecitation
Homocysteine is a risk factor for vascular damage.
“Homocysteine is a risk factor for vascular damage.296”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [296] source
- Premisecitation
In a randomized trial of women with cardiovascular disease or risk factors, a 6-year B vitamin supplement intervention to lower plasma homocysteine had no benefit on cognitive function.
“In a randomized trial of women with cardiovascular disease or risk factors for cardiovascular disease,285,300 there was no benefit to cognitive function from a 6-year intervention that used a supplement with B vitamins to lower plasma homocysteine levels.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
An important factor limiting study of genetic factors of VCI is the lack of a clear phenotype determination, because superimposed Alzheimer disease processes cannot be ruled out.
“An important factor limiting the study of genetic factors of VCI is the lack of a clear determination of the phenotype, because superimposed Alzheimer disease processes cannot be ruled out.”
Quote in the paperSubstantial claim - Premisecitation
The brains of older people have multiple morbidities that can lead to the same phenotype.
“The brains of older people have multiple morbidities that can lead to the same phenotype.18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] source
- Premisecitation
Folic acid and vitamins B12 and B6 are key components of the pathways leading to the production and metabolism of homocysteine.
“Folic acid and vitamins B12 and B6 are key components of the pathways leading to the production and metabolism of homocysteine.296”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [296] source
- Premisecitation
Some but not all studies of middle-aged and older subjects with 5 to 6 years of follow-up suggest increasing levels of n-3 polyunsaturated fatty acids are associated with better cognitive function and less cognitive decline.
“Some,290–292 but not all,293 studies of middle-aged and older subjects with 5 to 6 years of follow-up suggest increasing levels of n-3 polyun-saturated fatty acids are associated with better cognitive function and less cognitive decline.”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Reverse causation must be considered because a risk factor level may be a response to rather than a cause of the outcome.
“Reverse causation must be considered because it is possible that the risk factor level is a response to rather than a “cause” of the outcome.260”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [260] source
- Premisecitation
Body mass index has a U-shaped relationship with total dementia and VaD, with higher frequency at the lower and upper ends relative to normal body mass index.
“Body mass index has a U-shaped relationship with total dementia and VaD, so that subjects at the lower and upper ends of body mass index distribution had a higher frequency of dementia relative to subjects with a normal body mass index.319”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [319] source
- Interpretationreasoning
The association between social support and cognition has not been tested in randomized controlled trials.
“However, these observations have not been tested in randomized controlled trials”
Quote in the paperNot a substantial claim - Interpretationcitation
Differences in study results on obesity and cognition may reflect different weight trajectories in midlife and late life relative to the age when cognition is measured or dementia occurs.
“The differences in study results may reflect the different weight trajectories in midlife and late life relative to the age when cognition is measured or dementia occurs.321”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [321] source
- Premisecitation
The elevated cognitive-decline risk in smokers may be confined to particular cognitive domains.
“although risk may be specific for certain cognitive domains,325”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [325] source
- Premisecitation
Multiple mechanisms related to diabetes-related glucose and insulin dysregulation can lead to vascular and neuronal damage.
“Multiple mechanisms related to diabetes-related glucose and insulin dysregulation can lead to vascular and neuronal damage.344”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [344] source
- Interpretationreasoning
Data on social support and cognition can only be extrapolated to patients with VCI.
“and data can only be extrapolated to patients with VCI.”
Quote in the paperNot a substantial claim - Interpretationcitation
Depression can be considered a comorbidity, prodromal factor, or consequence of VCI rather than a factor that specifically alters vascular physiology or neuronal health to cause cognitive impairment.
“It can be considered a comorbidity, prodromal factor, or a consequence of VCI rather than a factor that specifically alters vascular physiology or neuronal health, leading to cognitive impairment.47”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] source
- Interpretationcitation
The controversy about later-life hypertension and cognitive decline arises because the longitudinal relationship is sensitive to age, follow-up duration, number of blood pressure measurements, treatment status, comorbidity with cardiovascular disease and stroke, and possibly subclinical dementia.
“The controversy about the association between later life hypertension and cognitive decline arises because the longitudinal relationship between cognitive change and blood pressure is sensitive to the effects of age, duration of follow-up and number of blood pressure measurements, hypertensive treatment status, comorbidity with cardiovascular diseases and stroke, and possibly subclinical dementia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [343] source
- Premisecitation
The Chicago Health and Aging Project, a cohort with low physical activity, found no association between cognitive decline and physical activity in the 2 weeks before examination.
“The Chicago Health and Aging Project (CHAP), which was based on a cohort with low physical activity, found no association between cognitive decline and physical activity carried out in the 2 weeks before the study examination.303”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [303] source
- Premisecitation
In the Three City Study, controlling for current depressive symptoms attenuated the significant association between 4-year cognitive decline and history of major depression.
“However, when investigators in the Three City Study controlled for current depressive symptoms, there was attenuation of a significant association between 4-year cognitive decline and history of major depression.”
Quote in the paperNot a substantial claim - Premisecitation
Several longitudinal studies, including those measuring exposure in middle age, have found some cognitive benefit of more alcohol use compared with infrequent or no use.
“Despite this, several longitudinal studies, including those with measures of exposure in middle age, have found some benefit in relation to cognition of more use of alcohol compared with infrequent use or no (“never”) use of alcohol.315–317”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationnone given
For many lifestyle factors, there is evidence for plausible biological mechanisms by which they may increase VCI risk.
“and for many there is evidence for plausible biological mechanisms by which these factors may heighten risk of VCI.”
Quote in the paperNot a substantial claim - Premisecitation
High blood pressure causes stroke.
“High blood pressure has long been known to cause stroke.336”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [336] source
- Premisecitation
A recent meta-analysis shows that high waist-hip ratio is associated with greater risk of dementia in all studies.
“A recent meta-analysis shows that high waist-hip ratio is associated with greater risk of dementia in all studies.319”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [319] source
- Interpretationnone given
Lifestyle factors may be risk factors for VCI.
“Lifestyle factors may be risk factors for VCI”
Quote in the paperSubstantial claim - Interpretationreasoning
Diet-cognition associations are difficult to interpret.
“Diet-cognition associations are difficult to interpret for the reasons described.”
Quote in the paperNot a substantial claim - Premisecitation
Prospective studies indicate that smokers have a higher risk of cognitive decline than nonsmokers.
“Several prospective studies show an increased risk for cognitive decline in smokers compared with nonsmokers,323,324”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Midlife hypertension is an important modifiable risk factor for late-life cognitive decline, mild cognitive impairment, and VaD.
“Midlife hypertension ranks as an important modifiable risk factor for late-life cognitive decline,337 mild cognitive impairment,338,339 and VaD.340,341”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Social networks and patient and family support are associated with cognitive functioning in elderly populations in longitudinal and cross-sectional epidemiological studies.
“Social networks and patient and family support have been associated with cognitive functioning in elderly populations in longitudinal and cross-sectional epidemiological studies.327–330”
Quote in the paperNot a substantial claim0 of 4 sources checked - Premisecitation
In the Cardiovascular Health Study, vascular factors did not mediate the association of depressive symptoms with incident MCI.
“Investigators in the Cardiovascular Health Study (CHS) could not confirm that vascular factors mediated an association of depressive symptoms with incident MCI.335”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [335] source
- Premisecitation
Obesity or body fat is an emerging risk marker of interest because of its metabolic consequences and recent reports of associations with total dementia.
“Obesity, or body fat, is an emerging risk marker of interest because of its metabolic consequences and recent reports of associations with total dementia.318”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [318] source
- Premisecitation
Atrial fibrillation, especially without adequate anticoagulation, is a risk factor for stroke.
“Atrial fibrillation, especially if not treated with adequate anticoagulation, is a risk factor for stroke.370”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [370] source
- Premisecitation
Hyperglycemia is associated with functional changes in cerebral blood flow that are reversible when good glycemic control is restored.
“Of note, hyperglycemia is associated with functional changes in cerebral blood flow that are reversible when good glycemic control is restored.351”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [351] source
- Premisecitation
Greater carotid-femoral pulse wave velocity is associated with lower cognitive function in the Maine-Syracuse Study.
“A greater carotid-femoral pulse wave velocity was associated with lower cognitive function in the Maine-Syracuse Study.379”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [379] source
- Interpretationnone given
The association between chronic kidney disease and cognitive impairment could be confounded by shared vascular risk factors for small-vessel brain disease.
“The association between chronic kidney disease and cognitive impairment could be confounded by shared vascular risk factors for small-vessel brain disease.”
Quote in the paperNot a substantial claim - Premisecitation
Among people with severe and moderate chronic kidney disease (eGFR <30 and <60), there is a graded increase in prevalence of cognitive impairment affecting multiple domains.
“Data from multiple studies of different populations suggest that among all people with severe and moderate chronic kidney disease (estimated glomerular filtration rate <30 and <60 mL/min per 1.73 m2, respectively), there is a graded increase in the prevalence of cognitive impairment affecting multiple domains.367,368”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Animal and human observations suggest chronic hypoperfusion induces development and progression of WMLs.
“Animal and human observations suggest that chronic hypoperfusion induces the development and progression of WMLs.385–387”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Cognitive disturbance is a risk factor for hypoglycemia in older adults.
“and that cognitive disturbance, in turn, represents a risk factor for hypoglycemia in older adults.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [353] source
- Premisecitation
Recurrent hypoglycemia may cause permanent cognitive impairment in older subjects.
“It is remarkable to consider that recurrent episodes of hypoglycemia may cause permanent cognitive impairment in older subjects353”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [353] source
- Premisecitation
A trial of pravastatin in older people at risk for cardiovascular disease found no difference between placebo and treatment arms in multiple cognitive domains.
“A trial of pravastatin in older people at risk for cardiovascular disease found no difference between the placebo and treatment arms in multiple cognitive domains.358”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [358] source
- Interpretationcitation
C-reactive protein, a marker of inflammation, is associated with VaD.
“C-reactive protein, a marker of inflammation, is associated with VaD.”
Quote in the paperSubstantial claim - Premisecitation
Subclinical decrease in cardiac output is associated with lower cognitive function.
“A subclinical decrease in cardiac output has also been shown to be associated with lower cognitive function.380”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [380] source
- Premisecitation
In CHS, moderate chronic kidney disease is related to risk of incident VaD.
“In the CHS, moderate chronic kidney disease was related to risk of incident VaD.369”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [369] source
- Premisecitation
In HAAS and CHS, low ankle-brachial index is associated with increased VaD risk.
“In the Honolulu-Asia Aging Study (HAAS) and CHS, a low ankle-brachial index, a measure of peripheral arterial disease, was associated with an increased risk of VaD.377,378”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Adjustment for WMLs, SBI, cerebral microbleeds, and brain volumes attenuated the association between coronary artery calcium and cognition, implicating other vascular mechanisms.
“Adjustment for WMLs, SBI, cerebral microbleeds, and brain volumes attenuated the observed association between coronary artery calcium and cognition, implicating other vascular mechanisms.363”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [363] source
- Interpretationreasoning
Prevention of chronic vascular diseases may help reduce the population burden of vascular dementia.
“Prevention of chronic vascular diseases may help reduce the population burden of vascular dementia.”
Quote in the paperSubstantial claim - Premisecitation
In the Conselice Study, high C-reactive protein combined with high interleukin-6 led to nearly a 3-fold increased risk of VaD over 4 years.
“In the Conselice Study of Brain Aging, with 4 years of follow-up, the combination of high levels of C-reactive protein and interleukin-6 led to a nearly 3-fold increased risk of VaD.361”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [361] source
- Premisecitation
In CHS and AGES-RS, CT-based coronary artery calcium is associated with higher risk of cognitive impairment.
“In the CHS and Age, Gene, Environment Susceptibility–Reykjavik Study (AGES-RS), computed tomography–based coronary artery calcium, a measure of severity of coronary atherosclerosis, was associated with a higher risk of cognitive impairment.362,363”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In several large community-based samples and a prospectively studied cardiac catheterization registry, atrial fibrillation was cross-sectionally an independent risk factor for lower cognitive performance and higher VaD risk.
“In several large community-based samples and in a prospectively studied registry of people undergoing cardiac catheterization, cross-sectionally it was an independent risk factor for lower cognitive performance and a higher risk of VaD.371–374”
Quote in the paperSubstantial claim0 of 4 sources checked - Premisecitation
C-reactive protein levels are increased 25 years before VaD onset.
“C-reactive protein levels were increased 25 years before the onset of VaD.360”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [360] source
- Interpretationreasoning
Stroke could serve as a marker of cumulative exposure to vascular risk factors.
“That is, stroke could be serving as a marker of cumulative exposure to vascular risk factors.”
Quote in the paperSubstantial claim - Interpretationnone given
The adverse effect profile of pharmacotherapy for VaD is similar to that seen in Alzheimer disease trials.
“The adverse effect profile is similar to that seen in Alzheimer disease trials.”
Quote in the paperNot a substantial claim - Premisecitation
Pivotal trials testing Alzheimer disease drugs in VaD patients failed to achieve regulatory approval.
“Pivotal trials to test drugs approved for Alzheimer disease in patients with VaD,388 however, have failed to achieve regulatory approval.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [388] source
- Premisecitation
An association between midlife hypertension and late-life cognitive decline or dementia has been found in a majority of observational studies, including cohort studies with decades of follow-up.
“An association between midlife hypertension and late-life cognitive decline or dementia has been found in a majority of observational studies, including cohort studies with follow-up spanning several decades.”
Quote in the paperSubstantial claim - Premisecitation
A small sertraline study showed benefits on the Executive Interview (EXIT-25), an executive function test.
“A small study of sertraline showed benefits on the Executive Interview (EXIT-25), an executive function test.418”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [418]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationnone given
The adverse effect safety profile of these agents is generally similar to that in Alzheimer disease studies.
“The adverse effect safety profile is generally similar to that of Alzheimer disease studies.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Whether there are differential benefits within or between drug classes is unclear because no head-to-head trials have been conducted.
“Whether there are any differential benefits within or between the drug classes is not clear from the available evidence, because no head-to-head trials have been conducted.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Initial and recurrent stroke significantly increase the risk of clinical dementia.
“Initial and recurrent stroke significantly increase the risk of clinical dementia.”
Quote in the paperSubstantial claim - Premisecitation
Two memantine studies showed cognitive benefit without global or functional benefit.
“Two studies with memantine, an N-methyl d-aspartate antagonist, likewise showed cognitive benefit without global or functional benefit.406,407”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Double-blind, placebo-controlled, randomized clinical trials lasting 6 months have tested cholinesterase inhibitors for cognitive, global, and daily functioning in VaD.
“Double-blind, placebo-controlled, randomized clinical trials lasting 6 months have tested the efficacy of cholinesterase inhibitors in cognitive, global, and daily functioning in VaD.”
Quote in the paperNot a substantial claim - Premisecitation
There is pathological and clinical evidence for cholinergic compromise in VCI as occurs in Alzheimer disease.
“There is pathological and clinical evidence for cholinergic compromise in VCI as occurs in Alzheimer disease.393–395”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationnone given
In galantamine trials, less decline in cognitive, functional, and global outcomes was shown, driven by participants with mixed VaD/Alzheimer disease.
“In trials of galantamine, less decline in cognitive, functional and global outcomes was shown in trial results driven by participants with mixed VaD/Alzheimer disease.”
Quote in the paperSubstantial claim - Premisecitation
Diabetes conveys a high risk of dementia based on observational epidemiological data.
“Furthermore, on the basis of observational epidemiological data, diabetes conveys a high risk of dementia.”
Quote in the paperSubstantial claim - Premisecitation
Trials of cytidinediphosphocholine, nimodipine, piracetam, huperzine A, and vinpocetine have not produced convincing data.
“Trials have been conducted with other compounds, including cytidinediphosphocholine,412,413 nimodipine,414 piracetam,415 huperzine A,416 and vinpocetine,417 but so far without convincing data”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
Only limited evidence exists to support nonpharmacological modalities for management of VCI.
“Only limited evidence exists to support nonpharmacological modalities for management of VCI.”
Quote in the paperSubstantial claim - Interpretationreasoning
Emphasis on including those with memory loss made it challenging to exclude concomitant Alzheimer disease.
“and the emphasis on inclusion of those with memory loss made it challenging to exclude concomitant Alzheimer disease.”
Quote in the paperSubstantial claim - Interpretationreasoning
People at risk might die of competing causes before manifesting dementia symptoms.
“Such people might die of competing causes before manifesting the symptoms of dementia.”
Quote in the paperSubstantial claim - Interpretationcitation
Concern that frontline clinicians could not distinguish VaD from Alzheimer disease made regulators reluctant to grant a separate indication.
“Finally, concern that frontline clinicians could not distinguish VaD from Alzheimer disease made regulators reluctant to grant a separate indication.389”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [389] source
- Interpretationown data
The pure VaD subgroup in the galantamine study was underpowered to show definite benefit.
“The pure VaD subgroup was underpowered statistically to show definite benefit.”
Quote in the paperSubstantial claim - Interpretationnone given
Few nonpharmacological therapies have been tested and found beneficial in the VCI population.
“Few nonpharmaco-logical therapies have been tested and found to be beneficial in the VCI population.”
Quote in the paperNot a substantial claim - Interpretationcitation
Safeguarding normal cognitive development during childhood and adolescence is a prerequisite for prevention of cognitive impairment.
“In addition, safeguarding normal cognitive development during childhood and adolescence based on the new understanding of the importance of early-life factors for adult health and disease,425 as well as for cognitive function, is a prerequisite for prevention of cognitive impairment.426”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationcitation
High specificity but low sensitivity of VaD criteria hampered recruitment.
“Furthermore, high specificity but low sensitivity of VaD criteria10 hampered recruitment”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] source
- Premisecitation
In a post hoc analysis of a large donepezil VaD trial (n=974), placebo patients with hippocampal atrophy declined more than those without atrophy, who remained cognitively stable.
“A post hoc analysis in a recent large randomized controlled trial of donepezil in VaD (n=974) showed that as assessed by a standardized visual rating scale, patients with hippocampal atrophy who received placebo declined more than those without hippocampal atrophy, who remained cognitively stable.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [398] source
- Interpretationreasoning
Trials failed partly because global and daily function benefits were inconsistent and difficult to evaluate when physical deficits with stroke coexist.
“and inconsistent benefits in global and daily function, which are difficult to evaluate when physical deficits with stroke coexist.”
Quote in the paperSubstantial claim - Premisenone given
Donepezil's side-effect profile in VaD was similar to that in Alzheimer disease trials.
“The side-effect profile was similar to that of donepezil for Alzheimer disease trials.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Because most common dementias affect the elderly, even a modest delay in cognitive deterioration could translate into a relatively large reduction in disease incidence.
“Because the most common forms of dementia affect the elderly, even a modest delay in the appearance or worsening of cognitive deterioration could translate into a relatively large reduction of the incidence of disease.”
Quote in the paperNot a substantial claim - Premisecitation
In HAAS, the range of follow-up was large enough to study the effect of treatment duration >12 years.
“In HAAS there was a large enough range of duration of follow-up to study the effect of duration of treatment >12 years.431”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [431] source
- Study design and conductown data
HYVET-COG was stopped early after mean 2.2 years because of significant reductions in stroke and total mortality.
“The trial was stopped prematurely, however, after a mean of 2.2 years of follow-up because of a significant reduction in stroke and total mortality.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Observational studies point to some benefit of antihypertensive treatment for Alzheimer disease risk.
“To summarize: Observational studies point to some benefit of antihypertensive treatment for risk for Alzheimer disease.”
Quote in the paperSubstantial claim - Interpretationreasoning
Results regarding type of antihypertensive treatment were less consistent.
“Regarding type of treatment, results were less consistent.”
Quote in the paperNot a substantial claim - Premisecitation
In a large US Veterans Affairs administrative database composed almost exclusively of men (98%), patients treated with angiotensin receptor blockers had lower risk of dementia and Alzheimer disease than those treated with lisinopril or other cardiovascular drugs.
“In a recently published study, 3 treatment groups were compared in a large US Veterans Affairs administrative database composed almost exclusively of men (98%). Patients treated with angiotensin receptor blockers were found to have a lower risk of dementia and Alzheimer disease than those treated with lisinopril, an angiotensin-converting enzyme inhibitor, or with other cardiovascular drugs.438”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [438] source
- Premisecitation
One trial reported a beneficial effect of antihypertensive treatment on dementia risk.
“However, 1 study reported a beneficial effect on the risk of dementia,442 and another reported an effect on the risk of PSD445”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [442] source
- Premisecitation
A reanalysis of SHEP suggests differential dropout may have biased the treatment effect toward the null.
“A recent reanalysis of the SHEP data suggests that differential dropout may have biased the treatment effect toward the null.447”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [447] source
- Study design and conductreasoning
Published trials had differential dropout that could overestimate or underestimate treatment effect.
“(5) differential dropout, which could lead to overestimating or underestimating the treatment effect.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Antihypertensive treatment appears more effective in the youngest old than in the oldest people.
“Treatment appears more effective in the youngest old than in the oldest people.”
Quote in the paperSubstantial claim - Premisecitation
In SCOPE, there was no major treatment effect on cognition.
“There was no major treatment effect on cognition.443”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [443] source
- Premisecitation
The pattern of increased protection for dementia and Alzheimer disease with longer antihypertensive treatment was also found in HAAS.
“This pattern of increased protection for dementia and Alzheimer disease with an increased duration of antihypertensive treatment was also found in HAAS.431”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [431] source
- Premisecitation
In PROGRESS, a similar subgroup result was observed for cognitive decline defined as ≥3-point MMSE drop.
“A similar result was observed for cognitive decline, defined as a drop of ≥3 points in the MMSE.445”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [445] source
- Premiseown data
In PROGRESS, active treatment significantly reduced dementia risk in patients with prior stroke compared with those without (34% vs 1%; P=0.03).
“Evaluation within 2 dementia subgroups (with or without prior stroke), however, showed a significant reduction in the risk of dementia with active treatment in patients with a prior history of stroke compared with patients without prior stroke (34% versus 1%; P=0.03).”
Quote in the paperSubstantial claim - Premisecitation
Another trial reported an effect of antihypertensive treatment on risk of post-stroke dementia.
“However, 1 study reported a beneficial effect on the risk of dementia,442 and another reported an effect on the risk of PSD445”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [445] source
- Premisecitation
Several studies were unable to show any evidence of the effect of a particular class of antihypertensive drugs.
“Several studies were unable to show any evidence of the effect of a particular class of antihypertensive drugs.429,430,432,434”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationnone given
The longer the antihypertensive treatment duration, the stronger the preventive effect.
“The longer the duration of treatment, the stronger the preventive effect.”
Quote in the paperSubstantial claim - Interpretationreasoning
The neutral SCOPE cognition result must be interpreted in light of small between-group BP differences (3.2/1.6 mm Hg).
“This lack of benefit must be interpreted in the context of small blood pressure differences observed between the active treatment group and the control group (3.2/1.6 mm Hg).”
Quote in the paperSubstantial claim - Premisenone given
Five meta-analyses have been published on dementia risk in antihypertensive trials.
“To date, 5 meta-analyses have been published on the risk of dementia in antihypertensive trials (Table 7).”
Quote in the paperNot a substantial claim - Premisecitation
In the Kungsholmen project and Cache County Study, diuretics, particularly potassium-sparing diuretics in Cache County, had a stronger effect than other antihypertensive drugs.
“In both the Kungsholmen project435 and the Cache County Study,436 a stronger effect of diuretics and particularly potassium-sparing diuretics for the latter436 was found compared with other antihypertensive drugs.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premiseown data
Most dementia cases in Syst-Eur were Alzheimer disease.
“Most cases of dementia were Alzheimer disease.”
Quote in the paperNot a substantial claim - Premisecitation
In open-label follow-up of Syst-Eur, the principal dementia result was confirmed with twice as many dementia cases.
“In an open-label follow-up study of the same patients in the trial, the principal result was confirmed with twice as many cases of dementia.450”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [450] source
- Premisecitation
In a PROGRESS MRI substudy, active BP lowering stopped or delayed progression of white matter hyperintensities.
“Furthermore, in a PROGRESS MRI substudy, it was shown that active blood pressure lowering stopped or delayed the progression of white matter hyperintensities.452”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [452] source
- Premiseown data
In PROGRESS, overall active treatment produced a nonsignificant 12% reduction in dementia risk (range -8% to -28%).
“Overall, there was a nonsignificant 12% (range –8% to –28%) reduction in the risk of dementia in the active treatment group.”
Quote in the paperSubstantial claim - Premisecitation
A post hoc reanalysis of SCOPE patients not receiving add-on therapy did not change the neutral cognition/dementia result.
“A post hoc reanalysis of the data in patients not receiving add-on therapy after randomization, although showing evidence of a stronger effect on cardiovascular events, mortality, and vascular mortality, did not change the neutral result on cognition and dementia.448”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [448] source
- Interpretationown data
In none of the reviewed longitudinal studies was antihypertensive treatment associated with an increased risk of dementia.
“In none of these studies was antihypertensive treatment associated with an increased risk of dementia.”
Quote in the paperSubstantial claim - Premisenone given
The role of smoking cessation in changing cognitive function has not been studied.
“Even though smoking is a well-known risk factor for vascular pathology, the role of smoking cessation has not been studied in relation to changes in cognitive function.”
Quote in the paperNot a substantial claim - Premisecitation
Aerobic exercise has been shown to be useful.
“Aerobic exercise has been shown to be useful.”
Quote in the paperNot a substantial claim - Premisecitation
A systematic review found no convincing evidence linking type or intensity of diabetic treatment to prevention or management of cognitive impairment in type 2 diabetes.
“On the basis of a systematic review, there is no convincing evidence relating type or intensity of diabetic treatment to the prevention or management of cognitive impairment in type 2 diabetes mellitus.459”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [459] source
- Interpretationreasoning
A few observational studies and very few intervention trials show lifestyle modification (diet, physical activity) may improve cognitive function.
“A few observational studies and very few intervention trials have shown that lifestyle modification (eg, diet, physical activity) may improve cognitive function.”
Quote in the paperSubstantial claim - Premisecitation
Careful blood glucose control has not been shown to prevent stroke.
“However, the prevention of stroke has not been shown with careful control of blood glucose, and no studies have specifically investigated possible protective effects by reduction of hyperglycemia in mild VCI or early stages of dementia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [457] source
- Interpretationnone given
The level of evidence for a protective effect of reducing hyperglycemia is very low.
“The level of evidence for a protective effect of reduction of hyperglycemia is very low.”
Quote in the paperSubstantial claim - Premisecitation
It is now accepted that many traditional stroke risk factors are also risk markers for Alzheimer disease and VCI.
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
Quote in the paperSubstantial claim0 of 10 sources checked - Interpretationnone given
There is limited evidence that physical therapy could contribute to preventing cognitive decline.
“There is only limited evidence to support the idea that physical therapy could contribute to prevention of cognitive decline.”
Quote in the paperNot a substantial claim - Premiseown data
Across meta-analyses, the variance for dementia risk reduction ranged from 11% to 20%.
“Overall, the variance for reduction of risk for dementia ranged from 11% to 20% (Table 7).”
Quote in the paperNot a substantial claim - Premisecitation
Hyperglycemia and hyperinsulinemia in the metabolic process leading to type 2 diabetes are linked to cognitive dysfunction and stroke-related dementia.
“Among risk factors for cognitive dysfunction and dementia, it has been documented that both hyperglycemia and hyperinsulinemia, as part of the metabolic process leading to type 2 diabetes mellitus, are associated with cognitive dysfunction and stroke dementia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 438a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
No randomized controlled study has tested similar Mediterranean diet effects in healthy subjects.
“There is no randomized controlled study of similar effects in healthy subjects.”
Quote in the paperNot a substantial claim - Premisenone given
No intervention studies prove benefits of smoking cessation on preserving cognitive function.
“There are no intervention studies to prove the benefits of smoking cessation on preserving cognitive function.”
Quote in the paperNot a substantial claim - Premisecitation
In the AAA trial, 3350 participants aged 50-75 randomized to aspirin 100 mg daily or placebo showed no difference in cognitive ability over 5 years.
“In the Aspirin for Asymptomatic Atherosclerosis (AAA) trial, 3350 participants 50 to 75 years of age were randomly assigned to receive long-term use of enteric-coated aspirin 100 mg once daily or placebo. During a 5-year follow-up, no difference in cognitive ability was found between the aspirin and placebo arms.469”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [469] source
- Premisenone given
No studies have specifically investigated whether reducing hyperglycemia protects against mild VCI or early dementia.
“However, the prevention of stroke has not been shown with careful control of blood glucose, and no studies have specifically investigated possible protective effects by reduction of hyperglycemia in mild VCI or early stages of dementia.”
Quote in the paperSubstantial claim - Premisecitation
In PROSPER, 4 years of pravastatin vs placebo produced no difference in cognitive function as measured by MMSE.
“In the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER), after 4 years of treatment, no difference in cognitive function was shown, as evaluated by the MMSE, between patients receiving pravastatin or placebo.358”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [358] source
- Premisenone given
Adherence to a Mediterranean-type dietary pattern is associated with less cognitive decline in several observational studies.
“Adherence to a Mediterranean-type dietary pattern has been associated with less cognitive decline in several observational studies.”
Quote in the paperSubstantial claim - Interpretationcitation
No improvement in cognitive function has been proven when homocysteine reduction is achieved with vitamin B supplementation.
“No improvement of cognitive function has been proven when reduction of homocysteine was reached with supplementation with vitamin B.”
Quote in the paperSubstantial claim - Interpretationreasoning
Considerable uncertainty remains about efficacy of antihypertensive drugs for lowering dementia risk in general and Alzheimer disease specifically.
“They share several limitations, and therefore, considerable uncertainty remains about the efficacy of antihypertensive drugs for lowering the risk of dementia in general and Alzheimer disease in particular.”
Quote in the paperSubstantial claim - Premisecitation
In an Australian study of 276 healthy elderly, vitamin B supplementation to lower homocysteine showed no cognitive benefit after 1 and 2 years.
“With regard to lowering homocysteine by vitamin B supplementation, no benefit was shown in 1 Australian study that included 276 healthy elderly subjects with repeated tests of cognitive function after 1 and 2 years.478”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [478]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Intensified hyperglycemia treatment is not protective against stroke.
“Thus, intensified treatment of hyperglycemia is not protective of stroke,457 a risk factor for cognitive decline.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [457] source
- Premisenone given
Few large BP-lowering trials have included cognitive assessment and dementia diagnosis.
“Few large blood pressure–lowering trials have incorporated cognitive assessment and diagnosis of dementia.”
Quote in the paperSubstantial claim - Premisenone given
Only one small intervention trial has followed up subjects for cognitive improvement after increasing physical exercise.
“The same beneficial effects of increased physical activity on cognitive function have also been documented in observational studies,472 but only 1 small intervention trial has followed up subjects for cognitive improvement after increasing physical exercise.”
Quote in the paperNot a substantial claim - Premisecitation
In ADVANCE, combined treatment of hyperglycemia and hypertension reduced macrovascular endpoints and mortality.
“In the ADVANCE trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation), the combined approach to treat both hyperglycemia and hypertension has been effective to reduce macrovascular end points and mortality.”
Quote in the paperNot a substantial claim - Premisecitation
A meta-analysis of 15 observational studies suggests significant and consistent protection against cognitive decline from all levels of physical activity.
“The results of a recently published meta-analysis on the effect of physical activity on cognitive decline, based on 15 observational studies, suggest a significant and consistent protection afforded by all levels of physical activity against the occurrence of cognitive decline.475”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [475] source
- Premisecitation
In LEADe, adding atorvastatin 80 mg to donepezil in 640 patients with mild Alzheimer disease did not improve cognitive function over 72 weeks.
“In the recently published Lipitor's Effect in Alzheimer's Dementia (LEADe) trial, which included 640 randomized patients with mild Alzheimer disease, intensive lipid lowering by the addition of atorvastatin (80 mg) to donepezil did not improve cognitive function over a 72-week period.464”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [464] source
- Premisecitation
Several meta-analyses concluded statin therapy has no measurable influence on cognitive dysfunction in humans.
“Several meta-analyses have concluded that there is no measurable influence of statin therapy on cognitive dysfunction in humans,462 even if animal experiments in rodents have supported the notion that some protection is offered by statin therapy.463”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [462]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Animal experiments in rodents support some protection against cognitive dysfunction from statin therapy.
“Several meta-analyses have concluded that there is no measurable influence of statin therapy on cognitive dysfunction in humans,462 even if animal experiments in rodents have supported the notion that some protection is offered by statin therapy.463”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [463] source
- Premisecitation
Epidemiological studies show traditional cardiovascular risk factors also increase Alzheimer disease risk.
“Epidemiological evidence to support the convergence of mechanisms is observed in studies that show traditional cardiovascular risk factors also heighten risk of Alzheimer disease.”
Quote in the paperSubstantial claim
- May combine two claims. 168
- Classified as probably not a substantial claim. 47
May combine two claims.
PremisecitationVascular oxidative stress and inflammation impede proliferation, migration, and differentiation of oligodendrocyte progenitor cells and compromise repair of damaged white matter.
“Vascular oxidative stress and inflammation impede the proliferation, migration, and differentiation of oligodendrocyte progenitor cells and compromise repair of the damaged white matter.108,132,133”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [108] source
- cites [132] source
The Discussion (page unavailable) reports that cultured rat OPCs were vulnerable to hydrogen-peroxide oxidative stress, and the paper states that OPCs contribute to white-matter repair. It does not show that vascular oxidative stress or inflammation impedes OPC proliferation, migration, or differentiation, or directly demonstrate impaired repair of damaged white matter. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [133] source
The Discussion states that the inflammatory response associated with demyelination provides a powerful impetus for remyelination—the opposite of the claim that inflammation impedes repair. The paper attributes impaired progenitor recruitment and differentiation to aging, but the cited passages do not establish vascular oxidative stress as their cause. No page number is supplied in our copy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenIt is unclear what confounding factors were taken into account in these analyses.
“It is unclear what confounding factors were taken into account in these analyses.322”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [322] source
The Methods section explicitly states which factors were included in the adjusted models, including demographics, cardiovascular and dementia risk factors, smoking, physical activity, and ApoE genotype. The claim that it is unclear which confounding factors were taken into account is therefore contrary to the cited paper's account. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationRisk of new-onset dementia after stroke is approximately twice that of age- and sex-matched controls and averages about 10% after first stroke, depending on location, volume, severity, and early complications.
“The risk of new-onset dementia after a stroke is approximately twice the rate for age- and sex-matched control subjects270 and averages ≈10% after the first stroke, depending on the location, volume of damaged brain tissue,30 clinical severity, and presence of early poststroke complications (seizure, delirium, hypoxia, hypotension).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [270] source
- cites [30] source
The citation is attached to the claim that new-onset dementia risk is approximately twice that of age- and sex-matched controls. The Results report an adjusted odds ratio of 9.4 for dementia after stroke versus stroke-free controls, and the methods say the groups differed by sex; the study assessed dementia three months after stroke rather than establishing new onset. The later ≈10% and complication claims are not attached to this citation. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
Study design and conductcitationPublished trials enrolled patients at low dementia risk (young mean age) and with high baseline MMSE.
“(3) patients at low risk for dementia (young mean age)441,445 and with high baseline MMSE;”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [441] source
The Methods (Selection) explicitly exclude pharmaceutical clinical trial volunteers and restrict the review to community-dwelling adults aged 60 or older. The Results (Cognitive Dysfunction) describe population-based prospective studies with mean baseline ages including 68.9, 75.6, and 83 years, rather than trials characterized by a young mean age. The paper mentions MMSE as an outcome measure but does not establish that participants had high baseline MMSE scores. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [445] source
May combine two claims.
PremisecitationExecutive dysfunction has not been shown to specifically point to cerebrovascular disease, whereas a pattern of memory deficits may be associated more with Alzheimer disease and its associated pathology than with cerebrovascular disease.
“Executive dysfunction has not been shown to specifically point to cerebrovascular disease, whereas a pattern of memory deficits may be associated more with Alzheimer disease and its associated pathology than with cerebrovascular disease.”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationChronic macroscopic infarcts are very common, occurring in approximately one third to one half of older people, a frequency far greater than the frequency of clinical stroke.
“Chronic macroscopic infarcts are very common, occurring in approximately one third to one half of older people,13,54–56 a frequency far greater than the frequency of clinical stroke.”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [13] source
- cites [54] source
The Results (Probable AD in the community versus clinic; page unavailable) report that macroscopic infarcts were more common in the community cohort than in the clinic cohort. The available passages do not establish that they occurred in one third to one half of older people or that their frequency was far greater than that of clinical stroke. (LLM, conf=0.81)
Experimental — accuracy not yet measured - cites [55] source
- cites [56] source
May combine two claims.
PremisecitationOther common vascular brain pathologies in older people include white matter degeneration and primary vessel disease such as arteriolosclerosis/lipohyalinosis, atherosclerosis, and cerebral amyloid angiopathy.
“There are other common vascular pathologies in the brains of older people, including white matter degeneration70,71 and primary vessel disease (ie, arteriolosclerosis/lipohyalinosis, atherosclerosis, and cerebral amyloid angiopathy [CAA]).70,72,73”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [70] source
- cites [71] source
- cites [72] source
- cites [73] source
The Discussion (page not available) says sclerotic medullary arteries are commonly seen in older people and that some are associated with diffuse ischemic white matter change. The Results (page not available) describe fibrohyaline thickening but state that atherosclerosis and amyloid angiopathy were not observed in the medullary arteries. This paper therefore supports part of the broad claim, not the full list of vessel diseases as common findings in its studied arteries. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAlthough the specific importance of subcortical infarcts and interaction has not been confirmed, subsequent studies have established that infarcts are additive with Alzheimer disease pathology in lowering cognitive function and increasing the odds of dementia or clinical Alzheimer disease.
“Although the specific importance of subcortical infarcts and interaction has not been confirmed, subsequent studies have established that infarcts are additive with Alzheimer disease pathology in lowering cognitive function17,57 and increasing the odds of dementia17,18,62,63 or clinical Alzheimer disease.61”
Quote in the paperSubstantial claim3 of 6 sources checked- cites [17] source
- cites [57] source
- cites [18] source
- cites [62] source
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [63] source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [61] source
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMost people with dementia and almost half of those with clinically probable Alzheimer disease have mixed pathology, most commonly Alzheimer disease and infarcts.
“In addition, most people with dementia12 and almost half of those with clinically probable Alzheimer disease61 have mixed pathology, most commonly Alzheimer disease and infarcts.”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationIn animal models, hypertension, aging, and diabetes impair endothelium-dependent responses in the cerebral microcirculation and blunt functional hyperemia.
“In animal models, the major risk factors for VCI and Alzheimer disease —hypertension, aging, and diabetes110—impair endothelium-dependent responses in the cerebral microcirculation and blunt functional hyper-emia.101,111,112”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [110] source
- cites [101] source
- cites [111] source
The Discussion (page unavailable) reports that aging impairs endothelial function in mouse cerebral arteries and states that neurovascular coupling decreases with aging. The study tested isolated basilar arteries, not functional hyperemia, and the cited passages do not establish the claimed effects of hypertension or diabetes. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [112] source
May combine two claims.
PremisecitationEndothelial mediators serve functions including local flow distribution, immune surveillance, and hemostatic balance.
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
Quote in the paperNot a substantial claim1 of 3 sources checkedMay combine two claims.
PremisecitationCerebral smooth muscle cells of patients with Alzheimer disease have increased constrictor tone, which may contribute to the cerebral blood flow reduction observed in this condition.
“Cerebral smooth muscle cells of patients with Alzheimer disease have increased constrictor tone,118 which may contribute to the CBF reduction observed in this condition.100”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationIn vascular cognitive impairment and Alzheimer disease, microvessels have thickened basement membranes, become tortuous, and are reduced in number.
“Microvessels have thickened basement membranes, become tortuous, and are reduced in number.71,105–107”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [71] source
- cites [105] source
- cites [106] source
The Introduction describes tortuosity in arterioles supplying the deep white matter in leukoaraiosis, while the Abstract reports reduced microvascular density in leukoaraiosis and preliminary evidence of reduced density in Alzheimer’s disease. Neither passage describes thickened basement membranes, and the tortuosity finding is not established for Alzheimer’s disease. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [107] source
May combine two claims.
PremisecitationThe brain depends on a continuous blood supply, and interruption of cerebral blood flow leads to brain dysfunction and death.
“The brain depends on a continuous blood supply, and interruption of cerebral blood flow (CBF) leads to brain dysfunction and death.86”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [86] source
May combine two claims.
PremisecitationEndothelial cells exert trophic actions critical for brain development, neuroplasticity, and repair, with endothelial growth factors orchestrating neuroblast migration and differentiation.
“Endothelial cells exert trophic actions that are critical in brain development, neuroplasticity, and repair when endothelial growth factors orchestrate the migration and differentiation of neuroblasts.96–99”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [96] source
- cites [97] source
The Discussion reports that endothelial cells secrete factors regulating neuronal differentiation in vitro and that vascular ligands guide neuroblast migration after stroke. It does not establish that those ligands orchestrate neuroblast differentiation, or that these actions are critical across brain development and neuroplasticity. The relevant indexed passages have no page numbers. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [98] source
- cites [99] source
May combine two claims.
PremisecitationLow-density lipoprotein receptor-related protein-1, a critical amyloid beta brain clearance receptor, is downregulated in cerebral blood vessels of patients with Alzheimer disease, leading to accumulation of amyloid around blood vessels and worsening of vascular dysfunction.
“the low-density lipoprotein receptor–related protein-1, a critical Aβ brain clearance receptor, is downregulated in cerebral blood vessels of patients with Alzheimer disease, leading to accumulation of amyloid around blood vessels and worsening of vascular dysfunction.129”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [129] source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPittsburgh Compound B retention is not specific for cerebral amyloid angiopathy as opposed to Alzheimer disease because the compound binds to both vascular and parenchymal amyloid, but the two pathologies may be distinguishable in part by the relative occipital predominance of labeling in cerebral amyloid angiopathy.
“Pittsburgh Compound B retention is not specific for CAA as opposed to Alzheimer disease, because the compound binds to both vascular and parenchymal amyloid158; however, the 2 pathologies may be distinguishable in part by the relative occipital predominance of labeling in CAA.156,157”
Quote in the paperNot a substantial claim1 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA single nucleotide polymorphism in the COL4A1 gene was associated with pulse wave velocity, an index of arterial stiffness, in a population.
“a single nucleotide polymorphism in the COL4A1 gene was associated with pulse wave velocity, an index of arterial stiffness, in a population.180”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [180] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMultiple strictly lobar hemorrhages without other definite causes have been defined by the Boston criteria as probable cerebral amyloid angiopathy and validated against neuropathologically or genetically diagnosed cerebral amyloid angiopathy.
“The presence of multiple strictly lobar hemorrhages in the absence of other definite causes such as head trauma, brain tumor, or supratherapeutic anticoagulation has been defined by the Boston criteria as “probable CAA” and validated against neuropathologically or genetically diagnosed CAA.153,154”
Quote in the paperNot a substantial claim1 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe lumen-intima and media-adventitia separation can be determined to within about 0.1 mm on longitudinal B-mode ultrasound images of the extracranial carotid arteries where these interfaces are readily apparent.
“The lumen-intima and media-adventitia separation can be determined to within ≈0.1 mm on longitudinal B-mode ultrasound images of the extracranial carotid arteries where these interfaces are readily apparent.183,184”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [183] source
- cites [184] source
The Subjects and Methods section (page not specified in our copy) describes measurements of the far-wall intimal-medial thickness in extracranial carotid arteries and reports approximately 0.10 mm axial resolution. That is the minimum spacing at which adjacent boundaries can be distinguished, not a demonstrated measurement accuracy of within 0.1 mm; the paper also does not specify longitudinal images for this claim. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMutations of the COL4A1 type IV collagen subunit gene have also been reported in association with congenital porencephaly, leukoencephalopathy, or intracerebral hemorrhage.
“Mutations of the COL4A1 type IV collagen subunit gene have also been reported in association with congenital porencephaly, leukoencephalopathy, or intracerebral hemorrhage.178,179”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationOther potential diagnostic approaches for cerebral amyloid angiopathy include detection of reduced amyloid beta in cerebrospinal fluid and increased retention of Pittsburgh Compound B on positron emission tomography imaging.
“Other potential diagnostic approaches have been explored, including detection of reduced Aβ in cerebrospinal fluid155 or increased retention of the amyloid ligand Pittsburgh Compound B on positron emission tomography imaging.156,157”
Quote in the paperNot a substantial claim1 of 3 sources checkedMay combine two claims.
PremisecitationAlthough no treatments have been identified to modify the course of CADASIL, cardiovascular risk factors such as hypertension, elevated hemoglobin A1c, and smoking may be associated with a worse clinical and radiographic phenotype.
“Although no treatments have been identified to modify the course of CADASIL, it is notable that cardiovascular risk factors such as hypertension, elevated hemoglobin A1c, and smoking may be associated with a worse clinical and radiographic phenotype.171,172”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [171] source
- cites [172] source
The Results (Presence of CM and associated factors; Cerebral microhaemorrhages and neurological outcome, pages unavailable) associate hypertension and elevated HbA1c with microhaemorrhages, and systolic blood pressure with poor functional outcome. The Discussion says treatment benefits remain to be tested. But the study does not support including smoking: its tables show no significant association with either microhaemorrhages or poor functional outcome. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationSeveral pathways may connect aortic stiffness to microvascular brain damage, including endothelial dysfunction and oxidative stress, mutually reinforcing remodeling of large and small arteries, and exposure of small vessels to high-pressure fluctuations in the cerebral circulation.
“Several pathways may link aortic stiffness to microvascular brain damage. They include endothelial dysfunction and oxidative stress,209 a mutually reinforcing remodeling of large and small vessels (ie, large-/small-artery cross talk),210 and exposure of small vessels to the high-pressure fluctuations of the cerebral circulation,211”
Quote in the paperSubstantial claim1 of 3 sources checkedMay combine two claims.
PremisecitationRetinal arterial narrowing correlates with increased arterial stiffness and cerebral small-vessel disease.
“Retinal arterial narrowing correlates with increased arterial stiffness219 and cerebral small-vessel disease.218,220,221”
Quote in the paperNot a substantial claim1 of 3 sources checkedMay combine two claims.
PremisecitationAge-related arterial stiffening (arteriosclerosis) is associated with quantitatively less elastin and more collagen but is also associated with qualitative changes in the arterial wall.
“The well-known, age-related arterial stiffening process (arteriosclerosis) is associated with quantitatively less elastin and more collagen but is also associated with qualitative changes in the arterial wall.143,199,200”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [143] source
- cites [199] source
In “Determinants of Arterial Stiffness” (page not available), the paper links aging to thinning and fragmentation of elastic fibers, increased collagenous material, and qualitative changes in the arterial wall. It does not explicitly establish a quantitative decrease in elastin, so that part of the claim is not fully supported. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [200] source
The Essential Hypertension section (page unavailable) says central arteries stiffen with age, elastic fibers lose their orderly arrangement and undergo thinning and fragmentation, and collagenous material increases. These passages support age-related stiffening, increased collagen, and qualitative wall changes, but they do not establish a quantitative decrease in elastin content. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe inverse relationship between carotid intima-media thickness and cognition was significant after controlling for age and education; some studies further adjusted for depressive symptoms and/or cardiovascular risk factor level.
“This relationship was significant after controlling for age and education; some studies further adjusted for the presence of depressive symptoms187,189 and/or cardiovascular risk factor level.189”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationProposed mechanisms linking atherosclerotic cerebrovascular pathology to vascular cognitive impairment include thrombotic occlusion of large vessels with subsequent chronic cerebral hypoperfusion, cerebral embolism from ruptured or thrombotic carotid plaques targeting distal vessels, increased parenchymal oxidative stress, blood pressure dysregulation affecting blood-brain barrier integrity, and a
“The mechanisms by which atherosclerotic cerebrovascular pathology might be associated with VCI include thrombotic occlusion of large vessels with subsequent chronic cerebral hypoperfusion; cerebral embolism originating from ruptured or thrombotic carotid plaques and targeting distal vessels; increased parenchymal oxidative stress; blood pressure dys-regulation affecting BBB integrity; and a common”
Quote in the paperNot a substantial claim3 of 5 sources checked- cites [189] source
The Discussion proposes chronic cerebral hypoperfusion as a mechanism linking subclinical vascular disease to cognitive impairment. It does not specify thrombotic large-vessel occlusion as its cause, or describe plaque-derived embolism, parenchymal oxidative stress, or blood-pressure dysregulation affecting blood–brain barrier integrity. No page number is available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [195] source
- cites [196] source
The Discussion (page not provided) proposes chronic cerebral hypoperfusion as a contributor to brain dysfunction in patients with cardiovascular disease. The Abstract (page not provided) also links atherosclerosis to cerebral vessel changes and blood-pressure abnormalities to impaired cerebral hemodynamics. Our copy does not support the specified mechanisms of large-vessel thrombotic occlusion, carotid-plaque embolism, oxidative stress, or blood-pressure effects on blood–brain barrier integrity. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [197] source
- cites [198] source
The “Carotid Disease and the Brain” section (page unavailable) proposes large-vessel occlusion with hypoperfusion and embolism from ruptured or thrombotic carotid plaques. It does not describe the hypoperfusion as chronic or propose oxidative stress or blood-pressure dysregulation affecting blood–brain barrier integrity as mechanisms. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAge-specific definitions of extensive WMLs can be created and are useful for defining risk for VCI in a community cohort.
“Importantly, age-specific definitions of extensive WMLs can be created240 and prove useful in defining risk for VCI in a community cohort.240”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [240] source
The Methods (MRI scans; page not provided) define extensive white matter hyperintensity volume using age-specific thresholds. The Results and Discussion report that this measure predicted incident dementia in a community cohort and amnestic MCI only among participants aged 60 or older. The study did not specifically establish risk for vascular cognitive impairment (VCI). (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationWMLs are associated with incident MCI, dementia, and death.
“Similarly, WMLs have been associated with declining scores in the modified MMSE and the Digit Symbol Substitution Test,246,247 as well as with incident MCI, dementia, and death.240”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [240] source
The Results sections on dementia, MCI, and mortality associate white matter hyperintensity measures with incident dementia and death. For MCI, however, the paper finds no overall association; increased risk of amnestic MCI appears only in certain subgroups, including participants aged 60 or older. The unqualified reference to incident MCI overstates that finding. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPrevalence estimates of silent cerebral infarction on MRI in community-based samples range from 5.8% to 17.7%, averaging 11%, and vary by age, ethnicity, comorbidities, and imaging technique.
“Estimates of the prevalence of silent cerebral infarction on MRI in community-based samples vary between 5.8% and 17.7%, with an average of 11%, depending on age, ethnicity, presence of comorbidities, and imaging techniques.237”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [237] source
The Abstract’s Background and Purpose gives the 5.8%–17.7% range for community-based MRI samples and attributes variation to age, ethnicity, comorbidities, and imaging techniques. It does not give an 11% average across those samples; the Abstract’s Results report 10.7% for the Framingham sample alone. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMost studies suggest that CVBI measures are usually associated with non-memory-related cognitive deficits, but a number also show similar associations with memory impairment.
“Interestingly, although most studies suggest that these measures of CVBI are usually associated with non–memory-related cognitive deficits,241 a number of studies also show similar associations with memory impairment.240,242,243”
Quote in the paperNot a substantial claim1 of 3 sources checkedMay combine two claims.
PremisecitationMost silent cerebral infarcts are single lesions, most often located in the basal ganglia (52%), followed by other subcortical (35%) and cortical (11%) areas.
“Most have a single lesion, and the infarcts are most often located in the basal ganglia (52%), followed by other subcortical (35%) and cortical (11%) areas.237”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [237] source
May combine two claims.
PremisecitationIn the Framingham study, silent cerebral infarction prevalence is about 10% in the fifth to seventh decades, rises to 17% in the eighth decade, and approaches 30% in the ninth decade.
“In the Framingham study, for example, the prevalence of silent cerebral infarction between the fifth and seventh decades of life is ≈10% but increases rapidly in the eighth decade to 17% and in the ninth decade to nearly 30%.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [237] source
The Results report 10.7% prevalence overall in the Framingham Offspring sample and an increase with age, from under 8% at ages 30–49 to over 15% at ages 70–89. Our copy does not give the claimed decade-specific figures of 17% in the eighth decade or nearly 30% in the ninth; the Results refer to Figure 1 for age-specific data without stating those values in the retrieved text. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationHippocampal volumes are associated with both hippocampal sclerosis and Alzheimer disease.
“Gray matter volumes, however, were associated with both vascular and Alzheimer disease processes, and hippocampal volumes were associated with both hippocampal sclerosis and Alzheimer disease.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [82] source
May combine two claims.
PremisecitationThe presence of SBI more than doubles the risk of dementia and the risk of stroke.
“For example, the presence of SBI more than doubles the risk of dementia and risk of stroke.240,244,245”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [240] source
The indexed Results summary reports that MRI-defined brain infarcts (BI) were associated with more than double the risk of incident stroke (HR 2.84) and dementia (HR 6.12). However, the Methods define BI by MRI appearance, not by whether the infarct was silent; the Results also include participants with prior stroke. The reported estimates therefore do not specifically establish the claim for silent brain infarcts (SBI). (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [244] source
- cites [245] source
May combine two claims.
PremisecitationIn a study of pathological correlates of in vivo MRI evidence of CVBI, WMLs were highly correlated with pathological features of ischemic white matter injury but not with Alzheimer disease pathology.
“In a study that examined the pathological correlates of in vivo MRI evidence of CVBI,82 WMLs were highly correlated with pathological features of ischemic white matter injury but not Alzheimer disease pathology.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [82] source
May combine two claims.
PremisecitationCognitive tests for VCI are to a degree nonspecific for vascular disease, and different criteria for VaD identify different sets of people.
“The cognitive tests for VCI are, to a degree, nonspecific for vascular disease, and different criteria for VaD identify different sets of people.29”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecent studies show that, similar to Western countries, Alzheimer disease is the leading cause of dementia in Asian populations.
“Recent studies have shown that similar to Western countries, Alzheimer disease is the leading cause of dementia in Asian populations.275”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [275] source
The Results (p. 3) report that Alzheimer’s disease accounted for most dementia cases in this US cohort, supporting the Western comparison. The paper does not report whether it is the leading cause of dementia in Asian populations, which is the claim’s central point. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn a pooled analysis of major European population-based studies, VaD was prevalent in 1.6% of subjects over 65 years, with large variation in 5-year age-specific prevalence.
“In a pooled analysis of major European population–based studies, VaD was prevalent in 1.6% of subjects >65 years of age, but there was a large variation in 5-year age-specific prevalence.264”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [264] source
The Results and Statistical analysis sections describe a Boston dietary-questionnaire validation sample, not a pooled analysis of European population-based studies. Searches for vascular dementia, 1.6% prevalence, and five-year age-specific prevalence found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationOne study found an association of lower circulating vitamin D levels with poorer cognitive function, but another found no association.
“Recently, 1 study found an association of lower circulating vitamin D levels with poorer cognitive function,294 but another found no association.295”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationThe age-related increase in VaD follows the pattern of stroke, although dementia after stroke may be more frequent in people under 80 years old.
“This age-related increase in VaD follows the pattern of stroke,269 although dementia after stroke may be more frequent in people <80 years old.270”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [269] source
The Results report that all-cause dementia incidence increased with age among people aged 90 and older, and that 22% of examiner-diagnosed cases were vascular dementia. They do not report age-specific vascular dementia rates or compare their pattern with stroke. The separate claim about dementia after stroke in people under 80 is attached to citation 270, not this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [270] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent study reported VaD prevalence in developing countries ranging from 0.6% to 2.1%.
“A recent study reporting on the prevalence of VaD in developing countries reported a range of 0.6% to 2.1%.3,33”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationChronic hyperglycemia, increased insulin, metabolic syndrome, and diabetes are associated with VCI, VaD, or dementia with stroke.
“Chronic hyperglycemia, increased insulin, the metabolic syndrome, and diabetes are associated with VCI,337,345–348 as well as VaD or dementia with stroke.349,350”
Quote in the paperSubstantial claim2 of 6 sources checked- cites [337] source
- cites [345] source
- cites [346] source
- cites [347] source
The Comment and Results (pages unavailable) link metabolic syndrome and high fasting glucose to cognitive impairment in older women. They do not establish an association specifically with vascular cognitive impairment (VCI), and the paper does not report an association for increased insulin. The citing sentence assigns its separate claim about vascular dementia or dementia with stroke to other citations. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [348] source
- cites [349] source
May combine two claims.
PremisecitationBody mass index measured in midlife is more strongly associated with VCI, whereas body weight measured later in life has an inverse association with cognitive impairment, with obesity associated with lower risk of dementia.
“Body mass index measured in midlife is more strongly associated with VCI, whereas body weight measured later in life has an inverse association with cognitive impairment, where obesity is associated with a lower risk of dementia.320”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [320] source
The Introduction says high BMI has been associated with dementia, and the Results report that women overweight or obese in midlife had a higher blood–brain barrier permeability measure 24 years later. The paper does not establish a stronger association specifically with vascular cognitive impairment (VCI), compare midlife BMI with later-life weight as predictors of cognitive impairment, or report that later-life obesity lowers dementia risk. The cited passages have no page numbers in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPhysical activity may increase brain neurotrophins such as brain-derived neurotrophic factor, improve cerebrovascular functioning and brain perfusion, reduce response to stress, and increase brain plasticity through synaptogenesis and neurogenesis.
“Physical activity may increase brain neurotrophins, such as brain-derived neurotrophic factor, improve cerebrovascular functioning and brain perfusion, reduce response to stress, and increase brain plasticity through synaptogenesis and neurogenesis.302”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [302] source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA recent review identified older age, lower education, prestroke cognitive impairment, diabetes, and atrial fibrillation as factors increasing risk, but second stroke was one of the strongest predictors of cognitive decline after initial stroke.
“A recent review identified older age, lower education, prestroke cognitive impairment, diabetes, and atrial fibrillation as factors that increased the risk, but one of the strongest predictors of cognitive decline after an initial stroke was the occurrence of a second stroke.269,270”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationReduced cardiac output is associated with executive dysfunction (mainly sequencing and planning difficulties) and regional WMLs adjacent to subcortical nuclei.
“Specifically, reduced cardiac output has been associated with executive dysfunction (mainly sequencing and planning difficulties)381 and regional WMLs adjacent to the subcortical nuclei.382”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [381] source
The Discussion mentions white matter lesions in relation to diabetes, but does not link them to cardiac output or locate them adjacent to subcortical nuclei. Searches for reduced cardiac output and regional white matter lesions found no passage addressing that association. Citation 382 is attached to the white-matter-lesion part of the citing sentence. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [382] source
The Discussion reports that, among older adults with cardiovascular disease, reduced cardiac output was associated with executive dysfunction and white matter hyperintensities. It does not specify sequencing or planning difficulties, or locate the lesions adjacent to subcortical nuclei. The paper’s own Results found only a borderline association with a combined executive-function/information-processing score. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationManagement of vascular risks and symptomatic pharmacotherapy targeting VaD has been the primary approach.
“Management of vascular risks and symptomatic pharmacotherapy targeting VaD has been the primary approach.390”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [390] source
May combine two claims.
PremisecitationBalanced nutrition in early life is important for normal neurocognitive development, which continues until late adolescence.
“The importance of balanced nutrition in early life for normal neurocognitive development, a process that is not finished until late adolescence, has been widely recognized.427”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [427] source
The Medical and Public Health Implications section links maternal nutrition and early development with the infant’s cognitive development, supporting the importance of early-life nutrition. It does not say that neurocognitive development continues until late adolescence; no page number is available in our copy. (LLM, conf=0.81)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationCognitive rehabilitation and cognitive stimulation have not proven effective.
“Cognitive rehabilitation and cognitive stimulation so far have not proven effective.419,420”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [419] source
The Methods and Results sections describe trials comparing vinpocetine with placebo, and the Discussion concludes that evidence for vinpocetine's benefit is inconclusive. Searches for cognitive rehabilitation, cognitive stimulation, and nonpharmacological interventions found no passage assessing whether either approach has proven effective. Page numbers were not available in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [420] source
May combine two claims.
PremisecitationDonepezil produced cognitive benefit in VaD, but global and functional efficacy was less consistent across individual studies.
“Cognitive benefit was found, but global and functional efficacy was less consistent in the individual studies.396,400”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [396] source
The Discussion (page unavailable) examines white matter hyperintensities and cognition, and says their effect on response to cholinesterase inhibitors remains to be determined. Searches for donepezil and for global and functional treatment outcomes found no passage assessing those outcomes in vascular dementia. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [400] source
May combine two claims.
PremisecitationResults of studies on late-life blood pressure and dementia are less consistent, with most finding no association with hypertension or an association with low blood pressure and dementia.
“Results of studies on blood pressure measured in late life and dementia are less consistent, with most finding no association with hypertension or an association with low blood pressure and dementia.343,428”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [343] source
- cites [428] source
The Common cause hypothesis and Reverse causality sections discuss cognitive ageing and illness in older people, but neither addresses blood pressure and dementia. Searches for late-life blood pressure, hypertension, and dementia found no passage reporting the claimed pattern of study results. (LLM, conf=0.74)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn HYVET-COG, treatment had no effect on dementia risk or cognitive decline.
“The treatment was found to have no effect on the risk of dementia or cognitive decline.444”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [444] source
The Introduction (page unavailable) says HYVET-COG confirmed a non-significant reduction in dementia risk, which supports a finding of no statistically significant effect—not proof of no effect. It does not report HYVET-COG's cognitive-decline result; the no-difference finding for cognitive decline in the Discussion concerns PRoFESS patients instead. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn 3 studies there was no association between hypertension treatment and Alzheimer disease risk, whereas in others there was a decreased Alzheimer disease risk among those receiving antihypertensive treatment.
“In 3 studies there was no association between hypertension treatment and risk of Alzheimer disease,432–434 whereas in others there was a decreased risk of Alzheimer disease among those receiving antihypertensive treatment.429,431,435–437”
Quote in the paperSubstantial claim1 of 5 sources checkedMay combine two claims.
PremisecitationIn type 2 diabetes, cognitive dysfunction independently predicts clinical outcomes but does not modify effects of BP lowering or glucose control on major cardiovascular events.
“It was concluded that cognitive dysfunction is an independent predictor of clinical outcomes in patients with type 2 diabetes mellitus but does not modify the effects of blood pressure lowering or glucose control on the risk of major cardiovascular events.458”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [458] source
The Background lists diabetes as a possible baseline risk factor, but the Discussion addresses whether blood-pressure lowering prevents cognitive decline or dementia in hypertensive patients without prior cerebrovascular disease. Searches for the claimed independent prediction and for glucose control and major cardiovascular events found no passage addressing those findings in patients with type 2 diabetes. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationStatin therapy protects against stroke in primary and secondary studies, based on meta-analysis and SPARCL.
“Treatment with statin therapy has been documented to protect against stroke, both in primary460 and secondary studies, based on data from meta-analysis36 and a single trial, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL).461”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [460] source
- cites [36] source
- cites [461] source
The Introduction (p. 2) describes ADVANCE as studying blood-pressure lowering and intensive glucose control, and the Discussion (p. 7) discusses stroke in relation to blood-pressure treatment. Searches for statins, SPARCL, and meta-analysis found no passage in our copy addressing the claimed protection against stroke in primary or secondary studies. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationObservational studies document that people consuming a Mediterranean diet have better cognition and lower dementia risk than those consuming other diets.
“A few observational studies have documented that people who consume a Mediterranean diet have better cognition and less risk of dementia than people consuming other diets.470”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [470] source
The Introduction (page unavailable) discusses observational findings about NSAID use and Alzheimer’s risk, not Mediterranean diets. Searches for “Mediterranean diet” and “diet cognition dementia risk” found no passage in our copy addressing diet, cognition, or a dietary comparison. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThese meta-analyses varied in model type (fixed or random) and patient selection.
“These studies had variable methods in relation to model type (fixed or random) and selection of patients.453,454”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [453] source
The Subjects and Methods section describes statistical analyses of the Syst-Eur trial, not a comparison of meta-analyses. Searches for fixed versus random models, patient selection, and meta-analysis found no passage in our copy addressing the claimed variation in methods. Page numbers were not available in the indexed passages. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [454] source
May combine two claims.
PremisecitationIn a Finnish cohort, combined elevated systolic BP, hypercholesterolemia, and obesity increased Alzheimer disease risk about sixfold, while each factor alone increased risk about twofold.
“For example, in a cohort in Finland, the combination of elevated systolic blood pressure, hypercholesterolemia, and obesity increased the risk of Alzheimer disease by ≈6 times, whereas individually, any of these factors alone increased risk by ≈2 times.494”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [494] source
Subjects and Methods (p. 2) describes a Finnish cohort of patients with ischemic stroke, while the Discussion (p. 4) compares criteria for diagnosing vascular dementia. Our copy does not address Alzheimer disease risk from the specified combination of blood pressure, cholesterol, and obesity, or report the claimed sixfold and twofold increases (searched those factors and risk estimates). (LLM, conf=0.78)
Experimental — accuracy not yet measured
May combine two claims.
Premisenone givenCarotid intimal-medial thickness and arterial stiffness are emerging as markers of arterial aging and may serve as risk markers for vascular cognitive impairment.
“Carotid intimal-medial thickness and arterial stiffness are emerging as markers of arterial aging and may serve as risk markers for VCI.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenThe neuropathology of late-life cognitive impairment often involves a mixture of Alzheimer disease and microvascular brain damage, which may overlap and synergize to increase cognitive impairment risk.
“The neuropathology of cognitive impairment in later life is often a mixture of Alzheimer disease and microvascular brain damage, which may overlap and synergize to heighten the risk of cognitive impairment.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationDementia criteria based on memory deficits are derived from concepts proposed for Alzheimer disease, but these may not be suitable for the dementia syndrome associated with cerebrovascular disease, in which memory-related structures could be intact, resulting in relatively preserved memory functions.
“Dementia criteria based on memory deficits are derived from concepts proposed for Alzheimer disease, but these may not be suitable for the dementia syndrome associated with cerebrovascular disease, in which memory-related structures (eg, mesial temporal lobe, thalamus) could be intact, resulting in relatively preserved memory functions.”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenVascular contributions to cognitive impairment and dementia in later life are common.
“Vascular contributions to cognitive impairment and dementia of later life are common.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisereasoningThese risks may include atrial fibrillation, hypertension, diabetes mellitus, and hypercholesterolemia.
“These risks may include but are not limited to atrial fibrillation, hypertension, diabetes mellitus, and hypercholesterolemia.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningAs the diagnostic threshold is expanded, frequency rates increase accordingly.
“As the threshold is expanded, the frequency rates increase accordingly.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThis synergistic effect between Alzheimer disease and cerebrovascular disease pathology may explain why patients with mesial temporal lobe atrophy have an increased risk of dementia after stroke compared with those without atrophy, because hippocampal atrophy may also be caused by vascular disease.
“This synergistic effect between Alzheimer disease and cerebrovascular disease pathology may explain why patients with mesial temporal lobe atrophy, presumably attributable to Alzheimer disease, have an increased risk of dementia after stroke compared with those without atrophy, because hippocampal atrophy may also be caused by vascular disease.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAll of the major criteria for vascular dementia have a different definition of dementia, and this results in challenges in reliability studies.
“All of the major criteria for VaD have a different definition of dementia, and this results in challenges in reliability studies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThese same vascular risk factors may be risk markers for Alzheimer disease.
“Furthermore, these same vascular risk factors may be risk markers for Alzheimer disease.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenAlthough some authors propose that symptoms should appear within 3 months after a stroke, this is arbitrary, and symptoms may develop after this time frame.
“Although some authors propose that the symptoms should appear within 3 months after a stroke,30 this is arbitrary, and symptoms may develop after this time frame.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenCurrently, no specific treatments for vascular cognitive impairment have been approved by the US Food and Drug Administration.
“Currently, no specific treatments for VCI have been approved by the US Food and Drug Administration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome studies contend that mixed pathologies, including degenerative components caused by Alzheimer disease and vascular factors, are the most common explanation for cognitive impairment in aging.
“Some studies contend that mixed pathologies, including the degenerative components caused by Alzheimer disease and vascular factors, are the most common explanation for cognitive impairment in aging.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningFormal search strategies were used for evaluation of clinical trial information.
“Formal search strategies, however, were used as indicated for evaluation of clinical trial information.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningSome of the literature review was based on the expert panel's knowledge of the field and therefore may be subject to bias.
“Some of the literature review was based on the expert panel's knowledge of the field and therefore may be subject to bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationConsensus-based recommendations for standardized imaging, cognitive, and pathological protocols have been developed.
“Importantly, consensus-based recommendations for standardized imaging, cognitive, and pathological protocols have been developed.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThe more liberal criteria for vascular dementia proposed by Hachinski et al result in large numbers, whereas the more conservative NINDS-AIREN criteria yield more modest rates.
“the more liberal criteria for VaD proposed by Hachinski et al result in large numbers, whereas the more conservative criteria such as those of the National Institute of Neurological Disorders and Stroke–Association Internationale pour la Recherché et l'Enseignement en Neurosciences (NINDS-AIREN) yield more modest rates.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenUnderstanding of vascular cognitive impairment has evolved substantially in recent years, based on preclinical, neuropathologic, neuroimaging, physiological, and epidemiological studies.
“Understanding of VCI has evolved substantially in recent years, based on preclinical, neuropathologic, neuroimaging, physiological, and epidemiological studies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAlthough Tomlinson et al described 100 mL of tissue loss as sufficient for dementia, those with lesser volumes of loss also had dementia.
“Indeed, although Tomlinson et al described 100 mL of tissue loss as sufficient for dementia, those with lesser volumes of loss also had dementia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] source
May combine two claims.
PremisecitationDepression or depressive symptoms can severely influence patients' activities of daily living and cognitive performance, although some symptoms can revert with treatment, and consequently cognition can improve.
“these behaviors (depression or depressive symptoms) can severely influence patients’ activities of daily living and cognitive performance, although some symptoms can revert with treatment (eg, depression), and consequently cognition can improve.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningDetermining the volume or number necessary for vascular cognitive impairment or dementia has proved difficult, and unlike with Alzheimer disease, there are no currently accepted neuropathological criteria to confirm a clinical diagnosis of vascular cognitive impairment.
“However, determining the volume or number necessary for VCI or dementia has proved difficult, and unlike with Alzheimer disease and other neurodegenerative diseases, there are no currently accepted neuropathological criteria to confirm a clinical diagnosis of VCI.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn clinical-pathological studies, larger volumes and an increased number of macroscopic infarcts are associated with an increased likelihood of dementia.
“In clinical-pathological studies, larger volumes39,51 and an increased number11,13,39,55,56 of macroscopic infarcts are as sociated with an increased likelihood of dementia.”
Quote in the paperSubstantial claim0 of 6 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFor decades it has been recognized that cerebrovascular disease is associated with dementia.
“For decades it has been recognized that cerebrovascular disease is associated with dementia”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationThis research area is complicated by the difficulty of clinically differentiating Alzheimer disease or vascular cognitive impairment from mixed disease, which may be more common than either pure Alzheimer disease or pure vascular cognitive impairment.
“This research area is complicated by the difficulty of clinically differentiating Alzheimer disease or VCI from mixed (Alzheimer disease plus cerebrovascular disease) disease, which may be more common than either “pure” Alzheimer disease or “pure” VCI.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] source
May combine two claims.
Interpretationnone givenPrimary vessel disease may be associated with focal or diffuse tissue damage or may result in nonmorphologic functional changes.
“whereas primary vessel disease may be associated with focal (eg, infarct) or diffuse tissue damage (eg, white matter degeneration) or may result in nonmorphologic functional changes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOne study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] source
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenVascular and degenerative pathologies are common in later life and often coexist.
“Vascular and degenerative pathologies are 2 common disorders in later life and often coexist”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe interplay between macroscopic and microscopic infarcts and other vascular and degenerative pathologies in the development of clinical Alzheimer disease and vascular cognitive impairment is complex.
“The interplay between macroscopic and microscopic infarcts and other vascular and degenerative pathologies in the development of clinical Alzheimer disease and VCI is complex.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenVascular and degenerative pathologies each separately increase the likelihood of cognitive impairment and dementia.
“and each separately adds to the likelihood of cognitive impairment and dementia.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenVascular and degenerative pathologies may result in overlapping clinical and imaging phenotypes.
“In addition, vascular and degenerative pathologies may result in overlapping clinical and imaging phenotypes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLoss of energy-saving saltatory conduction increases metabolic demands and enhances local energy deficit and hypoxia.
“loss of energy-saving saltatory conduction increases metabolic demands and enhances local energy deficit and hypoxia.128”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [128] source
May combine two claims.
PremisecitationAmyloid beta is a potent vasoconstrictor and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
Quote in the paperSubstantial claim0 of 5 sources checkedMay combine two claims.
PremisecitationPlasma amyloid beta is elevated in some patients with vascular cognitive impairment and Alzheimer disease, induces cerebrovascular insufficiency, and may contribute to white matter alterations observed in both conditions.
“Plasma Aβ, which is elevated in some patients with VCI and Alzheimer disease, induces cerebrovascular insufficiency and could play a role in the white matter alterations observed in both conditions.130,131”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationFree radicals can induce inflammation by activating redox-sensitive proinflammatory transcription factors, and oxidative stress-induced endothelial dysfunction can release vascular endothelial growth factor and prostanoids, promoting vascular leakage, protein extravasation, and cytokine production.
“Although free radicals can induce inflammation by activating redox-sensitive proinflammatory transcription factors, the endothelial dysfunction induced by oxidative stress can release vascular endothelial growth factor and prostanoids, which promote vascular leakage, protein extravasation, and cytokine production.125”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [125] source
May combine two claims.
PremisecitationIn Alzheimer disease and cerebral amyloid angiopathy, accumulation of amyloid beta in the media of cortical arterioles weakens the vessel wall and increases the chance of lobar hemorrhages.
“in Alzheimer disease and CAA, accumulation of Aβ in the media of cortical arterioles weakens the vessel wall and increases the chance of lobar hemorrhages.109”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [109] source
May combine two claims.
PremisecitationArterioles exhibit onion-skin-type changes and undergo hyaline degeneration (lipohyalinosis), a cause of microhemorrhages.
“Arterioles exhibit signs of “onion skin”–type changes and undergo hyaline degeneration (lipohyalinosis), a cause of microhemorrhages.105”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] source
May combine two claims.
PremisecitationIn models of autoimmune white matter injury, extravasation of plasma protein triggers vascular inflammation and axonal demyelination, which disrupts saltatory conduction and slows nerve impulse transmission.
“In models of autoimmune white matter injury, extravasation of plasma protein triggers vascular inflammation and axonal demyelination,127 which in turn disrupts saltatory conduction,128 slowing the transmission of nerve impulses.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationCerebral amyloid angiopathy appears in about 10% to 30% of unselected brain autopsies and 80% to 100% when accompanying Alzheimer disease is present.
“CAA appears in ≈10% to 30% of unselected brain autopsies and 80% to 100% when in the presence of accompanying Alzheimer disease.136”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] source
May combine two claims.
Premisenone givenDiagnostic approaches to cerebral amyloid angiopathy and CADASIL have improved, but no disease-modifying therapies have been identified.
“Diagnostic approaches to CAA (and to CADASIL, the most common form of hereditary small-vessel disease) have improved, but no disease-modifying therapies have been identified.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenVascular oxidative stress and inflammation underlie many deleterious effects and are potential therapeutic targets.
“Vascular oxidative stress and inflammation underlie many of these deleterious effects and are potential therapeutic targets.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFew animal models of cognitive impairment and white matter damage exist, but models recapitulating features of cerebral amyloid angiopathy, CADASIL, cerebral hypoperfusion, and hypertensive vasculopathy have been developed, mainly in rodents.
“Although there are relatively few animal models of cognitive impairment and white matter damage, models recapitulating features of CAA, CADASIL, cerebral hypoperfusion, and hypertensive vasculopathy have been developed, mainly in rodents.5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] source
May combine two claims.
Premisenone givenCarotid wall thickening and aortic stiffening likely reflect atherosclerosis and arteriosclerosis, respectively.
“They include carotid wall thickening and aortic stiffening, which also likely reflect atherosclerosis and arteriosclerosis, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenNeurovascular dysfunction increases the brain's susceptibility to injury by altering regulation of cerebral blood supply, disrupting blood-brain barrier function, and reducing trophic support and repair potential of the injured brain.
“Neurovascular dysfunction increases the brain's susceptibility to injury by (a) altering regulation of the cerebral blood supply, (b) disrupting BBB function, and (c) reducing the trophic support and repair potential of the injured brain.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCADASIL can present clinically as migraines with aura, mood disturbances, recurrent strokes, or cognitive impairment, and radiographically as extensive white matter lesions, lacunar infarcts, microbleeds, and brain atrophy.
“This disorder can present clinically as migraines with aura, mood disturbances, recurrent strokes, or cognitive impairment163 and radiographically by the appearance of extensive WMLs, lacunar infarcts, microbleeds, and brain atrophy.164”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationCerebral amyloid angiopathy can trigger vascular or perivascular inflammation, manifesting as vasogenic edema of subcortical white matter and more rapidly progressive cognitive decline.
“CAA can also trigger vascular or perivascular inflammation,150,151 manifesting as vasogenic edema of subcortical white matter and more rapidly progressive cognitive decline.152”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Premisenone givenRodent models are well suited to genetic manipulations and large-scale studies but can be problematic because of their small amount of white matter and limited behavioral repertoire.
“Rodent models, although well suited to genetic manipulations and large-scale studies, can be problematic because of their small amount of white matter and limited behavioral repertoire.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenT2*-weighted gradient-echo MRI sequences provide substantially increased sensitivity for detection of cerebral microbleeds and are key to the diagnosis of probable cerebral amyloid angiopathy.
“T2*-weighted gradient-echo MRI sequences provide substantially increased sensitivity for detection of cerebral microbleeds and are key to the diagnosis of probable CAA.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenOther hereditary small-vessel syndromes of the brain are rare and have generally not been reported as causes of sporadic disease via de novo mutation.
“Other hereditary small-vessel syndromes of the brain are rare and have generally not been reported as causes of sporadic disease via de novo mutation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenCentral systolic blood pressure and pulse pressure can be estimated noninvasively either from the radial artery waveform using a transfer function or from the common carotid waveform.
“Central systolic blood pressure and pulse pressure can be estimated noninvasively either from the radial artery waveform, using a transfer function, or from the common carotid waveform.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMicrobleeds seen on MRI and microinfarcts discovered at autopsy occur more frequently among people diagnosed with dementia during life.
“Furthermore, the relative contributions to VCI of microbleeds seen on MRI or microinfarcts discovered at autopsy remain uncertain, although both occur with increased frequency among people diagnosed with dementia during life.77,233”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenCarotid intima-media thickness can reflect media thickening in response to increased blood pressure in hypertensive patients, intima thickening in response to atherosclerotic risk factors, or most often a combination of both.
“Carotid IMT can reflect either a media thickening in response to the increase in blood pressure in hypertensive patients, an intima thickening in response to atherosclerotic risk factors, or most often a combination of both.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningCommon cardiovascular factors likely influence both intima-media thickness and vascular cognitive impairment independently, but the consequences of vascular disease may also directly affect cognitive function.
“In all likelihood, common cardiovascular factors influence both IMT and VCI independently, but the consequences of vascular disease may also directly affect cognitive function.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBoth aortic pulse wave velocity and central systolic blood pressure and pulse pressure predict cardiovascular events independent of classic cardiovascular risk factors.
“Both aortic pulse wave velocity and central systolic blood pressure and pulse pressure predict cardiovascular events independent of classic cardiovascular risk factors.182”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [182] source
May combine two claims.
PremisecitationSmall-vessel disease increases with age and is accelerated by vascular risk factors, especially hypertension and diabetes.
“Small-vessel disease increases with age and is accelerated by vascular risk factors, most notably, hypertension and diabetes.223”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [223] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenVCI may have a variety of clinical presentations that depend on the setting in which patients are evaluated.
“As previously discussed, VCI may have a variety of clinical presentations that may depend on the setting in which patients are evaluated.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenAnalysis of the aortic pressure waveform allows calculation of central systolic blood pressure and pulse pressure, which are influenced by aortic stiffness and the geometry and vasomotor tone of small arteries.
“The analysis of aortic pressure waveform allows the calculation of central systolic blood pressure and pulse pressure, which are influenced by aortic stiffness and the geometry and vasomotor tone of small arteries.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLeft hemisphere, anterior and posterior cerebral artery distribution, multiple infarcts, and strategic infarcts have been associated with poststroke dementia in at least two studies.
“Left hemisphere, anterior and posterior cerebral artery distribution, multiple infarcts, and strategic infarcts have been associated with PSD in at least 2 studies.40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] source
May combine two claims.
PremisecitationMeasures of cerebral gray matter and hippocampal volume were both associated with declines in memory performance.
“Conversely, measures of cerebral gray matter and hippocampal volume were both associated with declines in memory performance.256”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [256] source
May combine two claims.
PremisecitationWMLs share risk factors with stroke, although advancing age remains a strong effect.
“WMLs also share risk factors with stroke,239 although advancing age remains a strong effect.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [239] source
May combine two claims.
PremisecitationSilent cerebral infarcts, white matter changes, and global and medial temporal lobe atrophy are associated with increased risk of poststroke dementia.
“Among neuroimaging findings, silent cerebral infarcts, white matter changes, and global and medial temporal lobe atrophy are associated with increased risk of PSD.252”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [252] source
May combine two claims.
PremisecitationPatients with poststroke dementia have functional impairment and high mortality rates.
“Patients with PSD have degrees of functional impairment and high mortality rates.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [252] source
May combine two claims.
PremisecitationIn a Rochester community-based stroke study, dementia prevalence was 30% immediately after stroke, and new-onset dementia incidence increased from 7% at 1 year to 48% at 25 years.
“In a Rochester, MN, community-based study of stroke, the prevalence of dementia was 30% immediately after stroke, and the incidence of new-onset dementia increased from 7% after 1 year to 48% after 25 years.250”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [250] source
May combine two claims.
PremisecitationWMLs are more common than silent infarcts and are generally present in most people over 30 years of age, increasing steadily with advancing age.
“WMLs are even more common and are generally present in most people >30 years of age,231 increasing steadily in extent with advancing age.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [231] source
May combine two claims.
PremisecitationRisk of dementia after stroke is higher with increased age, fewer years of education, history of diabetes mellitus and atrial fibrillation, and recurrent stroke.
“Risk of dementia is higher with increased age and fewer years of education, history of diabetes mellitus and atrial fibrillation, and recurrent stroke.251”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [251] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenPrevalence estimates of VaD vary widely.
“Prevalence estimates of VaD vary widely.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAfter age 65, prevalence and incidence of VaD increase exponentially with age, although trends after 90 years are not well established.
“In general, however, after age 65 years, there is an exponential increase in prevalence and incidence of VaD as age increases,265,266 although the trends after 90 years of age have not been well established.4,267,268”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationThe clinical presentation and course of CVBI are highly variable, and the classic phenotype of stepwise decline with stroke is a relatively uncommon presentation for VCI.
“The clinical presentation and course of CVBI are highly variable, with the classic phenotype of stepwise decline in association with stroke10 being a relatively uncommon presentation for VCI.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] source
May combine two claims.
InterpretationreasoningStructural MRI provides a fairly sensitive and specific marker for CVBI, but the relationship between CVBI and cognitive impairment is confounded by frequent Alzheimer disease changes and co-occurrence of cerebrovascular depression.
“Structural MRI provides a fairly sensitive and specific marker for CVBI, but the relationship between CVBI and cognitive impairment is confounded by the frequent presence of Alzheimer disease changes of the brain and co-occurrence of depression on a cerebrovascular basis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAntioxidants, including vitamins E, C, and beta carotene, consumed as part of the diet or as supplements, have been reported to reduce the risk of cognitive impairment.
“Antioxidants, which include vitamins E,282 C, and beta carotene,283 consumed either as a part of the diet (fruits and vegetables) or as supplements, have been reported to reduce the risk of cognitive impairment.284”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSome studies report a higher incidence of VaD in men than women, although a pooled analysis of incidence studies found no difference.
“Some studies report a higher incidence of VaD in men than in women,4,271 although a pooled analysis of incidence studies found no difference.272”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFish oil n-3 polyunsaturated fatty acids are of interest because of their antioxidant and antiinflammatory properties and because they are major components of brain membrane phospholipids and play a critical role in neuronal function.
“Fish oil n-3 polyunsaturated fatty acids are of interest because of their antioxidant and antiinflammatory properties and because they are major components of membrane phospholipids in the brain and play a critical role in neuronal function.288”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [288] source
May combine two claims.
PremisecitationThe apolipoprotein E ε4 allele is associated with increased levels of cardiovascular risk factors and is a strong indicator of genetic risk for Alzheimer disease.
“The apolipoprotein E ε4 allele is associated with increased levels of cardiovascular risk factors276 and is a strong indicator of genetic risk for Alzheimer disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [276] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMCI may not differ by sex.
“MCI may not differ by sex,273 but additional studies are needed to answer this question.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [273] source
May combine two claims.
PremisecitationIncidence of VaD appears higher in blacks than whites or in Hispanics with a history of stroke, possibly reflecting group differences in cerebrovascular risk profile.
“The incidence of VaD appears to be higher in blacks than in whites4 or in Hispanics with a history of stroke,274 possibly reflecting group differences in cerebrovascular risk profile.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThere are a number of possible explanations or confounders in relation to education level and VCI.
“Thus, there are a number of possible explanations or confounders in relation to education level and VCI.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVascular risk factors are also importantly associated with Alzheimer disease, mixed dementia, and amnestic MCI.
“We recognize that this is a somewhat arbitrary choice, because many articles and reviews show that vascular risk factors are also importantly associated with Alzheimer disease, mixed dementia, and amnestic MCI.110,260,261”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Premisenone givenProspective cohort findings for diastolic blood pressure and cognitive decline are less consistent, but many report an inverse relation.
“Findings from these prospective cohort studies for diastolic blood pressure and cognitive decline are less consistent; however, many have reported a similar inverse relation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn longitudinal cohort studies, higher systolic blood pressure is associated with greater late-life cognitive decline, although some studies report J- or U-shaped relations.
“In longitudinal cohort studies, higher systolic blood pressure has been associated with greater late-life cognitive decline, although some studies have reported a J- or U-shaped relation.342”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [342] source
May combine two claims.
InterpretationreasoningData on later-life blood pressure and hypertension in relation to cognition are inconsistent, leaving the issue of treating blood pressure in older people open.
“The data on the role of blood pressure and hypertension in later life are not consistent, leaving open the issue of blood pressure treatment in older people.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningStudies vary in the amount of alcohol associated with a positive effect, the relative significance for global, memory, and executive function, and whether the effect varies by sex.
“However, studies vary in the amount of alcohol associated with a positive effect; the relative significance of global, memory, and executive function; and whether the effect varies by sex.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationNicotine may stimulate cholinergic pathways in the brain, which could help explain domain-specific effects of smoking on cognition.
“possibly because nicotine may also stimulate cholinergic pathways within the brain.326”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [326] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThere is a relative paucity of data on the type and frequency of physical activity and its short- and long-term benefits for preservation of brain health.
“There is a relative paucity of data on the type and frequency of physical activity and what the short- and long-term benefits of physical activity are for preservation of brain health.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLong-term regular physical activity, including vigorous activity and walking, is strongly associated with higher cognitive function, less cognitive decline, and less VaD.
“However, long-term regular physical activity, including vigorous activity and walking, was strongly associated with higher levels of cognitive function, less cognitive decline, and less VaD.303–306”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Premisenone givenDepression may affect cognitive functions and may mimic cognitive decline.
“Depression may impact cognitive functions and may mimic cognitive decline.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningMidlife systolic and diastolic blood pressure, history of hypertension, and total cholesterol level predict VCI.
“Midlife systolic and diastolic blood pressure, history of hypertension, and total cholesterol level predict VCI.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn the CAIDE study, midlife total cholesterol significantly predicted cognitive impairment 21 years later, and the association was attenuated after accounting for statin therapy.
“In the Finnish study Cardiovascular Risk Factors Aging and Dementia (CAIDE), midlife measures of total cholesterol significantly predicted cognitive impairment 21 years later, an association that was attenuated after accounting for statin therapy.354”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [354] source
May combine two claims.
PremisecitationSevere chronic kidney disease is associated with metabolic (uremic) and hypertensive encephalopathy and increased stroke risk.
“Severe chronic kidney disease has been associated with metabolic (uremic) and hypertensive encephalopathy and an increased risk of stroke.366”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [366] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThese findings have been reported across multiple populations.
“These findings have been reported across multiple populations.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLate-life cohort findings on cholesterol vary, with some showing higher cholesterol associated with lower risk and others with higher VaD risk.
“Findings in late-life cohorts vary, with some finding higher levels of cholesterol associated with a lower risk356 and others finding a higher risk for VaD.357”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThere are scarce data relating flow-mediated endothelial dilatation with cognition.
“There are scarce data relating flow-mediated endothelial dilatation (brachial artery reactivity) with cognition.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningDifferences in atrial fibrillation findings could be related to age or sex (weaker effect in women and older people) and to administration and effectiveness of anticoagulation.
“Some of these differences could be related to age or sex (the effect was weaker in women and older people) and the administration and effectiveness of anticoagulation.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe relation of late-life VCI to later-life blood pressure and cholesterol remains uncertain and requires further study, although higher exposure may prove beneficial.
“The relation of late-life VCI to measures of blood pressure and cholesterol in later life remains uncertain and requires further study, although higher levels of exposure to these risk factors may prove to be beneficial.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningInconsistencies in cholesterol findings may reflect timing of measurements relative to age, older people being less likely to receive lipid-lowering therapy, and clinical onset of dementia.
“As with blood pressure, inconsistencies may reflect timing of the cholesterol measurements relative to age, older people possibly being less likely to receive lipid-lowering therapy (“generational effect”), and clinical onset of dementia.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenCoronary artery bypass graft is associated with poorer initial cognitive function and higher late-life dementia risk.
“Coronary artery bypass graft has been associated with poorer initial cognitive function and a higher late-life dementia risk.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenMany facets of dementia care do not involve therapies directed at disease modification.
“Many facets of dementia care do not involve therapies directed at disease modification.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCochrane reviews concluded donepezil studies provide the best available evidence for a beneficial effect in VaD and galantamine for mixed states, while benefit of memantine and rivastigmine is still not proven.
“Cochrane reviews of VaD trials concluded that donepezil studies have provided the best available evidence for a beneficial effect for VaD397 and galantamine for mixed states,402 whereas a benefit of memantine410 and rivastigmine is still not proven.404”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationA subsequent pure VaD study (n=788) showed cognitive treatment benefits, including an executive measure but not daily functions, with an overall trend for global benefit (P=0.06).
“A subsequent study of “pure” VaD patients (n=788) showed cognitive treatment benefits, including benefit for an executive measure but not for daily functions; however, there was an overall trend for global benefit (P=0.06).401”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [401] source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenOver the past decade, the role of vascular brain disease as a cause of cognitive impairment has become increasingly evident, alone or combined with Alzheimer disease.
“Over the past decade, the role of vascular brain disease as a cause of cognitive impairment has become increasingly evident, alone or combined with Alzheimer disease.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn a recent study, more deaths occurred in the donepezil treatment group, attributed to a lower-than-expected death rate in the placebo group.
“In a recent study, however, more deaths occurred in the donepezil treatment group; this was attributed to the less than expected death rate in the placebo group.398”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [398] source
May combine two claims.
PremisecitationThe association with dementia appears stronger for vascular factors measured in midlife than in old age, suggesting midlife may be a critical period.
“The timing of such interventions may be important, because the association with dementia appears to be stronger for vascular factors and when measured in midlife rather than in old age, which suggests that midlife may be a critical period.424”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [424] source
May combine two claims.
PremisecitationAn 18-week donepezil study in 168 CADASIL patients had a neutral result but showed benefit in executive function measures in secondary analysis.
“An 18-week study of donepezil in 168 patients with CADASIL had a neutral result but showed benefit in executive function measures in secondary analysis.408”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [408] source
Classified as probably not a substantial claim.
InterpretationcitationHippocampal volume may need to be accounted for in future VaD trials.
“This finding suggests that hippocampal volume may need to be accounted for in future VaD trials.398”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [398] source
May combine two claims.
InterpretationreasoningDisease of coronary or peripheral arterial circulations, atrial fibrillation, and clinically detectable renal and cardiac failure have each been associated with cognitive impairment.
“In an analogous manner, disease of the coronary or peripheral arterial circulations, atrial fibrillation, and clinically detectable renal and cardiac failure have each been associated with cognitive impairment.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationGalantamine produced statistically significant less decline in cognition, function, and behavior, driven by the mixed AD/VaD subgroup, while placebo subjects declined.
“There was statistically significant less decline in cognition, function, and behavior with galantamine, driven by the mixed subgroup, whereas subjects treated with placebo showed decline.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [403] source
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningVascular and metabolic risk factors should be regarded as potential major targets for prevention of dementia.
“Vascular and metabolic risk factors should therefore be regarded as potential major targets for the prevention of dementia.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIt has been estimated that among 106 million Alzheimer disease cases expected worldwide by 2050, about 23 million could be avoided if onset were delayed by 2 years.
“It has been estimated, for example, that among the 106 million cases of Alzheimer disease expected worldwide by the year 2050, ≈23 million could be avoided completely if it were possible to delay the onset of disease by 2 years.423”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [423] source
May combine two claims.
InterpretationreasoningThe increased dementia risk after stroke is caused in part by loss of brain tissue, but may also reflect a direct effect of vascular risk factors on both stroke risk and cognitive function.
“Although this is caused in part by loss of brain tissue, it may also reflect a direct effect of vascular risk factors on both risk of stroke and cognitive function.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOne meta-analysis commented that cognitive benefits of cholinergic agents and memantine were of uncertain clinical significance in VaD, and more data are required before widespread use.
“One meta-analysis commented that the cognitive benefits of cholinergic agents and memantine were of uncertain clinical significance in VaD, and more data are required before widespread use of these agents is to be considered.411”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [411] source
May combine two claims.
InterpretationreasoningSpecific pharmacotherapy trials targeting VaD have shown consistent, modest cognitive improvements with donepezil, galantamine, and memantine, but functional and global benefits have been less consistent, with evidence only from 2 large donepezil trials.
“Specific pharmacotherapy trials targeting VaD have shown consistent, modest cognitive improvements with donepezil, galantamine, and memantine, but functional and global benefits have been less consistent, with evidence only from 2 large donepezil trials.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenThere are few randomized controlled trials and methodological limitations in existing studies of cognitive rehabilitation/stimulation.
“However, there are few randomized controlled trials, and there are methodological limitations in existing studies in the area.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDonepezil trials focused on pure VaD (n=1219), with placebo groups stable over 6 months, requiring improvement to show efficacy.
“The donepezil trials focused on “pure” VaD (n=1219), in which placebo groups were stable over 6 months, requiring improvement to show efficacy.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenNonpharmacological approaches have also been tried.
“Nonpharmacological approaches have also been tried.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRivastigmine has been less well studied, but beneficial effects on an executive measure were found in a 22-month open-label controlled study (n=16) and in a double-blind placebo-controlled trial targeting vascular cognitive impairment, no dementia (n=50).
“Rivastigmine has been less well studied, but beneficial effects on an executive measure were found in a 22-month, open-label controlled (n=16) study409 and in a double-blind placebo-controlled trial targeting vascular cognitive impairment, no dementia (n=50).405”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn longitudinal studies of antihypertensive drugs and dementia risk, mean follow-up was ≤5 years for most studies, except 2 studies with 13 and 19 years follow-up and younger participants at inclusion.
“Mean duration of follow-up was ≤5 years for most studies, except 2 studies with a follow-up of 13429 and 19430 years and that included participants who were a younger age at inclusion.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAcupuncture showed cognitive benefit in a rodent model of VaD, but a Cochrane review of acupuncture in human VaD was inconclusive.
“Acupuncture showed cognitive benefit in a rodent model of VaD,421 but a Cochrane review of acupuncture in human VaD was inconclusive,422”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningTrials failed partly because standard cognitive measures showed only modest benefit and undersampled executive functioning.
“Reasons include only modest benefit on standard cognitive measures, which undersampled executive functioning”
Quote in the paperSubstantial claimMay combine two claims.
Premiseown dataIn PROGRESS, during 4-year follow-up, dementia was diagnosed in 410 patients, 108 after stroke.
“During the 4-year follow-up, dementia was diagnosed in 410 patients, of whom 108 had dementia preceded by a stroke.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningComparing angiotensin receptor blockers with an angiotensin-converting enzyme inhibitor is a remarkable attempt to overcome confounding by indication because the two drug classes are similar in novelty and price.
“By comparing angiotensin receptor blockers with an angiotensin-converting enzyme inhibitor, 2 classes of drug similar in novelty and price, this study is a remarkable attempt to overcome confounding by indication.”
Quote in the paperSubstantial claimMay combine two claims.
Premiseown dataIn the Syst-Eur extension, nitrendipine treatment reduced both Alzheimer disease and VaD.
“In the extension study, both Alzheimer disease and VaD were reduced by treatment with nitrendipine.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe findings on diuretic class effects were based on limited follow-up, relatively small numbers of dementia cases, and confounding by indication.
“These findings, however, were based on a limited follow-up, a relatively small number of dementia cases, and confounding by indication.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe Veterans Affairs study had relatively short follow-up and did not assess ethnic disparities.
“Furthermore, the follow-up was relatively short, and ethnic disparities were not assessed.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataSyst-Eur was stopped early after median 2 years because nitrendipine significantly reduced stroke risk.
“The trial was stopped prematurely after a median follow-up period of 2 years on evidence of significant benefits from treatment with nitrendipine for lowering the risk of stroke.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenPublished trials had small numbers of incident cases and low statistical power.
“(4) small numbers of incident cases and low statistical power;”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenUse of administrative databases is subject to limitations such as lack of precision in dementia/Alzheimer disease diagnosis and inability to account for major confounders such as educational level.
“The use of administrative databases, however, is subject to limitations such as a lack of precision concerning diagnosis of dementia and Alzheimer disease or the impossibility of taking into account potential major confounders such as educational level.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningIn SCOPE, control patients received antihypertensive drugs during the trial for ethical reasons, reducing between-group BP differences and study power.
“Although initially planned as a trial of an angiotensin receptor blocker versus placebo, during the trial and for ethical reasons, antihypertensive drugs were administered to patients in the control group. Therefore, between-group blood pressure differences and the study power were reduced.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn PROGRESS, combination perindopril plus diuretic reduced systolic BP by 12 mm Hg, diastolic by 5 mm Hg, and stroke risk by 43%.
“Combination therapy reduced systolic and diastolic blood pressure by 12 and 5 mm Hg, respectively, and stroke risk by 43%.451”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [451] source
May combine two claims.
PremisecitationTwo analyses of the same study showed different results by follow-up duration: no effect on dementia and Alzheimer disease with 2.2 years follow-up, and a 5% reduction in dementia risk per year of treatment (6% for Alzheimer disease) with much longer follow-up.
“Interestingly, 2 analyses of the same study showed different results according to the duration of follow-up: no effect on dementia and Alzheimer disease in a first study with only 2.2 years of follow-up432 and a 5% reduction in risk of dementia per year of treatment (6% for Alzheimer disease) in a study with a much longer follow-up.429”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationLonger duration of antihypertensive treatment and lower age were associated with a stronger protective effect against dementia.
“Longer duration of treatment and lower age were associated with a stronger protective effect.429”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [429] source
May combine two claims.
InterpretationreasoningA few studies suggest a greater effect of some classes of antihypertensive therapy, but evidence remains limited and subject to bias, so no firm conclusion can be drawn.
“A few studies suggest a greater effect of some classes of antihypertensive therapy, but the evidence remains limited and is subject to bias so that no firm conclusion can be drawn about this relationship.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSome observational studies suggest aspirin benefits cognition, while others do not confirm this.
“Some observational studies have suggested a beneficial effect of aspirin on cognition,465,466 although this was not confirmed in others.467,468”
Quote in the paperNot a substantial claim0 of 4 sources checkedMay combine two claims.
PremisecitationLong-duration diabetes increases risk of cognitive decline, dementia, depression, and other aging phenotypes.
“Patients with diabetes of long duration are at increased risk of cognitive decline, dementia, and depression, as well as other phenotypes associated with aging.438a”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 438a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationnone givenDiabetes is an important risk factor for mental symptoms and cognitive impairment, but available data are mostly observational.
“Diabetes is an important risk factor for mental symptoms and cognitive impairment, but available data are based mostly on observational studies.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningMeta-analyses are subject to limitations similar to therapeutic trials and yield no substantial additional information.
“They are subject to limitations similar to those of therapeutic trials and do not yield any substantial additional information.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningEvidence generally lacks for positive benefit of antiaggregants and vitamin supplementation on cognitive function.
“There is generally a lack of evidence for a positive benefit of antiaggregants and vitamin supplementation on cognitive function.”
Quote in the paperSubstantial claimMay combine two claims.
Premiseown dataOnly one meta-analysis found significantly decreased dementia risk, but it was embedded in the HYVET report and scantily described, especially selection criteria.
“Only 1 trial found that the risk for dementia was significantly decreased, but it was embedded in the report of the HYVET results, and its description was scant, especially concerning selection criteria for the studies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDepression and anxiety are more prevalent in established type 2 diabetes.
“This is often accompanied by other disturbances of mental function, such as depression or anxiety, all of these conditions being described as being more prevalent in established type 2 diabetes mellitus.438a”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 438a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationnone givenEvidence from observational studies on statin effects on cognitive function is scant and low-level.
“There is scant evidence from observational studies on the effects of statin therapy on cognitive function, and the level of evidence is low.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenObservational studies suggest some benefit of antihypertensive treatment on Alzheimer disease risk, apparently greater in the youngest old than the oldest.
“Observational studies point to some benefit of antihypertensive treatment on the risk for Alzheimer disease, the treatment being apparently more effective in the youngest old than in the oldest people.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTreatment of hyperglycemia prevents microvascular and some macrovascular events, based on a recent meta-analysis.
“The treatment of hyperglycemia is associated with prevention of both microvascular and, to some degree, macrovascular events, based on data from a recent meta-analysis.457”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [457] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenIntensive control-induced hypoglycemia may affect cognitive function in older people with diabetes, an aspect not yet explored.
“The possible effect of intensive control–induced hypoglycemia on cognitive function represents a relevant and yet-to-be-explored aspect in older people with diabetes.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenIn severe hyperglycemia, cognitive dysfunction is acutely impaired by hyperosmolar influences and electrolyte disturbances, which acute insulin therapy can improve.
“In severe cases of hyperglycemia, the cognitive dysfunction is acutely impaired by hyperosmolar influences and electrolyte disturbances, conditions that are possible to improve by acute insulin therapy.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationAlthough statin therapy prevents stroke, it does not prevent cognitive decline in the elderly.
“Although lipid control by statin therapy is able to prevent stroke, these drugs do not prevent cognitive decline in the elderly.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningMeta-analyses neither prove nor disprove efficacy of antihypertensive treatment on dementia risk.
“Meta-analyses neither prove nor disprove the efficacy of antihypertensive treatment on the risk of dementia.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationcitationIt has been proposed that pathogenic mechanisms converge in vascular and neurodegenerative processes causing cognitive impairment.
“Therefore, it has been proposed that there may be a convergence of pathogenic mechanisms in vascular and neurodegenerative processes that cause impairment of cognition.101,493”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAn angiogenesis hypothesis for Alzheimer disease exists, and genes may contribute to neurovascular unit dysfunction in that disease.
“In fact, there is an angiogenesis hypothesis for Alzheimer disease and a possible role for genes in neurovascular unit dysfunction in Alzheimer disease.107,492”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationCovert brain injury from subclinical CVBI, stroke, and vascular risk factors may relate to neuropsychological deficits and add to VCI and later manifest stroke sequelae.
“In addition, as subclinical CVBI, stroke, and vascular risk factors have been a major focus of this statement, a better understanding of the prevention of “silent” strokes and WMLs (ie, “covert” brain injury) is necessary, because these events may be associated with neuropsychological deficits and contribute to VCI and eventual manifest stroke sequelae risk.498”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [498] source
- Rests on an assumption: Silent strokes outnumber clinically manifest strokes by more than nine to one.
- Rests on an assumption: The proportion of people with milder VCI is about twice that with severe VCI (VaD).
The authors state this as an assumption.
The underlying neuropathological substrate of amnestic mild cognitive impairment is pure Alzheimer disease pathology rather than vascular or mixed pathology.
“assuming the underlying neuropathological substrate of amnestic MCI is pure Alzheimer disease pathology rather than vascular or mixed pathology”
The paper relies on this without support.
Neuroimaging detects macroscopic infarcts about 3 mm or more in size, but microscopic infarcts and small-vessel disease are currently not within the resolution of most scans.
“First, neuroimaging detects macroscopic infarcts, ≈3 mm or more in size, but microscopic infarcts and small-vessel disease (eg, arteriolosclerosis) are currently not within the resolution of most scans.”
The paper relies on this without support.
Stiffer large arteries are associated with increased left ventricular mass.
“Additionally, stiffer large arteries are associated with increased left ventricular mass.”
The paper relies on this without support.
No study has investigated the relationship between small-artery remodeling and cognitive decline or white matter lesions.
“To the best of our knowledge, no study has investigated the relationship between small-artery remodeling and cognitive decline or WMLs.”
The paper relies on this without support.
In community-based studies, evidence of CVBI and cognitive impairment is often found without a history of a strokelike event.
“For example, in community-based studies, evidence of CVBI and cognitive impairment is often found without a history of a strokelike event.”
The paper relies on this without support.
Late-life depression may be accompanied by a higher frequency of brain white matter damage and other subcortical lesions, such as lacunar infarcts.
“There may be a higher frequency of brain white matter damage and other subcortical lesions, such as lacunar infarcts.”
The paper relies on this without support.
Depression with a cerebrovascular basis may respond to treatment with certain selective serotonin-reuptake inhibitors.
“Depression with a cerebrovascular basis may respond to treatment with certain selective serotonin-reuptake inhibitors.”
The paper relies on this without support.
The activity of biomarkers in the brain generally cannot be measured directly.
“The activity of biomarkers in the brain generally cannot be measured directly.”
The paper relies on this without support.
The only clear risk for cognitive impairment from alcohol intake is heavy alcohol use.
“The risks and benefits of alcohol intake have been debated for years, with the only clear risk for cognitive impairment being heavy alcohol use.”
The paper relies on this without support.
Smoking's effects on the cardiovascular system and neurons are mediated generally by oxidative stress and inflammation.
“Smoking has well-known effects on the cardiovascular system and neurons, which are mediated generally by oxidative stress and inflammation.”
The paper relies on this without support.
Inflammation is a key process linking many cardiovascular risk factors to vascular and neuronal damage.
“Inflammation is a key process linking many cardiovascular risk factors to vascular and neuronal damage.”
The paper relies on this without support.
During midlife, the population-attributable risk of dementia is highest for hypertension, up to 30% of late-life dementia cases.
“In relation to the role of vascular risk factors, during midlife the population-attributable risk of dementia has been reported to be highest for hypertension (up to 30% of cases of late-life dementia).”
The paper relies on this without support.
Smoking is a risk factor for stroke-associated dementia.
“Smoking is a risk factor for stroke-associated dementia.”
The paper relies on this without support.
Hyperlipidemia or dyslipidemia is a metabolic condition of importance for cognitive function.
“Hyperlipidemia or dyslipidemia is a metabolic condition of importance for cognitive function.”
The paper relies on this without support.
Cognitive function is an important predictor of morbidity and mortality in the elderly.
“Cognitive function, an important predictor of morbidity and mortality in the elderly, however, is frequently not screened for in clinical practice as part of global cardiovascular risk and target-organ damage assessments.”
The paper relies on this without support.
Silent strokes outnumber clinically manifest strokes by more than nine to one.
“It is estimated that “silent” strokes outnumber clinically manifest ones by a factor of >9:1”
The paper relies on this without support.
The proportion of people with milder VCI is about twice that with severe VCI (VaD).
“and the proportion of those with a milder form of VCI is approximately 2-fold greater than those with a severe form of VCI (ie, VaD).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neither of the previous guidelines includes advances in understanding the pathophysiology and measurement of cerebral small vessel disease.
“neither include advances in understanding the pathophysiology and measurement of SVD”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
The cited statement discusses small-vessel disease pathophysiology in §6.3, including vascular risk factors and proposed mechanisms. It also describes methods for measuring small-artery remodeling there and the capabilities and limits of neuroimaging in §3.6. That is contrary to the claim that it does not include these topics. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredAs pointed out by Gorelick et al., a comprehensive assessment strategy is necessary for examining vascular contributions to subtle cognitive impairment, MCI, and dementia; and it notably differs from those strategies expressed by McKhann et al. that bedside mental status testing-though not optimal-is acceptable or by the DSM-5 which recommends cognitive impairment be assessed either by neuropsych
“As pointed out by Gorelick et al. [56], a comprehensive assessment strategy is necessary for examining vascular contributions to subtle cognitive impairment, MCI, and dementia; and it notably differs from those strategies expressed by McKhann et al. [6] that bedside mental status testing—though not optimal—is acceptable or by the DSM-5 which recommends cognitive impairment be assessed either by”
From Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates (2014) · cites this paper as [56]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredMultiple MVLs in standard sections of brain are associated with increased likelihood of cognitive impairment or dementia.
“one MVL identified in standard sections of brain (Table 1 regions shaded green) is of unclear relationship to cognitive function, while multiple MVLs in these regions are associated with increased likelihood of cognitive impairment or dementia [24,52,62].”
From National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2012) · cites this paper as [24]
Section 3.2 (page not available in our copy) reports that some studies associate multiple microscopic infarcts with dementia, even after accounting for macroscopic infarcts. It does not establish the claim for MVLs generally or specify that the lesions were identified in standard brain sections. (LLM, conf=0.82)
Experimental — accuracy not yet measuredOne MVL identified in standard sections of brain is of unclear relationship to cognitive function.
“one MVL identified in standard sections of brain (Table 1 regions shaded green) is of unclear relationship to cognitive function, while multiple MVLs in these regions are associated with increased likelihood of cognitive impairment or dementia [24,52,62].”
From National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2012) · cites this paper as [24]
Section 3.2 (page unavailable) says the number of infarcts needed for cognitive impairment is difficult to determine and reports that multiple microscopic infarcts may be related to dementia. It does not specifically assess the cognitive significance of one MVL identified in standard brain sections. (LLM, conf=0.82)
Experimental — accuracy not yet measuredThe American Heart Association statement included a class 2 recommendation for neuroimaging as part of clinical investigation of vascular cognitive impairment.
“included a class 2 recommendation for neuroimaging as part of the clinical investigation of vascular cognitive impairment.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
Neither of the previous guidelines provides comprehensive recommendations for the many forms of cerebral small vessel disease seen on neuroimaging.
“neither of these guidelines provide comprehensive recommendations for the many forms of SVD seen on neuroimaging”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
A scientific statement from the American Heart Association incorporated neuroimaging evidence for cerebral small vessel disease or stroke into criteria for probable vascular mild cognitive impairment and dementia.
“a scientific statement from the American Heart Association incorporated neuroimaging evidence for SVD or stroke as part of the criteria for probable vascular mild cognitive impairment and dementia”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [12]
Macroscopic infarcts occur in about one third to one half of elderly people, and a vascular component is present in up to 80% of major cognitively impairing disorders including Alzheimer disease.
“Furthermore, macroscopic infarcts occur in about one third to one half of elderly individuals, and of all major cognitively impairing disorders, including AD, there is a vascular component in up to 80%.4,18,19”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
Modifiable cardiovascular risks-uncontrolled hypertension, diabetes, obesity, physical inactivity, smoking, and depression-are associated with worse brain health.
“Modifiable risks associated with poor cardiovascular health such as uncontrolled hypertension, diabetes mellitus, obesity, physical inactivity, smoking, and depression are associated with compromised brain health.4”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
The 2011 AHA/ASA scientific statement did not recommend changes to current management of cardiovascular risk factors to prevent dementia.
“The statement did not recommend changes to the current management of cardiovascular risk factors to prevent dementia”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
The only Class I recommendation in the 2011 statement was that hypertension treatment is recommended in people at risk for vascular cognitive impairment.
“The only Class I recommendation was, “In people at risk for vascular cognitive impairment, treatment of hypertension is recommended.”4”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [4]
Vascular dementia accounts for at least 20% of dementia cases.
“Vascular dementia (VaD), the second most common cause of dementia after Alzheimer's disease (AD), accounts for at least 20% of cases. 3”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
Vascular dementia is the second most common form of dementia after Alzheimer's disease.
“Vascular dementia is now recognized as the second most common form of dementia after Alzheimer's disease”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
Rates of conversion to dementia, institutionalization, and mortality are significantly increased in patients with VCI.
“Rates of conversion to dementia, institutionalization, and mortality are significantly increased in these patients, identifying patients with VCI as an important target population for prevention. 3,8-11”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
These aspects have not been operationalized in current diagnostic criteria.
“However, these aspects have not been operationalized in current diagnostic criteria. 3”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
Available diagnostic criteria vary with regard to sensitivity and specificity and are not interchangeable.
“However, available diagnostic criteria vary with regard to sensitivity and specificity and are, thus, not interchangeable. 3,18,22-25”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
The efficacy of blood pressure lowering to prevent cognitive impairment in the elderly beyond stroke prevention is still controversial.
“The efficacy of blood pressure (BP) lowering to prevent cognitive impairment in the elderly beyond stroke prevention is still controversial. 3”
From Vascular Cognitive Impairment (2017) · cites this paper as [3]
Vascular risk factors increase the risk of cognitive disorders.
“A number of ‘vascular’ risk factors, variably referred to as ‘cardiovascular’ or ‘cerebrovascular’, have been identified as increasing the risk of cognitive disorders.”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [24]
Carotid intimal-medial thickness and arterial stiffness are associated with arterial ageing and may serve as risk markers of vascular cognitive disorder.
“Emerging markers include carotid intimal-medial thickness and arterial stiffness, which are associated with arterial ageing and may serve as risk markers of VCD.24”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [24]
Vascular dementia accounts for at least 20% of dementia cases and is second only to Alzheimer's disease.
“Vascular dementia, a heterogeneous group of brain disorders in which cognitive impairment is attributable to cerebrovascular pathologies, is responsible for at least 20% of cases of dementia, being second only to Alzheimer’s disease (AD) (Gorelick et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
Cerebrovascular disease is a primary cause of cognitive impairment and also amplifies dementia caused by other factors, including Alzheimer's disease.
“Recent clinical-pathological studies have highlighted the role of cerebrovascular disease, not only as a primary cause of cognitive impairment, but also as an adjuvant to the expression of dementia caused by other factors, including AD and other neurodegenerative pathologies (Gorelick et al., 2011; Schneider et al., 2007a; Toledo et al., 2013).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
There is a general correlation between total vascular pathology burden and cognitive deficits.
“As for the other pathologies underlying VCI, there is a general correlation between the total burden of vascular pathology and cognitive deficits (Gelber et al., 2012; Gorelick et al., 2011; Inzitari et al., 2009).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
Confluent white matter lesions and lacunes occur commonly in VCI and show strong links to cardiovascular risk factors such as hypertension, diabetes, hyperlipidemia, and smoking.
“Confluent white matter lesions, the imaging correlate of which is termed leukoaraiosis (fig. 3), and lacunes, small (<1.5 cm) white matter infarcts typically in the basal ganglia, are common occurrence in VCI and are strongly associated with cardiovascular risk factors, especially hypertension, diabetes, hyperlipidemia and smoking (Gorelick et al., 2011; Wardlaw et al., 2013b).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
Advanced age is a strong risk factor for vascular cognitive impairment, and the prevalence and incidence of cognitive impairment rise steeply after age 65.
“Advanced age is a powerful risk factor for VCI, and the prevalence and incidence of cognitive impairment increases exponentially after age 65 (Gorelick et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
Developing treatments for vascular cognitive impairment has been hampered by the lack of a suitable animal model that recapitulates the multifaceted features of the disease.
“The development of treatments for VCI has been hampered by the lack of a suitable animal model recapitulating the multifaceted features of the disease (Gorelick et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Gorelick et al., 2011
Vascular dementia has seen a broadening of the concept to vascular cognitive impairment and dementia, and new diagnostic criteria have been proposed.
“Vascular dementia has seen a broadening of the concept to vascular cognitive impairment and dementia 156 , and new diagnostic criteria157, 158 have been proposed.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [156]
Vascular risk factors should raise the index of suspicion but should not be used as diagnostic criteria.
“A number of vascular risk factors that should raise the index of suspicion have been recognized, 34 but these factors should not be used as diagnostic criteria.”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [34]
Vascular disease predisposes to cognitive impairment in older adults.
“Vascular disease also predisposes to cognitive impairment in older adults.182”
Cerebral infarcts and neurovascular dysfunction are the most important cerebrovascular pathologies contributing to cognitive impairment and dementia in CVD, and both may benefit from regular physical activity.
“however, cerebral infarcts and neurovascular dysfunction are the most important cerebrovascular pathologies,182 both of which may benefit from regular physical activity.”
Substantial evidence supports a link between cognition and cardiovascular risk factors.
“Substantial evidence exists supporting the link between cognition and cardiovascular risk factors.10”
High blood pressure has been linked with the pathophysiology of MCI and with Alzheimer disease and vascular dementia.
“In particular, high blood pressure has been linked with the pathophysiology of MCI other than with Alzheimer disease and vascular dementia.10,11”
Evidence from randomized clinical trials that treating hypertension reduces dementia risk and that drugs targeting angiotensin II and its receptors have a class-specific effect is lacking.
“However, evidence from randomized clinical trials that treatment of hypertension reduces dementia risk and that there is a class-specific effect of drugs targeting ANGII and its receptors is lacking (3).”
From Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension (2016) · cites this paper as [3]
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553 · see citing works
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works
Self-citationMild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works
Self-citationExpert consensus document on arterial stiffness: methodological issues and clinical applications
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl254 · Cited by 6,077 · see citing works
Self-citationScreening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30622-6 · Cited by 5,403 · see citing works
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · see citing works
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170 · see citing works
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works
Self-citationAndresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · PubMed · Cited by 4,426 · see citing works
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017 · see citing works
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708473 · Cited by 3,898 · see citing works
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370 · see citing works
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989 · see citing works
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887 · see citing works
Exercise: a behavioral intervention to enhance brain health and plasticity
Cotman, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02143-4 · Cited by 2,739 · see citing works
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650 · see citing works
Self-citationDSM-IV: Diagnostic and Statistical Manual of Mental Disorders
Bell, C. C. (1994) · JAMA · doi:10.1001/jama.1994.03520100096046 · Cited by 2,608 · see citing works
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1399 · Cited by 2,404 · see citing works
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313 · see citing works
Exercise builds brain health: key roles of growth factor cascades and inflammation
Cotman, C. W., Berchtold, N. C., & Christie, L.-A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.011 · Cited by 2,268 · see citing works
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · see citing works
Self-citationDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · see citing works
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997 · see citing works
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · see citing works
Self-citationThe Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930 · see citing works
Self-citationMechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926 · see citing works
Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study
Mattace-Raso, F. U. S., van der Cammen, T. J. M., Hofman, A., van Popele, N. M., Bos, M. L., Schalekamp, M. A. D. H., Asmar, R., Reneman, R. S., Hoeks, A. P. G., Breteler, M. M. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.555235 · Cited by 1,914 · see citing works
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160548.78317.29 · Cited by 1,854 · see citing works
Pendlebury, S. T., & Rothwell, P. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70236-4 · Cited by 1,853 · see citing works
Probability of stroke: a risk profile from the Framingham Study.
Wolf, P. A., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.3.312 · Cited by 1,782 · see citing works
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722 · see citing works
Self-citationSnowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · see citing works
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I. L., Kernan, W. N., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492 · see citing works
Longstreth, W. T., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., Enright, P. L., O'Leary, D., & Fried, L. (1996) · Stroke · doi:10.1161/01.str.27.8.1274 · Cited by 1,464 · see citing works
Larson, E. B., Wang, L., Bowen, J. D., McCormick, W. C., Teri, L., Crane, P., & Kukull, W. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-2-200601170-00004 · Cited by 1,463 · see citing works
Forette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441 · see citing works
The Study on Cognition and Prognosis in the Elderly (SCOPE)
Lithell, H., Hansson, L., Skoog, I. G., Elmfeldt, D., Albert Hofman, D., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,413 · see citing works
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · see citing works
Self-citationRay, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383 · see citing works
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · see citing works
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306 · see citing works
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · see citing works
O’Rourke, M. F., & Safar, M. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000168052.00426.65 · Cited by 1,279 · see citing works
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · see citing works
Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,249 · see citing works
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233 · see citing works
Physical activity and risk of cognitive decline: a meta-analysis of prospective studies
Sofi, F., Valecchi, D., Bacci, D., Abbate, R., Gensini, G. F., Casini, A., & Macchi, C. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02281.x · Cited by 1,210 · see citing works
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works
Self-citationChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · see citing works
Self-citationPhysical Activity, Including Walking, and Cognitive Function in Older Women
Weuve, J. (2004) · JAMA · doi:10.1001/jama.292.12.1454 · Cited by 1,175 · see citing works
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171 · see citing works
O'Brien, J. T., Erkinjuntti, T., Reisberg, ., Román, G. C., Pantoni, L., Bowler, J., Ballard, C., DeCarli, C., Gorelick, P., Rockwood, K., et al. (2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,165 · see citing works
Self-citationMcShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155 · see citing works
Glial regulation of the cerebral microvasculature
Iadecola, C., & Nedergaard, M. (2007) · Nature Neuroscience · doi:10.1038/nn2003 · Cited by 1,153 · see citing works
Self-citationO'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., et al. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00305-3 · Cited by 1,139 · see citing works
Self-citationThe age-dependent relation of blood pressure to cognitive function and dementia
Qiu, C., Winblad, B., & Fratiglioni, L. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70141-1 · Cited by 1,138 · see citing works
Angevaren, M., Aufdemkampe, G., Verhaar, H., Aleman, A., & Vanhees, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005381.pub3 · Cited by 1,130 · see citing works
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · see citing works
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · see citing works
MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093 · see citing works
Nagamatsu, L. S., Chan, A., Davis, J. C., Beattie, B. L., Graf, P., Voss, M. W., Sharma, D., & Liu-Ambrose, T. Y. L. (2013) · Journal of Aging Research · doi:10.1155/2013/861893 · Cited by 1,090 · see citing works
Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088 · see citing works
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015 · see citing works
Self-citationA white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014 · see citing works
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008 · see citing works
Self-citationBreteler, M. M. B., Swieten, J. C. V., Bots, M. L., Grobbee, D. E., Claus, J. J., Hout, J. H. W. V. D., van Harskamp, F., Tanghe, H. L. J., de Jong, P. T. V. M., van Gijn, J., et al. (1994) · Neurology · doi:10.1212/wnl.44.7.1246 · Cited by 1,006 · see citing works
(2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1069 · Cited by 988 · see citing works
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935 · see citing works
Self-citationPost-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · see citing works
Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921 · see citing works
Physical Activity, Diet, and Risk of Alzheimer Disease
Scarmeas, N. (2009) · JAMA · doi:10.1001/jama.2009.1144 · Cited by 916 · see citing works
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900 · see citing works
Forette, F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2046 · Cited by 898 · see citing works
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883 · see citing works
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882 · see citing works
A Neurovascular Niche for Neurogenesis after Stroke
Ohab, J. J., Fleming, S., Blesch, A., & Carmichael, S. T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4323-06.2006 · Cited by 878 · see citing works
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846 · see citing works
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works
The question of familial meningiomas and schwannomas:
King, A. A., & Gutmann, D. H. (2000) · Neurology · doi:10.1212/wnl.54.1.4 · Cited by 814 · see citing works
Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Diehr, P., O’Meara, E. S., Longstreth, W. T., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.582 · Cited by 796 · see citing works
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review
Eichner, J. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.6.487 · Cited by 796 · see citing works
The cognitive correlates of white matter abnormalities in normal aging: A quantitative review.
Gunning-Dixon, F. M., & Raz, N. (2000) · Neuropsychology · doi:10.1037/0894-4105.14.2.224 · Cited by 794 · see citing works
Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study
Vernooij, M. W., van der Lugt, A., Ikram, M. A., Wielopolski, P. A., Niessen, W. J., Hofman, A., Krestin, G. P., & Breteler, M. M. B. (2008) · Neurology · doi:10.1212/01.wnl.0000307750.41970.d9 · Cited by 793 · see citing works
Ott, A., Breteler, M. M. B., van Harskamp, F., Claus, J. J., van der Cammen, T. J. M., Grobbee, D. E., & Hofman, A. (1995) · BMJ · doi:10.1136/bmj.310.6985.970 · Cited by 792 · see citing works
The cognitive correlates of white matter abnormalities in normal aging: A quantitative review.
Gunning‐Dixon, F. M., & Raz, N. (2000) · Neuropsychology · doi:10.1037//0894-4105.14.2.224 · Cited by 790 · see citing works
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
Yusuf, S., Diener, H.-C., Sacco, R. L., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804593 · Cited by 785 · see citing works
Self-citationPeters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., Waldman, A., Walton, I., Poulter, R., Ma, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70143-1 · Cited by 770 · see citing works
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758 · see citing works
Mediterranean Diet and Mild Cognitive Impairment
Scarmeas, N., Stern, Y., Mayeux, R., Manly, J. J., Schupf, N., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.536 · Cited by 757 · see citing works
Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia
Féart, C. (2009) · JAMA · doi:10.1001/jama.2009.1146 · Cited by 757 · see citing works
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08267-3 · Cited by 752 · see citing works
Coordinated Interaction of Neurogenesis and Angiogenesis in the Adult Songbird Brain
Louissaint, A., Rao, S., Leventhal, C., & Goldman, S. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00722-5 · Cited by 735 · see citing works
Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study
Ott, A., Breteler, M. M. B., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., & Hofman, A. (1997) · Stroke · doi:10.1161/01.str.28.2.316 · Cited by 732 · see citing works
Howard, G., Sharrett, A. R., Heiss, G., Evans, G. W., Chambless, L. E., Riley, W. A., & Burke, G. L. (1993) · Stroke · doi:10.1161/01.str.24.9.1297 · Cited by 724 · see citing works
The Natural History of Mental Disorder in Old Age
Roth, M. (1955) · Journal of Mental Science · doi:10.1192/bjp.101.423.281 · Cited by 723 · see citing works
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717 · see citing works
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710 · see citing works
Self-citationβ-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · see citing works
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686 · see citing works
Self-citation(2000) · PubMed · Cited by 683 · see citing works
Self-citationDiabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682 · see citing works
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08083-5 · Cited by 682 · see citing works
DeCarli, C., Massaro, J., Harvey, D., Hald, J., Tullberg, M., Au, R., Beiser, A., D’Agostino, R., & Wolf, P. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.004 · Cited by 680 · see citing works
Self-citationIncidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study
Vermeer, S. E., den Heijer, T., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2003) · Stroke · doi:10.1161/01.str.0000052631.98405.15 · Cited by 680 · see citing works
Alzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680 · see citing works
Clinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669 · see citing works
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662 · see citing works
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies
Andersen, K., Launer, L. J., Dewey, M. E., Letenneur, L., Ott, A., Copeland, J. R. M., Dartigues, J.-F., Kragh–Sorensen, P., Baldereschi, M., Brayne, C., et al. (1999) · Neurology · doi:10.1212/wnl.53.9.1992 · Cited by 650 · see citing works
Self-citationArterial Aging: Is It an Immutable Cardiovascular Risk Factor?
Najjar, S. S., Scuteri, A., & Lakatta, E. G. (2005) · Hypertension · doi:10.1161/01.hyp.0000177474.06749.98 · Cited by 640 · see citing works
Self-citationBlood brain barrier: ageing and microvascular disease-systematic review and meta-analysis
Farrall, A., & Wardlaw, J. M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.089 · Cited by 639 · see citing works
Research criteria for subcortical vascular dementia in clinical trials
Erkinjuntti, T., Inzitari, D., Pantoni, L., Wallin, A., Scheltens, P., Rockwood, K. J., Román, G. C., Chui, H. C., & Desmond, D. W. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_4 · Cited by 635 · see citing works
Self-citationIs Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?
Wardlaw, J. M., Sandercock, P. A. G., Dennis, M. S., & Starr, J. (2003) · Stroke · doi:10.1161/01.str.0000058480.77236.b3 · Cited by 628 · see citing works
Sim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02451.2002 · Cited by 625 · see citing works
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621 · see citing works
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., Jicha, G. A., Ivnik, R. J., Smith, G. E., Tangalos, E. G., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.665 · Cited by 616 · see citing works
Self-citationBourre, J. M. (2006) · PubMed · Cited by 609 · see citing works
Leys, D., Hénon, H., Mackowiak-Cordoliani, M.-A., & Pasquier, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70221-0 · Cited by 609 · see citing works
Fernando, M. S., Simpson, J. E., Matthews, F., Brayne, C., Lewis, C. E., Barber, R., Kalaria, R. N., Forster, G., Esteves, F., Wharton, S. B., et al. (2006) · Stroke · doi:10.1161/01.str.0000221308.94473.14 · Cited by 587 · see citing works
White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion
Shibata, M., Ohtani, R., Ihara, M., & Tomimoto, H. (2004) · Stroke · doi:10.1161/01.str.0000143725.19053.60 · Cited by 583 · see citing works
Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke
Gould, D. B., Phalan, F. C., van Mil, S. E., Sundberg, J. P., Vahedi, K., Massin, P., Bousser, M. G., Heutink, P., Miner, J. H., Tournier-Lasserve, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053727 · Cited by 581 · see citing works
Clare, L., & Woods, B. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003260 · Cited by 576 · see citing works
Longstreth, W. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1217 · Cited by 573 · see citing works
Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563 · see citing works
(2000) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 563 · see citing works
Self-citationCasserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560 · see citing works
Hypertension and Cerebrovascular Dysfunction
Iadecola, C., & Davisson, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.010 · Cited by 557 · see citing works
Self-citationThe overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557 · see citing works
Self-citationSolomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000231980 · Cited by 557 · see citing works
Linking oxidative stress to inflammation: Toll-like receptors
Gill, R., Tsung, A., & Billiar, T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.006 · Cited by 553 · see citing works
The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged
Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547 · see citing works
O’Rourke, M. F., & Nichols, W. W. (2005) · Hypertension · doi:10.1161/01.hyp.0000153793.84859.b8 · Cited by 543 · see citing works
Orgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J., & Forette, F. (2002) · Stroke · doi:10.1161/01.str.0000020094.08790.49 · Cited by 539 · see citing works
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537 · see citing works
Self-citationOtt, A., Slooter, A., Hofman, A., van Harskamp, F., Witteman, J., Van Broeckhoven, C., van Duijn, C., & Breteler, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07541-7 · Cited by 535 · see citing works
DeCarli, C., Murphy, D. G. M., Tranh, M., Grady, C. L., Haxby, J. V., Gillette, J. A., Salerno, J. A., Gonzales-Aviles, A., Honvitz, B., Rapoport, S. I., et al. (1995) · Neurology · doi:10.1212/wnl.45.11.2077 · Cited by 531 · see citing works
Self-citationVascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530 · see citing works
Dietary intake of fatty acids and fish in relation to cognitive performance at middle age
Kalmijn, S., van Boxtel, M. P. J., Ocké, M., Verschuren, W. M. M., Kromhout, D., & Launer, L. J. (2004) · Neurology · doi:10.1212/01.wnl.0000103860.75218.a5 · Cited by 524 · see citing works
Self-citationGrabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523 · see citing works
Self-citationDementia incidence continues to increase with age in the oldest old: The 90+ study
Corrada, M. M., Brookmeyer, R., Paganini‐Hill, A., Berlau, D., & Kawas, C. H. (2010) · Annals of Neurology · doi:10.1002/ana.21915 · Cited by 523 · see citing works
Debette, S., Beiser, A., DeCarli, C., Au, R., Himali, J. J., Kelly-Hayes, M., Romero, J. R., Kase, C. S., Wolf, P. A., & Seshadri, S. (2010) · Stroke · doi:10.1161/strokeaha.109.570044 · Cited by 508 · see citing works
Self-citationVinters, H. V., & Gilbert, J. J. (1983) · Stroke · doi:10.1161/01.str.14.6.924 · Cited by 504 · see citing works
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
Greenberg, S. M., Eng, J. A., Ning, M., Smith, E. E., & Rosand, J. M. (2004) · Stroke · doi:10.1161/01.str.0000126807.69758.0e · Cited by 503 · see citing works
Self-citationKavirajan, H., & Schneider, L. S. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70195-3 · Cited by 497 · see citing works
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495 · see citing works
Self-citationCerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease
Esiri, M. M., Nagy, Z., Smith, M. Z., Barnetson, L., & Smith, A. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02355-7 · Cited by 493 · see citing works
Newman, A. B., Fitzpatrick, A. L., Lopez, O., Jackson, S., Lyketsos, C., Jagust, W., Ives, D., DeKosky, S. T., & Kuller, L. H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53360.x · Cited by 492 · see citing works
The anatomic basis of pure alexia
Damasio, A. R., & Damasio, H. (1983) · Neurology · doi:10.1212/wnl.33.12.1573 · Cited by 492 · see citing works
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490 · see citing works
Li, N.-C., Lee, A., Whitmer, R. A., Kivipelto, M., Lawler, E., Kazis, L. E., & Wolozin, B. (2010) · BMJ · doi:10.1136/bmj.b5465 · Cited by 486 · see citing works
van Beek, A. H., Claassen, J. A., Rikkert, M. G. O., & Jansen, R. W. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.13 · Cited by 485 · see citing works
Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study
Jeerakathil, T., Wolf, P. A., Beiser, A., Massaro, J., Seshadri, S., D’Agostino, R. B., & DeCarli, C. (2004) · Stroke · doi:10.1161/01.str.0000135226.53499.85 · Cited by 479 · see citing works
Self-citationStewart, R., Masaki, K., Xue, Q.-L., Peila, R., Petrovitch, H., White, L. R., & Launer, L. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.55 · Cited by 478 · see citing works
Self-citationLopez, O. L., Jagust, W. J., Dulberg, C., Becker, J. T., DeKosky, S. T., Fitzpatrick, A., Breitner, J., Lyketsos, C., Jones, B., Kawas, C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.10.1394 · Cited by 477 · see citing works
Longstreth, W. T., Arnold, A. M., Beauchamp, N. J., Manolio, T. A., Lefkowitz, D., Jungreis, C., Hirsch, C. H., O’Leary, D. H., & Furberg, C. D. (2005) · Stroke · doi:10.1161/01.str.0000149625.99732.69 · Cited by 474 · see citing works
Amyloid β Protein Precursor Gene and Hereditary Cerebral Hemorrhage with Amyloidosis (Dutch)
Broeckhoven, C. V., Haan, J., Bakker, E., Hardy, J., Hul, W. V., Wehnert, A., der Vlis, M. V.-V., & Roos, R. A. C. (1990) · Science · doi:10.1126/science.1971458 · Cited by 471 · see citing works
Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study
Bachman, D. L., Wolf, P. A., Linn, R. T., Knoefel, J. E., Cobb, J. L., Belanger, A. J., White, L. R., & D'Agostino, R. B. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.515 · Cited by 470 · see citing works
Incidence of dementia: does gender make a difference?
Ruitenberg, A., Ott, A., van Swieten, J. C., Hofman, A., & Breteler, M. M. B. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00231-7 · Cited by 467 · see citing works
Barnes, D. E., Alexopoulos, G. S., Lopez, O. L., Williamson, J. D., & Yaffe, K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.273 · Cited by 465 · see citing works
Waldstein, S. R., Rice, S. C., Thayer, J. F., Najjar, S. S., Scuteri, A., & Zonderman, A. B. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.093674 · Cited by 462 · see citing works
Self-citationDufouil, C., Chalmers, J., Coskun, O., Besançon, V., Bousser, M.-G., Guillon, P., MacMahon, S., Mazoyer, B., Neal, B., Woodward, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.501163 · Cited by 461 · see citing works
Self-citationNeuropathologic Substrate of Mild Cognitive Impairment
Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460 · see citing works
Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease
Hara, K., Shiga, A., Fukutake, T., Nozaki, H., Miyashita, A., Yokoseki, A., Kawata, H., Koyama, A., Arima, K., Takahashi, T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0801560 · Cited by 460 · see citing works
Genomewide Association Studies of Stroke
Ikram, M. A., Seshadri, S., Bis, J. C., Fornage, M., DeStefano, A. L., Aulchenko, Y. S., Debette, S., Lumley, T., Folsom, A. R., van den Herik, E. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900094 · Cited by 458 · see citing works
Self-citationHaan, M. N. (1999) · JAMA · doi:10.1001/jama.282.1.40 · Cited by 457 · see citing works
Polyunsaturated Fatty Acids, Antioxidants, and Cognitive Function in Very Old Men
Kalmijn, S., Feskens, E. J. M., Launer, L. J., & Kromhout, D. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009029 · Cited by 453 · see citing works
Self-citationCukierman‐Yaffe, T., Gerstein, H. C., Williamson, J. D., Lazar, R. M., Lovato, L., Miller, M. E., Coker, L. H., Murray, A. M., Sullivan, M. D., Marcovina, S. M., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1153 · Cited by 452 · see citing works
Self-citationRichards, A., van den Maagdenberg, A. M. J. M., Jen, J. C., Kavanagh, D., Bertram, P. G., Spitzer, D., Liszewski, M. K., Barilla-LaBarca, M.-L., Terwindt, G. M., Kasai, Y., et al. (2007) · Nature Genetics · doi:10.1038/ng2082 · Cited by 441 · see citing works
Brain endothelial cells and the glio-vascular complex
Wolburg, H., Noell, S., Mack, A., Wolburg-Buchholz, K., & Fallier-Becker, P. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0658-9 · Cited by 438 · see citing works
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, H. H., Doody, R. S., Kivipelto, M., Sparks, D. L., Waters, D. D., Jones, R. W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6476a · Cited by 438 · see citing works
Incidence and Prevalence of Dementia in the Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Ives, D. G., Lopez, O. L., Jagust, W., Breitner, J. C. S., Jones, B., Lyketsos, C., & Dulberg, C. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52058.x · Cited by 438 · cited 1× · see citing works
“All published trials share common limitations: (1) short follow-up duration442,444; (2) heterogeneity in screening and diagnosis of dementia441; (3) patients at low risk for dementia (young mean age)441,445 and with high baseline MMSE; (4)”
Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study
White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437 · see citing works
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology
Schneider, J. A., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000118211.78503.f5 · Cited by 436 · see citing works
Self-citationAngevaren, M., Aufdemkampe, G., Verhaar, H. J. J., Aleman, A., & Vanhees, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005381.pub2 · Cited by 436 · see citing works
Structural and Genetic Bases of Arterial Stiffness
Laurent, S., Boutouyrie, P., & Lacolley, P. (2005) · Hypertension · doi:10.1161/01.hyp.0000164580.39991.3d · Cited by 435 · see citing works
Self-citationExtent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., & DeCarli, C. S. (2006) · Neurology · doi:10.1212/01.wnl.0000249119.95747.1f · Cited by 434 · see citing works
Self-citationDementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984)
Kokmen, E., Whisnant, J. P., O'Fallon, W. M., Chu, C.-P., & Beard, C. M. (1996) · Neurology · doi:10.1212/wnl.46.1.154 · Cited by 434 · see citing works
Role of the renin–angiotensin system in vascular inflammation
Marchesi, C., Paradis, P., & Schiffrin, E. L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.003 · Cited by 432 · see citing works
Pathological correlates of dementia in a longitudinal, population‐based sample of aging
Sonnen, J. A., Larson, E. B., Crane, P. K., Haneuse, S., Li, G., Schellenberg, G. D., Craft, S., Leverenz, J. B., & Montine, T. J. (2007) · Annals of Neurology · doi:10.1002/ana.21208 · Cited by 432 · see citing works
Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort
Tatemichi, T. K., Desmond, D. W., Mayeux, R., Paik, M., Stern, Y., Sano, M., Remien, R. H., Williams, J. B. W., Mohr, J. P., Hauser, W. A., et al. (1992) · Neurology · doi:10.1212/wnl.42.6.1185 · Cited by 420 · see citing works
Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417 · see citing works
Self-citationClinical manifestations of cerebral amyloid angiopathy–related inflammation
Eng, J. A., Frosch, M. P., Choi, K., Rebeck, G. W., & Greenberg, S. M. (2004) · Annals of Neurology · doi:10.1002/ana.10810 · Cited by 417 · see citing works
Self-citationVascular risk factors and dementia: How to move forward?
Viswanathan, A., Rocca, W. A., & Tzourio, C. (2009) · Neurology · doi:10.1212/01.wnl.0000341271.90478.8e · Cited by 414 · see citing works
Self-citationHigh total cholesterol levels in late life associated with a reduced risk of dementia
Mielke, M. M., Zandi, P. P., Sjögren, M., Gustafson, D., Östling, S., Steen, B., & Skoog, I. (2005) · Neurology · doi:10.1212/01.wnl.0000161870.78572.a5 · Cited by 411 · see citing works
Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia
Bunch, T. J., Weiss, J. P., Crandall, B. G., May, H. T., Bair, T. L., Osborn, J. S., Anderson, J. L., Muhlestein, J. B., Horne, B. D., Lappe, D. L., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.12.004 · Cited by 405 · see citing works
Associations of vegetable and fruit consumption with age-related cognitive change
Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000240224.38978.d8 · Cited by 404 · see citing works
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399 · see citing works
Self-citationDiabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis
Lu, F.-P., Lin, K.-P., & Kuo, H.-K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004144 · Cited by 398 · see citing works
Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population
Tangney, C. C., Kwasny, M. J., Li, H., Wilson, R. S., Evans, D. A., & Morris, M. C. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007369 · Cited by 397 · see citing works
Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia
Reitz, C., Tang, M.-X., Luchsinger, J., & Mayeux, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.705 · Cited by 397 · see citing works
Predictors of maintaining cognitive function in older adults: The Health ABC Study
Yaffe, K., Fiocco, A. J., Lindquist, K., Vittinghoff, E., Simonsick, E. M., Newman, A. B., Satterfield, S., Rosano, C., Rubin, S. M., Ayonayon, H. N., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a92c36 · Cited by 396 · see citing works
Obesity, diabetes and cognitive deficit: The Framingham Heart Study
Elias, M. F., Elias, P. K., Sullivan, L. M., Wolf, P. A., & D’Agostino, R. B. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.019 · Cited by 395 · see citing works
A Controlled Trial of Homocysteine Lowering and Cognitive Performance
McMahon, J. A., Green, T., Skeaff, C. M., Knight, R. G., Mann, J. I., & Williams, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054025 · Cited by 395 · see citing works
Flagged first, then by citations
12 of the 538 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: World Health Organization; 1993.
- Report of the Stroke Progress Review Group. Bethesda, MD: National Institute of Neurological Disorders and Stroke; 2002.
- Safar M, O'Rourke MF eds. Arterial Stiffness in Hypertension: Handbook of Hypertension, Volume 23. New York, NY: Elsevier; 2006.
- Roose S, Sneed JR. The current status of vascular depression. US Psychiatry. 2007; 1: 21–23.
Cited by
Sorted by citations
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,560 · see citing works
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works
Self-citationMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,992 · see citing works
Self-citationThe Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857 · see citing works
Self-citationMechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657 · see citing works
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness
Townsend, R. R., Wilkinson, I. B., Schiffrin, E. L., Avolio, A. P., Chirinos, J. A., Cockcroft, J. R., Heffernan, K. S., Lakatta, E. G., McEniery, C. M., Mitchell, G. F., et al. (2015) · Hypertension · doi:10.1161/hyp.0000000000000033 · Cited by 1,488 · see citing works
Diagnosis and Management of Dementia: Review
Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019) · JAMA · doi:10.1001/jama.2019.4782 · Cited by 1,451 · see citing works
Self-citationWhite matter hyperintensities, cognitive impairment and dementia: an update
Prins, N. D., & Scheltens, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.10 · Cited by 1,284 · see citing works
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260 · see citing works
Self-citationO'Brien, J. T., & Thomas, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00463-8 · Cited by 1,136 · see citing works
Classifying neurocognitive disorders: the DSM-5 approach
Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.181 · Cited by 1,116 · see citing works
Self-citationOlsen, M., Angell, S., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J., Damasceno, A. A., Delles, C., Gimenez-Roqueplo, A., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 825 · see citing works
Self-citationGlucose Levels and Risk of Dementia
Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., Haneuse, S., Craft, S., Montine, T. J., Kahn, S. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215740 · Cited by 929 · see citing works
Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
Claassen, J. A. H. R., Thijssen, D. H. J., Panerai, R. B., & Faraci, F. M. (2021) · Physiological Reviews · doi:10.1152/physrev.00022.2020 · Cited by 947 · see citing works
What are White Matter Hyperintensities Made of?
Wardlaw, J. M., Hernández, M. C. V., & Maniega, S. M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001140 · Cited by 902 · see citing works
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849 · see citing works
Inequalities in dementia incidence between six racial and ethnic groups over 14 years
Mayeda, E. R., Glymour, M. M., Quesenberry, C. P., & Whitmer, R. A. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.007 · Cited by 883 · see citing works
Overview and Findings from the Rush Memory and Aging Project
Bennett, D. A., Schneider, J. A., Buchman, A. S., Barnes, L. L., Boyle, P. A., & Wilson, R. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322663 · Cited by 837 · see citing works
Self-citationDiagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement
Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., Blazer, D. G., Chen, C., Chui, H., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000034 · Cited by 852 · see citing works
Self-citationVascular Cognitive Impairment and Dementia
Iadecola, C., Duering, M., Hachinski, V., Joutel, A., Pendlebury, S. T., Schneider, J. A., & Dichgans, M. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.034 · Cited by 831 · see citing works
“This new definition evolved from the American Heart Association/American Stroke Association (8) and National Institute of Neurological Disorders and Stroke-Canadian Stroke Network (13) consensus statements, and aligns with revised terminology in DSM-V, which distinguishes between major and minor neurocognitive disorde…”
BackgroundMethodInfluentialSelf-citationPost-Stroke Cognitive Impairment and Dementia
Rost, N. S., Brodtmann, A. G., Pase, M. P., van Veluw, S. J., Biffi, A., Duering, M., Hinman, J. D., & Dichgans, M. (2022) · Circulation Research · doi:10.1161/circresaha.122.319951 · Cited by 837 · see citing works
Obesity and neuroinflammation: A pathway to cognitive impairment
Miller, A. A., & Spencer, S. J. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.04.001 · Cited by 788 · see citing works
Impact of multiple pathologies on the threshold for clinically overt dementia
Kapasi, A., DeCarli, C., & Schneider, J. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1717-7 · Cited by 739 · see citing works
Self-citationIadecola, C., Yaffe, K., Biller, J., Bratzke, L. C., Faraci, F. M., Gorelick, P. B., Gulati, M., Kamel, H., Knopman, D. S., Launer, L. J., et al. (2016) · Hypertension · doi:10.1161/hyp.0000000000000053 · Cited by 746 · see citing works
Self-citationBondi, M. W., Initiative, F. T. A. D. N., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., Nation, D. A., Libon, D. J., Au, R., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140276 · Cited by 750 · see citing works
Arterial Stiffness and Cardiovascular Risk in Hypertension
Boutouyrie, P., Chowienczyk, P., Humphrey, J. D., & Mitchell, G. F. (2021) · Circulation Research · doi:10.1161/circresaha.121.318061 · Cited by 779 · see citing works
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739 · see citing works
“Epidemiological studies have shown that AD and CVD share common risk factors such as hypertension during midlife, diabetes mellitus, smoking, apolipoprotein E (ApoE) ε4 isoforms, hypercholesterolemia, homocysteinemia, and, in particular, age [16,30-34].”
BackgroundConsidering sex and gender in Alzheimer disease and other dementias
Podcasy, J., & Epperson, C. N. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/cepperson · Cited by 623 · see citing works
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671 · see citing works
Overview and Findings from the Religious Orders Study
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., & Wilson, R. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322573 · Cited by 647 · see citing works
Self-citationGale, S. A., Acar, D., & Daffner, K. R. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.01.022 · Cited by 702 · see citing works
Post-stroke cognitive impairment: epidemiology, mechanisms and management.
(2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.08.05 · Cited by 680 · see citing works
Cannistraro, R. J., Badi, M. K., Eidelman, B. H., Dickson, D. W., Middlebrooks, E. H., & Meschia, J. F. (2019) · Neurology · doi:10.1212/wnl.0000000000007654 · Cited by 655 · see citing works
Stroke injury, cognitive impairment and vascular dementia
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.015 · Cited by 647 · see citing works
Self‐Care for the Prevention and Management of Cardiovascular Disease and Stroke
Riegel, B. J., Moser, D. K., Buck, H. G., Dickson, V. V., Dunbar, S. B., Lee, C. S., Lennie, T. A., Lindenfeld, J. M., Mitchell, J. E., Treat‐Jacobson, D., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006997 · Cited by 640 · see citing works
The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow
Blinder, P., Tsai, P. S., Kaufhold, J. P., Knutsen, P. M., Suhl, H., & Kleinfeld, D. (2013) · Nature Neuroscience · doi:10.1038/nn.3426 · Cited by 573 · see citing works
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611 · see citing works
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603 · see citing works
Self-citationvan der Flier, W. M., Skoog, I. G., Schneider, J. A., Pantoni, L., Mok, V., Chen, C., & Scheltens, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.3 · Cited by 600 · see citing works
Self-citationOxidative stress and vascular inflammation in aging
Assar, M. E., Angulo, J., & Rodríguez‐Mañas, L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.003 · Cited by 576 · see citing works
Emerging concepts in sporadic cerebral amyloid angiopathy
Charidimou, A., Boulouis, G., Gurol, M. E., Ayata, C., Bacskai, B. J., Frosch, M. P., Viswanathan, A., & Greenberg, S. M. (2017) · Brain · doi:10.1093/brain/awx047 · Cited by 555 · see citing works
Self-citationSuper-resolution Ultrasound Imaging
Christensen-Jeffries, K. M., Couture, O., Dayton, P. A., Eldar, Y. C., Hynynen, K., Kiessling, F. M., O’Reilly, M. A., Pinton, G., Schmitz, G., Tang, M., et al. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2019.11.013 · Cited by 564 · see citing works
Hypertension-induced cognitive impairment: From pathophysiology to public health
Ungvari, Z., Toth, P., Tarantini, S., Prodan, C. I., Sorond, F., Merkely, B., & Csiszar, A. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00430-6 · Cited by 544 · see citing works
Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24647 · Cited by 542 · see citing works
Toth, P., Tarantini, S., Csiszar, A., & Ungvari, Z. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00581.2016 · Cited by 522 · see citing works
El Husseini, N., Katzan, I. L., Rost, N. S., Blake, M. L., Byun, E., Pendlebury, S. T., Aparicio, H. J., Marquine, M. J., Gottesman, R. F., Smith, E. E., et al. (2023) · Stroke · doi:10.1161/str.0000000000000430 · Cited by 539 · see citing works
Depression and postoperative complications: an overview
Ghoneim, M. M., & O’Hara, M. W. (2016) · BMC Surgery · doi:10.1186/s12893-016-0120-y · Cited by 491 · see citing works
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
Vogt, N. M., Romano, K. A., Darst, B. F., Engelman, C. D., Johnson, S. C., Carlsson, C. M., Asthana, S., Blennow, K., Zetterberg, H., Bendlin, B. B., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0451-2 · Cited by 471 · see citing works
The neuropathology and cerebrovascular mechanisms of dementia
Raz, L., Knoefel, J. E., & Bhaskar, K. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.164 · Cited by 470 · see citing works
Mild Cognitive Impairment in Clinical Practice: A Review Article
Jongsiriyanyong, S., & Limpawattana, P. (2018) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317518791401 · Cited by 474 · see citing works
Reynolds, C. F., Jeste, D. V., Sachdev, P. S., & Blazer, D. G. (2022) · World Psychiatry · doi:10.1002/wps.20996 · Cited by 465 · see citing works
Kalaria, R. N. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1571-z · Cited by 441 · see citing works
Skrobot, O. A., Black, S. E., Chen, C., DeCarli, C., Erkinjuntti, T., Ford, G. A., Kalaria, R. N., O'Brien, J., Pantoni, L., Pasquier, F., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.007 · Cited by 431 · see citing works
Self-citationSantos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431 · see citing works
White matter hyperintensities and imaging patterns of brain ageing in the general population
Habes, M., Erus, G., Toledo, J. B., Zhang, T., Bryan, R. N., Launer, L. J., Rosseel, Y., Janowitz, D., Doshi, J. J., der Auwera, S. V., et al. (2016) · Brain · doi:10.1093/brain/aww008 · Cited by 425 · see citing works
Self-citationPower, M. C., Adar, S. D., Yanosky, J. D., & Weuve, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.004 · Cited by 422 · see citing works
Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions
Nasrallah, I. M., Pajewski, N. M., Auchus, A. P., Chelune, G. J., Cheung, A. K., Cleveland, M. L., Coker, L. H., Crowe, M. G., Cushman, W. C., Cutler, J. A., et al. (2019) · JAMA · doi:10.1001/jama.2019.10551 · Cited by 427 · see citing works
Self-citationObesity and cognitive decline: role of inflammation and vascular changes
Nguyen, J. C. D., Killcross, S., & Jenkins, T. A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00375 · Cited by 429 · see citing works
Gorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411 · see citing works
Self-citationA clinicopathological approach to the diagnosis of dementia
Elahi, F. M., & Miller, B. L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.96 · Cited by 407 · see citing works
Tarantini, S., Tran, C. H. T., Gordon, G. R., Ungvari, Z., & Csiszar, A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.004 · Cited by 411 · see citing works
“Recently, to recognize the contribution of cerebromicrovascular mechanisms to age-related cognitive decline the phrase “vascular contributions to cognitive impairment and dementia (VCID)” was introduced (Corriveau et al. 2016; Gorelick et al. 2011; Snyder et al. 2015b).”
Smith, E. E., Saposnik, G., Biessels, G. J., Doubal, F. N., Fornage, M., Gorelick, P. B., Greenberg, S. M., Higashida, R. T., Kasner, S. E., & Seshadri, S. (2017) · Stroke · doi:10.1161/str.0000000000000116 · Cited by 404 · see citing works
Self-citationAssociation of Cerebral Microbleeds With Cognitive Decline and Dementia
Akoudad, S., Wolters, F. J., Viswanathan, A., de Bruijn, R. F., van der Lugt, A., Hofman, A., Koudstaal, P. J., Ikram, M. A., & Vernooij, M. W. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1017 · Cited by 403 · see citing works
A major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 401 · see citing works
Hill, M. D., Martin, R., Mikulis, D. J., Wong, J. H., Silver, F. L., terBrugge, K. G., Milot, G., Clark, W. M., Macdonald, R. L., Kelly, M., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70225-9 · Cited by 403 · see citing works
Defining the relationship between hypertension, cognitive decline, and dementia: a review
Walker, K. A., Power, M. C., & Gottesman, R. F. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0724-3 · Cited by 394 · see citing works
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
Lam, B., Masellis, M., Freedman, M., Stuss, D. T., & Black, S. E. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt155 · Cited by 386 · see citing works
Self-citationThe nutritional and health attributes of kiwifruit: a review
Richardson, D. P., Ansell, J., & Drummond, L. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1627-z · Cited by 411 · see citing works
Prevalence of Poststroke Cognitive Impairment
Douiri, A., Rudd, A. G., & Wolfe, C. D. A. (2012) · Stroke · doi:10.1161/strokeaha.112.670844 · Cited by 374 · see citing works
Hypertension: A Harbinger of Stroke and Dementia
Faraco, G., & Iadecola, C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01063 · Cited by 367 · see citing works
Self-citationMaddox, K. E. J., Elkind, M. S. V., Aparicio, H. J., Commodore-Mensah, Y. Y., de Ferranti, S. D., Dowd, W. N., Hernandez, A. F., Khavjou, O., Michos, E. D., Palaniappan, L. P., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001256 · Cited by 397 · see citing works
Pathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353 · see citing works
The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit
Shih, A. Y., Blinder, P., Tsai, P. S., Friedman, B., Stanley, G., Lyden, P. D., & Kleinfeld, D. (2013) · Nature Neuroscience · doi:10.1038/nn.3278 · Cited by 351 · see citing works
Faraco, G., Sugiyama, Y., Lane, D., Garcia-Bonilla, L., Chang, H., Santisteban, M. M., Racchumi, G., Murphy, M., Van Rooijen, N., Anrather, J., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86950 · Cited by 350 · see citing works
“However, evidence from randomized clinical trials that treatment of hypertension reduces dementia risk and that there is a class-specific effect of drugs targeting ANGII and its receptors is lacking (3).”
Self-citationRandomized clinical trial of comprehensive geriatric assessment and optimization in vascular surgery
Partridge, J. S. L., Harari, D., Martin, F. C., Peacock, J. L., Bell, R. B., mohammed, A. E., & Dhesi, J. K. (2017) · British journal of surgery · doi:10.1002/bjs.10459 · Cited by 350 · see citing works
Controversies and evolving new mechanisms in subarachnoid hemorrhage
Chen, S., Feng, H., Sherchan, P., Klebe, D. W., Zhao, G., Sun, X., Zhang, J., Tang, J., & Zhang, J. H. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.002 · Cited by 341 · see citing works
Mastroiacovo, D., Kwik-Uribe, C. L., Grassi, D., Necozione, S., Raffaele, A., Pistacchio, L., Righetti, R., Bocale, R., Lechiara, M. C., Marini, C., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092189 · Cited by 344 · see citing works
The pathology and pathophysiology of vascular dementia
Kalaria, R. N. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.030 · Cited by 344 · see citing works
B-Lymphocyte-Mediated Delayed Cognitive Impairment following Stroke
Doyle, K. P., Quach, L. N., Solé, M., Axtell, R. C., Nguyen, T. V., Soler-Llavina, G. J., Jurado, S., Han, J., Steinman, L., Longo, F. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4098-14.2015 · Cited by 338 · see citing works
Self-citationLaw, L. L. F., Barnett, F., Yau, M. K.-S., & Gray, M. A. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.02.008 · Cited by 341 · see citing works
Inoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 356 · see citing works
Tucsek, Z., Tóth, P., Sosnowska, D., Gautam, T., Mitschelen, M. C., Koller, Á., Szalai, G., Sonntag, W. E., Ungvari, Z. I., & Csiszár, A. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt177 · Cited by 324 · see citing works
The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
Koyama, A. K., O'Brien, J., Weuve, J., Blacker, D., Metti, A. L., & Yaffe, K. S. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls187 · Cited by 323 · see citing works
Coronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 344 · see citing works
Forman, D. E., Arena, R., Boxer, R., Dolansky, M. A., Eng, J. J., Fleg, J. L., Haykowsky, M., Jahangir, A., Kaminsky, L. A., Kitzman, D. W., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000483 · Cited by 319 · see citing works
Li, Q., Yang, Y., Reis, C., Tao, T., Li, W., Li, X., & Zhang, J. H. (2018) · Cell Transplantation · doi:10.1177/0963689718795148 · Cited by 327 · see citing works
Advances in the prevention of Alzheimer's disease and dementia
Solomon, A., Mangialasche, F., Richard, E., Andrieu, S., Bennett, D., Breteler, M. M. B., Fratiglioni, L., Hooshmand, B., Khachaturian, A. S., Schneider, L. S. S., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12178 · Cited by 316 · see citing works
Self-citationMaillard, P., Seshadri, S. S., Beiser, A., Himali, J. J., Au, R., Fletcher, E., Carmichael, O. T., Wolf, P. A., & DeCarli, C. S. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70241-7 · Cited by 312 · see citing works
Self-citationWeaver, N. A., Kuijf, H. J., Aben, H. P., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00060-0 · Cited by 316 · see citing works
Microvascular network alterations in the retina of patients with Alzheimer's disease
Cheung, C. Y.-L., Ong, Y., Ikram, M. K., Ong, S. Y., Li, X., Hilal, S., Catindig, J.-A. S., Venketasubramanian, N., Yap, P. L. K., Seow, D. C. C., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.06.009 · Cited by 315 · see citing works
Sleep Disturbance, Cognitive Decline, and Dementia: A Review
Wu, M. N., Rosenberg, P. B., Spira, A. P., & Wennberg, A. M. V. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1604351 · Cited by 310 · see citing works
Desideri, G., Kwik-Uribe, C., Grassi, D., Necozione, S., Ghiadoni, L., Mastroiacovo, D., Raffaele, A., Ferri, L., Bocale, R., Lechiara, M. C., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.193060 · Cited by 311 · see citing works
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M. I., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 325 · see citing works
Blood pressure from mid- to late life and risk of incident dementia
McGrath, E. R., Beiser, A. S., DeCarli, C., Plourde, K. L., Vasan, R. S., Greenberg, S. M., & Seshadri, S. (2017) · Neurology · doi:10.1212/wnl.0000000000004741 · Cited by 289 · see citing works
Self-citationBlood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
Bowman, G. L., Dayon, L., Kirkland, R. E., Wojcik, J., Peyratout, G., Severin, I. C., Henry, H., Oikonomidi, A., Migliavacca, E., Bacher, M., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2857 · Cited by 295 · see citing works
Rajeev, V., Fann, D. Y., Dinh, Q. N., Kim, H. A., Silva, T. M. D., Lai, M. K. P., Chen, C., Drummond, G. R., Sobey, C. G., & Arumugam, T. V. (2022) · Theranostics · doi:10.7150/thno.68304 · Cited by 314 · see citing works
Trajectories of Depressive Symptoms in Older Adults and Risk of Dementia
Kaup, A. R., Byers, A. L., Falvey, C., Simonsick, E. M., Satterfield, S., Ayonayon, H. N., Smagula, S. F., Rubin, S. M., & Yaffe, K. S. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0004 · Cited by 291 · see citing works
Knowledge Gaps in Cardiovascular Care of the Older Adult Population
Rich, M. W., Chyun, D. A., Skolnick, A. H., Alexander, K. P., Forman, D. E., Kitzman, D. W., Maurer, M. S., McClurken, J. B., Resnick, B. M., Shen, W. K., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.004 · Cited by 289 · see citing works
Bellou, V., Belbasis, L., Tzoulaki, I., Middleton, L. T., Ioannidis, J. P. A., & Εvangelou, Ε. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.07.152 · Cited by 287 · see citing works
Cuadrado‐Godia, E., Dwivedi, P., Sharma, S., Ois, Á., Roquer, J., Balcells, M., Laird, J. R., Turk, M., Suri, H. S., Nicolaides, A. N., et al. (2018) · Journal of Stroke · doi:10.5853/jos.2017.02922 · Cited by 291 · see citing works
- Authors
- Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., Petersen, R. C., Schneider, J. A., Tzourio, C., Arnett, D. K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R., Nilsson, P. M., Roman, G. C., Sellke, F. W., & Seshadri, S.
- Affiliations
- Alzheimer's Association (US)
- ORCID
- Gorelick, Philip B.
- Scuteri, Angelo
- Black, Sandra E.
- DeCarli, Charles
- Greenberg, Steven M.
- Iadecola, Costantino
- Launer, Lenore J.
- Nyenhuis, David
- Petersen, Ronald C.
- Schneider, Julie A.
- Tzourio, Christophe
- Arnett, Donna K.
- Bennett, David A.
- Chui, Helena C.
- Higashida, Randall T.
- Nilsson, Peter M.
- Sellke, Frank W.
- Seshadri, Sudha
- Venue
- Stroke
- Published
- 2011-09
- Volume
- 42
- Issue
- 9
- Pages
- 2672-2713
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- PMC
- PMC3778669
- OpenAlex
- W2527609605
- Semantic Scholar
- 349ef695d4a2dbdc85f5b635237c9068ec61b2ba
- Cited by
- 3,811
- References
- 538
- Citations by year
- 2026: 244 · 2025: 292 · 2024: 295 · 2023: 237 · 2022: 263 · 2021: 269 · 2020: 314 · 2019: 320 · 2018: 270 · 2017: 253 · 2016: 258 · 2015: 227 · 2014: 238 · 2013: 169 · 2012: 137
- FWCI
- 23.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- American Heart Association
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Massachusetts General Hospital
- University of Southern California
- University of Minnesota
- University of Pittsburgh
- Minneapolis Heart Institute
- Rush University
- Daiichi-Sankyo
- University of Toronto
- Eisai
- Servier
- H. Lundbeck A/S
- National Institutes of Health
- University of Illinois at Urbana-Champaign
- Weill Cornell Medical College
- University of California, Davis
- National Institute on Aging (P30AG010129, R01AG021028, R01AG020098, U19AG010483)
- National Institute of Neurological Disorders and Stroke (R01NS017950)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Keywords
- vascular cognitive impairment, dementia, mild cognitive impairment, neurovascular unit, cerebral autoregulation, cerebral amyloid angiopathy, Alzheimer's disease, white matter hyperintensities, stroke risk factors, atrial fibrillation, hypertension, diabetes mellitus, hypercholesterolemia, neuroimaging, prevention, treatment
- MeSH terms
- Alzheimer Disease, American Heart Association, Mental Disorders, Cerebral Angiography, Humans, Male, Risk Factors, United States, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review